Disfunção neuronal induzida por drogas de abuso by Oliveira, Maria Teresa Martins da Cunha
  
Maria Teresa Martins da Cunha Oliveira 
 
 
 
 
 
 
 
 
 
Neuronal dysfunction induced by drugs of abuse 
 
Disfunção neuronal induzida por drogas de abuso 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Universidade de Coimbra 
2007 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Maria Teresa Martins da Cunha Oliveira 
 
 
 
 
 
 
 
 
Neuronal dysfunction induced by drugs of abuse 
 
Disfunção neuronal induzida por drogas de abuso 
 
 
 
 
 
Dissertação apresentada à Faculdade de Ciências e Tecnologia da Universidade de Coimbra, 
para prestação de provas de Doutoramento em Biologia, na especialidade de Biologia Celular. 
 
Este trabalho foi realizado no Centro de Neurociências e Biologia Celular 
 da Universidade de Coimbra, ao abrigo de uma bolsa de Doutoramento atribuída 
 pela Fundação para a Ciência e Tecnologia (SFRH/BD/10910/2002). 
 
 
 
 
 
Universidade de Coimbra 
2007 
  
  
 
 
 
 
 
 
 
 
 
 
 
Ao meu filhote Miguel 
 
 
  
PUBLICATIONS 
 
The work presented in this thesis resulted in the following publications: 
 
(2006) TERESA CUNHA-OLIVEIRA, Ana Cristina Rego, Maria Teresa Morgadinho, 
Tice Macedo, Catarina Resende Oliveira. “Differential cytotoxic responses of PC12 
cells chronically exposed to psychostimulants or to hydrogen peroxide” Toxicology 217; 
54-62  
 
(2006) TERESA CUNHA-OLIVEIRA, Ana Cristina Rego, Maria Teresa Morgadinho, 
Tice Macedo, Catarina R. Oliveira “Efeito crónico da heroína e do peróxido de 
hidrogénio em células PC12” (Chronic effect of heroin and hydrogen peroxide in PC12 
cells) Coimbra Médica - V série 2; 21-29 
 
(2006) António Domingues* and TERESA CUNHA-OLIVEIRA*, Mário N. Laço, Tice 
Macedo, Catarina Resende Oliveira and Ana Cristina Rego “Expression of NR1/NR2B 
N-methyl-D-aspartate receptors enhance heroin toxicity in HEK293 cells” Ann N Y 
Acad Sci 1074; 458-465  
(*these authors contributed equally to the work) 
 
(2007) TERESA CUNHA-OLIVEIRA, A. Cristina Rego, Jorge Garrido, Fernanda 
Borges, Tice Macedo, Catarina Resende Oliveira. “Street heroin induces mitochondrial 
dysfunction and apoptosis in rat cortical neurons”. J Neurochem 101; 593-604 
 
  
AGRADECIMENTOS 
 
Este trabalho não teria sido possível sem a contribuição de várias pessoas, às 
quais não posso deixar de expressar o meu mais sincero agradecimento: 
 
Às minhas mestres 
 
À professora Catarina Oliveira, minha orientadora, por me ter aceite no seu 
laboratório, pelos seus ensinamentos e por sempre me ter apoiado e encorajado. 
 
 À professora Ana Cristina Rego, minha co-orientadora, pela sua presença e 
pelo acompanhamento científico durante toda a realização do trabalho. 
 
À professora Tice Macedo por todo o seu apoio, pela disponibilidade com que 
sempre atendeu todas as minhas solicitações e pela confiança que sempre depositou 
em mim. 
 
Aos meus amigos  
 
Ao Jorge Pereira, ao Jorge Oliveira, e às minhas amigonas Ana Duarte, Rosa 
Resende e Sílvia Neves, que sempre me deram apoio no trabalho e para além dele. 
 
À Inês Araújo e à Joana Gil pela vossa amizade e companheirismo 
 
À minha família 
 
Ao Miguelito e ao Feliciano por estarem comigo em todos os momentos 
 
e à minha mãe, que sempre me ajudou e apoiou 
 
 
            Quero também agradecer à Fundação para a Ciência e a Tecnologia a Bolsa 
de Doutoramento que me atribuiu, sem a qual este trabalho não teria sido possível.
 
  
 
ÍNDICE 
    ABBREVIATIONS ....................................................................... I 
      RESUMO....................................................................................V 
      ABSTRACT............................................................................... IX 
      OUTLINE.................................................................................XIII 
1 PART I - INTRODUCTION ......................................................... 1 
1.1 Historical and geographical perspective of drug abuse ............................... 3 
1.1.1 Present situation ......................................................................................... 5 
1.2 Polydrug use ..................................................................................................... 6 
1.3 Adulterants and contaminants ........................................................................ 7 
1.4 Drug addiction................................................................................................. 10 
1.4.1 Characteristics of psychoactive drugs....................................................... 11 
1.5 Brain circuits affected by the drugs of abuse.............................................. 13 
1.5.1 The reward pathway.................................................................................. 14 
1.5.2 Molecular mechanisms involved in the effects of the drugs of abuse in the 
brain…………………………………………………………………………………………15 
1.5.2.1 Neurotransmitter systems affected in drug addiction ............................ 20 
1.5.2.1.1 Monoamine neurotransmitters .................................................................... 20 
1.5.2.1.1.1 Dopaminergic pathways...................................................................................... 21 
1.5.2.1.2 Opioid neuropeptides.................................................................................. 23 
 1.5.2.2 Short-term (acute) effects ..................................................................... 24 
1.5.2.2.1 Psychostimulants and reward ..................................................................... 24 
1.5.2.2.2 Opiates and reward..................................................................................... 26 
1.5.2.3 Long-term homeostatic adaptations...................................................... 30 
1.5.2.4 Learning and memory ........................................................................... 34 
1.5.2.5 Stress and drug addiction ..................................................................... 35 
1.6 Drugs of abuse and neurotoxicity................................................................. 37 
1.6.1 Glutamate mediated effects of opiate drugs ............................................. 38 
1.6.2 Mitochondria in cell life and death............................................................. 41 
1.6.2.1 Drug-addiction and oxidative stress ...................................................... 43 
1.6.2.1.1 Detoxification of H2O2 ................................................................................. 44 
1.6.2.1.2 Amphetamines and oxidative stress ........................................................... 46 
1.6.2.1.3 Cocaine and oxidative stress ...................................................................... 47 
1.6.2.1.4 Opiates and oxidative stress....................................................................... 48 
1.6.2.2 Mitochondria in cell death ..................................................................... 49 
1.6.2.2.1 Regulation of mitochondrial membrane permeabilization ........................... 50 
1.6.2.2.1.1 Bax/Bak mediated OMM permeabilization.......................................................... 51 
1.6.2.2.1.2 IMM permeabilization – the permeability transition pore .................................... 52 
1.6.2.2.1.3 Reorganization of cristae .................................................................................... 53 
1.6.2.3 Drugs of abuse and apoptosis in the Central Nervous System............. 54 
1.6.2.4 Drugs of abuse and neurogenesis ........................................................ 56 
1.7 Pharmacotherapies for drug addiction......................................................... 57 
OBJECTIVES................................................................................. 61 
2 PART II - MATERIAL AND METHODS ................................... 63 
2.1 Materials .......................................................................................................... 65 
2.2 Methods ........................................................................................................... 66 
2.2.1 Cell culture ................................................................................................ 66 
  
2.2.1.1 Culture and incubation of PC12 cells .................................................... 66 
2.2.1.2 Culture and transfection of HEK293 cells ............................................. 67 
2.2.1.3 Culture of cortical neurons .................................................................... 67 
2.2.1.4 Culture of NT-2 cells ............................................................................. 68 
2.2.2 Assessment of cell viability ....................................................................... 69 
2.2.2.1 MTT assay ............................................................................................ 69 
2.2.2.2 LDH assay............................................................................................. 69 
2.2.3 Measurement of dopamine and DOPAC levels ........................................ 69 
2.2.4 Morphological analysis of PC12 cells........................................................ 70 
2.2.5 Measurement of intracellular ATP levels................................................... 70 
2.2.6 Evaluation of the activity of antioxidant enzymes...................................... 70 
2.2.6.1 Glutathione peroxidase (GPx) activity assay ........................................ 71 
2.2.6.2 Glutathione reductase (GRed) activity assay........................................ 71 
2.2.6.3 Superoxide dismutase (SOD) activity assay ......................................... 72 
2.2.7 Chemical analysis ..................................................................................... 72 
2.2.8 Immunocytofluorescence .......................................................................... 73 
2.2.8.1 Cytochrome c ........................................................................................ 73 
2.2.8.2 Cleaved PARP ...................................................................................... 73 
2.2.9 Fluorimetric evaluation of rhodamine-123 cellular retention ..................... 74 
2.2.10 Colorimetric evaluation of caspases-like activity....................................... 74 
2.2.11 Western blotting ........................................................................................ 75 
2.2.11.1 Sample preparation........................................................................... 75 
2.2.11.2 Immunoblotting procedures............................................................... 75 
2.2.12 Statistical analysis..................................................................................... 76 
3 PART III: RESULTS AND DISCUSSION................................. 77 
3.1 CHAPTER 1: Neuroadaptation induced by psychostimulants ................... 79 
3.1.1 MANUSCRIPT 1- Differential cytotoxic responses of PC12 cells chronically 
exposed to psychostimulants or to hydrogen peroxide............................................. 81 
3.1.1.1 Abstract ................................................................................................. 83 
 3.1.1.2 Introduction ........................................................................................... 84 
3.1.1.3 Results .................................................................................................. 87 
3.1.1.3.1 Chronic cocaine treatment sensitizes PC12 cells to acute cocaine ............ 87 
3.1.1.3.2 Cells chronically exposed to cocaine are partially resistant to H2O2 ........... 91 
3.1.1.3.3 Chronic exposure to cocaine or amphetamine induces changes in the 
activity of antioxidant enzymes...................................................................................... 93 
3.1.1.4 Discussion............................................................................................. 96 
3.1.1.4.1 Cocaine sensitization and dopamine toxicity .............................................. 96 
3.1.1.4.2 Amphetamine-induced dopamine depletion and amphetamine toxicity ...... 97 
3.1.1.4.3 Cocaine and amphetamine-induced partial resistance to H2O2 .................. 97 
3.1.1.4.3.1 Involvement of antioxidant enzymes................................................................... 98 
3.1.1.4.3.2 Involvement of intracellular signalling pathways and energy metabolism ........ 101 
3.2 CHAPTER 2: Neuroadaptation and neurotoxicity induced by street heroin
 ………………………………………………………………………………………..103 
3.2.1 MANUSCRIPT 2: Chronic effects of heroin and hydrogen peroxide in PC12 
cells ………………………………………………………………………………….105 
3.2.1.1 Abstract ............................................................................................... 107 
3.2.1.2 Introduction ......................................................................................... 108 
3.2.1.3 Results ................................................................................................ 109 
3.2.1.3.1 Street heroin induced changes in energy metabolism .............................. 110 
3.2.1.3.2 Role of dopamine in heroin sensitization .................................................. 111 
3.2.1.4 Discussion........................................................................................... 113 
3.2.2 MANUSCRIPT 3: Expression of NR1/NR2B N-methyl-D-aspartate 
receptors enhance heroin toxicity in HEK293 cells................................................. 117 
3.2.2.1 Abstract ............................................................................................... 119 
3.2.2.2 Introduction ......................................................................................... 120 
3.2.2.3 Results and Discussion....................................................................... 122 
3.2.3 MANUSCRIPT 4: Street heroin induces mitochondrial dysfunction and 
apoptosis in rat cortical neurons ............................................................................. 127 
3.2.3.1 Abstract ............................................................................................... 129 
3.2.3.2 Introduction ......................................................................................... 130 
  
3.2.3.3 Results ................................................................................................ 132 
3.2.3.3.1 Street heroin dose-dependently affects cell viability ................................. 132 
3.2.3.3.2 Caspases of the mitochondrial apoptotic pathway are preferentially activated 
by street heroin ........................................................................................................... 134 
3.2.3.3.3 DNA fragmentation induced by street heroin is completely dependent on 
caspase activity........................................................................................................... 136 
3.2.3.3.4 Caspase activation is not mediated by opioid or ionotropic glutamate 
receptors and appears to be independent of oxidative stress..................................... 138 
3.2.3.3.5 Street heroin induces cytochrome c release and mitochondrial dysfunction
 ……………………………………………………………………………………140 
3.2.3.4 Discussion........................................................................................... 144 
4 PART IV - CONCLUSIONS.................................................... 149 
      REFERENCES ....................................................................... 155 
 
  
 i
ABBREVIATIONS 
8OHdG 8-hydroxy-2-deoxyguanosine 
ΔΨm Mitochondrial membrane potential 
A1 Bcl-2-Related Protein A1 
Ac-DEVD-pNA N-Acetyl-Asp-Glu-Val-Asp p-nitroanilide 
Ac-IEPD-pNA N-Acetyl-Ile-Glu-Pro-Asp p-nitroanilide 
Ac-LEHD-pNA N-Acetyl-Leu-Glu-His-Asp p-nitroanilide 
Ac-VDVAD-pNA N-Acetyl-Val-Asp-Val-Ala-Asp p-nitroanilide 
Ac-VEID-pNA N-Acetyl-Val-Glu-Ile-Asp p-nitroanilide 
ACTH Adrenocorticotropic hormone 
ADHD Attention-Deficit Hyperactivity Disorder 
ADP Adenosine Diphosphate 
AIF Apoptosis Inducing Factor 
APAF-1 Apoptotic Protease Activating Factor 
AMP Adenosine Monophosphate 
ANT Adenine Nucleotide Translocator 
ATCC American Type Culture Collection 
ATP Adenosine Triphosphate 
Bad Bcl-2-antagonist of cell death 
Bak Bcl-2 antagonist killer 
Bax Bcl-2-associated X protein 
Bcl-2 B-cell leukemia/lymphoma 2 
Bcl w Bcl-2-Like 2 Protein 
Bcl-XL Bcl-2-Like 1 Protein large 
BDNF Brain Derived Neurotrophic Factor 
BH Bcl-2 homology 
Bid BH3 interacting domain death agonist 
Bim Bcl-2-interacting mediator of cell death 
Bik Bcl-2-interacting killer 
Boo Bcl-2-like 10 protein 
Bok Bcl-2-related ovarian killer 
BSA Bovine Seric Albumin 
cAMP Cyclic Adenosine Monophosphate 
CD95 Cluster of Differentiation 95 
CG Cingulate Gyrus 
CNS Central Nervous System 
COMT Catechol-O-Methyl Transferase 
CREB cAMP response element binding 
CRF Corticotropin-releasing factor 
CTOP D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 
CypD Cyclophylin D 
dAP5 D-2-amino-5-phosphonopentanoate 
DAT Dopamine Transporter 
dATP Deoxy-ATP 
DFF/CAD DNA fragmentation factor/caspase-associated DNAse 
DG Dentate Gyrus 
 ii 
DHBA Di-hydroxy-benzylamine 
DMSO Dimethyl sulfoxide 
DOPAC 3,4-dihydroxyphenylacetic acid 
ECF Enhanced Chemofluorescence 
EndoG Endonuclease G 
ER Endoplasmic Reticulum 
FAD Flavin Adenine Dinucleotide 
FMN Flavin Mononucleotide 
fMRI Functional Magnetic Ressonance Imaging 
GABA Gamma aminobutyric acid 
GAPDH Glyceraldehyde-3-Phosphate Dehydrogenase 
GFAP Glial fibrillary acidic protein 
GFP Green fluorescent protein 
GPx Glutathione peroxidase 
GRK G-protein receptor kinases 
GRed Glutathione reductase 
GSH Reduced glutathione 
GSSG Oxidized glutathione 
GST Glutathione-S-Transferase 
H2O2 Hydrogen peroxide 
HEK Human Embryonic Kidney 
HNE Hydroxy-nonenal 
HPA Hypothalamic-pituitary-adrenal axis 
HPLC High Performance Liquid Chromatography 
ICS Intracristal space 
IDT Instituto da Droga e da Toxicodependência 
IMM Inner mitochondrial membrane 
IMS Intermembrane space 
LAAM Levo-alpha-acetylmethadol 
LDH Lactate dehydrogenase 
L-DOPA L-3,4-dihydroxyphenylalanine 
LSD Lysergic acid 
6-MAM 6-Monoacetylmorphine 
MAO Monoamine Oxidase 
MAP-2 Microtubule Associated Protein 2 
MAPK Mitogen-Activated Protein Kinase 
Mcl1 Myeloid Cell Leukemia-1 
MDA Malondialdehyde 
MDMA Methylenedioxymethamphetamine 
Meth Methamphetamine 
MK-801 Dizocilpine maleate 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide 
NAc Nucleus Accumbens 
NADH Nicotinamide Adenine Dinucleotide 
NBQX 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione 
NBT Nitroblue-Tetrazolium 
NET Norepinephrine Transporter 
NMDA N-methyl-D-aspartate 
Noxa From the latin word for damage (noxa) 
NR NMDA receptor 
NT2 Neuroteratocarcinoma cells 
  
 iii
OFC Orbitofrontal Cortex 
.OH Hydroxyl radical 
Omi/HtrA2 Omi protease/High temperature requirement protease A2 
OMM Outer mitochondrial membrane 
Opa-1 Optic Atrophy 1 
PARL Presenilin-associated rhomboid like 
PARP Poly (ADP-ribose) polymerase 
PBR Peripheral Benzodiazepine Receptor 
PBS Phosphate Buffered Saline 
PC12 Pheochromocytoma 12 
PET Positron Emission Tomography 
Pi Inorganic Phosphate 
PKA Protein kinase A 
PKC Protein kinase C 
POMC Proopiomelanocortin 
PTP Permeability Transition Pore 
PUMA P53 Upregulated Modulator of Apoptosis 
PVDF Poly(vinylidene fluoride) 
ROS Reactive Oxygen Species 
RPMI Roswell Park Memorial Institute medium 
SBTI Soybean Trypsin Inhibitor 
SDS Sodium Dodecyl Sulfate 
SDS-PAGE SDS-Polyacrilamide Gel Electrophoresis 
SERT Serotonin Transporter 
SGZ Subgranular Zone 
Smac/DIABLO Second Mitochondria-Derived Activator of Caspases/ 
Direct IAP-Binding Protein with Low pI 
SOD Superoxide Dismutase 
SVZ Subventricular Zone 
SY5Y Human bone marrow neuroblastoma cells 
TBARS Thio-Barbituric Acid Reactive Substances 
TH Tyrosine Hydroxylase 
TNF Tumor Necrosis Factor 
TRAIL TNF-related apoptosis inducing ligand 
TUNEL Terminal dUTP nick-end labeling 
VDAC Voltage Dependent Anion Channel 
Vit E Vitamin E 
VMAT Vesicular Monoamine Transporter 
VTA Ventral Tegmental Area 
z-VAD-fmk Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone 
 
Resumo 
 
 v
RESUMO 
O abuso de substâncias e a toxicodependência estão entre as mais 
dispendiosas desordens neuropsiquiátricas. O abuso repetido de drogas está 
associado a alterações da actividade neuronal. Neste trabalho estudámos a disfunção 
neuronal induzida pelas drogas de abuso cocaína, anfetamina e heroína de rua, 
usando modelos in vitro. O trabalho experimental foi dividido em dois capítulos. No 
primeiro capítulo estudámos os efeitos crónicos das drogas de abuso estimulantes, 
cocaína e da anfetamina e no segundo capítulo estudámos os efeitos crónicos e 
agudos da heroína de rua. 
No primeiro capítulo, os efeitos da cocaína e da anfetamina foram avaliados em 
células PC12, uma linha celular catecolaminérgica, uma vez que os principais alvos 
dos estimulantes são os sistemas monoaminérgicos. A dopamina, em particular, está 
associada aos efeitos de recompensa induzidos por todas as drogas de abuso, e é um 
possível mediador dos efeitos neurotóxicos das drogas de abuso devido ao seu 
metabolismo oxidativo, que leva à produção de H2O2. Observámos que o tratamento 
crónico com cocaína (7-12 meses) sensibilizou as células PC12 para a toxicidade 
aguda da cocaína, o que poderá estar relacionado com o aumento da acumulação 
extracelular de dopamina induzido por um estímulo agudo com cocaína. A exposição 
crónica à anfetamina induziu deplecção da dopamina, embora a toxicidade aguda da 
anfetamina se tivesse mantido nestas células, sugerindo que a dopamina não é 
necessária para a citotoxicidade aguda da anfetamina. Contudo, as células PC12 
tratadas cronicamente com H2O2 apresentaram-se totalmente resistentes à 
citotoxicidade aguda do H2O2, mas não à citotoxicidade aguda da cocaína ou da 
anfetamina, sugerindo que a toxicidade aguda destas drogas é independente da 
adaptação ao stresse oxidativo. Em contraste, as células cronicamente expostas à 
cocaína ou à anfetamina apresentaram-se parcialmente resistentes ao H2O2, 
sugerindo que a exposição crónica a estas drogas envolve adaptação ao stresse 
oxidativo. Assim, estudámos a actividade de enzimas antioxidantes nas etapas iniciais 
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da exposição crónica à cocaína, anfetamina ou H2O2. A cocaína e a anfetamina 
afectaram de um modo diferente a actividade das enzimas antioxidantes. A cocaína 
induziu um aumento da actividade da glutationa peroxidase (GPx) após 4 semanas de 
exposição. A anfetamina apresentou um efeito difásico, com um aumento inicial da 
actividade da GPx e uma diminuição das actividades da glutationa redutase (GRed) e 
da superóxido dismutase (SOD), após 3 semanas de exposição. Após 4 semanas de 
exposição à anfetamina a actividade das enzimas antioxidantes regressou a valores 
semelhantes ao controlo. A exposição crónica ao H2O2 induziu um aumento gradual da 
actividade da GPx e uma diminuição da actividade da SOD. A actividade da GRed 
aumentou após 1 semana de exposição ao H2O2, regressando a valores semelhantes 
ao controlo após 2 semanas de exposição ao H2O2. Estes resultados indicam que as 
primeiras etapas de adaptação à cocaína e à anfetamina envolvem alterações da 
actividade das enzimas antioxidantes, sugerindo uma adaptação ao stresse oxidativo, 
após exposição crónica a estas drogas de abuso. 
 
No segundo capítulo, estudámos os efeitos neurotóxicos da heroína de rua. Os 
efeitos crónicos da heroína de rua foram avaliados em células PC12. Apesar de os 
opiáceos não interagirem directamente com os sistemas monoaminérgicos, foi 
anteriormente demonstrado que as células PC12 apresentam um decréscimo dos 
níveis intracelulares de dopamina e um aumento dos níveis intracelulares de ácido 
dihidroxifenilacético (DOPAC), quando expostas agudamente à heroína de rua. A 
exposição crónica à heroína de rua sensibilizou as células PC12 para a toxicidade 
aguda desta droga de abuso, o que pode estar relacionado com um aumento da 
acumulação extracelular de dopamina induzido pela exposição aguda à heroína de rua 
nestas células. As células cronicamente expostas à heroína de rua apresentaram um 
aumento da resistência à toxicidade aguda do H2O2, que se relacionou com a 
manutenção dos níveis de ATP nestas condições. Contudo, as células cronicamente 
expostas à heroína de rua apresentaram níveis intracelulares de ATP e ADP mais 
baixos, o que pode explicar o maior grau de sensibilização destas células a uma 
exposição aguda à heroína de rua, quando comparadas com as células cronicamente 
expostas ao H2O2. 
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A neurotransmissão glutamatérgica envolvendo o receptor N-metil-D-aspartato 
(NMDA) contribui para a dependência de opiáceos em humanos. Por outro lado, a 
sobre-activação dos receptores ionotrópicos do glutamato é um dos mecanismos 
envolvidos na neurotoxicidade e na morte celular. De modo a avaliar a importância do 
receptor NMDA na citotoxicidade aguda da heroína de rua, utilizaram-se células 
HEK293 transfectadas com diferentes subunidades do receptor NMDA e neurónios 
corticais. As células HEK293 foram transfectadas com as subunidades NR1-GFP 
como controlo, ou NR1/NR2A ou NR1/NR2B. A heroína de rua induziu perda da 
integridade membranar em células transfectadas com as subunidades NR1/NR2B, e 
este efeito foi bloqueado pelo maleato de dizocilpina (MK-801), um antagonista dos 
receptores NMDA, indicando que os receptores NMDA compostos pelas subunidades 
NR1/NR2B estão envolvidos na neurotoxicidade da heroína de rua. 
A disfunção do córtex pré-frontal é uma característica importante da 
toxicodependência, contribuindo para a perda do controlo da impulsividade observada 
em toxicodependentes. Neste trabalho, determinou-se a composição química da 
amostra de heroína de rua e estudaram-se as vias apoptóticas envolvidas na 
neurotoxicidade desta droga de abuso, usada numa concentração que induziu um 
decréscimo moderado da viabilidade celular. A composição da heroína de rua 
apresentou 62% de heroína, 12% de 6-monoacetilmorfina e 1% de morfina. Quando 
usada numa concentração que induziu 10% de perda de viabilidade celular sem perda 
de integridade membranar, a heroína de rua induziu a activação de caspases da via 
apoptótica mitocondrial. Foi também observada fragmentação do ADN, que foi 
prevenida pelo inibidor não-selectivo de caspases z-VAD-fmk. A activação da 
caspase-3 não foi prevenida por antagonistas dos receptores opióides, antagonistas 
dos receptores ionotrópicos do glutamato nem por antioxidantes. A activação das 
caspases pareceu ter sido mediada pela disfunção mitocondrial envolvendo a 
libertação do citocromo c, a perda de potencial da mitocôndria e um decréscimo da 
razão Bcl-2/Bax. A heroína pura, na mesma concentração presente na heroína de rua, 
induziu apenas um pequeno aumento da activação da caspase-3, sugerindo que a 
activação da caspase-3 é potenciada pela presença da mistura de compostos 
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presentes na heroína de rua. Este resultado indica também que o abuso de heroína 
impura representa um risco neurotóxico superior. 
Estes resultados demonstram que as drogas de abuso induzem 
neurotoxicidade através de vários mecanismos celulares, culminando em stresse 
oxidativo e disfunção mitocondrial, que poderão representar importantes alvos para 
futuras estratégias terapêuticas. 
 
 
 
Abstract 
 
 ix
ABSTRACT 
Substance abuse and addiction are the most costly of all the neuropsychiatric 
disorders. The repeated abuse of drugs is associated with changes in neuronal activity. 
In this work, we studied the neuronal dysfunction induced by the drugs of abuse 
cocaine, amphetamine and street heroin, using in vitro models. The experimental work 
was divided into two chapters. In the first chapter we studied the chronic effects of the 
psychostimulant drugs cocaine and amphetamine, and in the second chapter we 
studied the chronic and acute effects of street heroin. 
In first chapter, chronic effects of cocaine and amphetamine were evaluated in 
PC12 cells, a catecholaminergic cell line, since the main targets of the stimulants are 
the monoaminergic systems. Dopamine, in particular, is associated with the rewarding 
effects of all the drugs of abuse, and is a candidate mediator of the neurotoxic effects 
of the drugs due to its oxidative metabolism, which produces hydrogen peroxide 
(H2O2). We observed that chronic cocaine treatment (7-12 months) sensitizes PC12 
cells to the acute toxicity of cocaine, which may be related to increased cocaine-
evoked extracellular dopamine accumulation in these cells. Chronic exposure to 
amphetamine induced dopamine depletion, but amphetamine maintained its acute 
toxicity in these cells, suggesting that dopamine is not required for acute amphetamine 
cytotoxicity. However, PC12 cells chronically treated with H2O2 were totally resistant to 
acute H2O2, but not to acute cocaine or amphetamine exposure, implicating that the 
acute toxicity induced by these stimulant drugs is unrelated to adaptation to oxidative 
stress. In contrast, cells chronically exposed to cocaine or amphetamine were partially 
resistant to H2O2, suggesting that chronic exposure to these drugs involves adaptation 
to oxidative stress. Therefore, we studied the activity of antioxidant enzymes in the 
early stages of exposure to cocaine, amphetamine and H2O2. Cocaine and 
amphetamine differentially affected the activity of the antioxidant enzymes. Cocaine 
induced an increase in the activity of glutathione peroxidase (GPx) at 4 weeks of 
exposure. Amphetamine seemed to have a biphasic effect, with an initial increase in 
GPx activity and a decrease in glutathione reductase (GRed) and superoxide 
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dismutase (SOD) activities (upon 3 weeks of exposure). One week later the activities 
returned to control levels. Chronic exposure to H2O2 induced a gradual increase in GPx 
activity and a decrease in SOD activity. GRed activity was increased upon 1 week 
exposure to H2O2, and returned to control levels after 2 weeks of H2O2 exposure. 
These data show that changes in the activity of antioxidant enzymes are involved in the 
chronic effects of cocaine and amphetamine, suggesting that oxidative stress is 
involved in the chronic effects of these drugs of abuse.  
In the second chapter we studied the neurotoxic effects of street heroin. Chronic 
effects of street heroin were also evaluated in PC12 cells. Although opiates do not 
directly interact with monoaminergic systems, PC12 cells were previously shown to 
have decreased intracellular dopamine levels and increased intracellular 
dihydroxyphenylacetic acid (DOPAC) levels, when acutely exposed to street heroin. 
Chronic exposure to street heroin or H2O2 sensitized PC12 cells to acute street heroin 
cytotoxicity, which may be related to increased extracellular dopamine accumulation 
induced by acute street heroin in these cells. Cells chronically exposed to street heroin 
presented increased resistance to acute H2O2 toxicity, which was correlated with the 
maintenance of ATP levels in these conditions. However, cells chronically exposed to 
street heroin presented lower intracellular levels of ATP and ADP, which may explain 
the higher degree of sensitization of these cells to acute street heroin exposure, when 
compared to cells chronically exposed to H2O2. 
Glutamatergic neurotransmission involving the N-methyl-D-aspartate (NMDA) 
receptor has been suggested to contribute to opiate dependence in humans. Moreover, 
hyperactivation of ionotropic glutamate receptors is one of the mechanisms involved in 
neurotoxicity and cell death. Taking this into account, we analysed the contribution of 
NMDA receptor subunits to acute neurotoxicity of street heroin n HEK293 cells, 
transfected with different subunits of the NMDA receptor, and in cortical neurons. 
HEK293 cells were transfected with NR1-GFP, as a control, or with NR1/NR2A or 
NR1/NR2B subunits. Street heroin induced loss of membrane integrity in NR1/NR2B 
transfected cells, and this effect was blocked by the NMDA receptor antagonist 
dizocilpine maleate (MK-801), indicating that NR1/NR2B composed receptors are 
involved in street heroin neurotoxicity. 
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Prefrontal cortex dysfunction is an important event in drug addiction, 
contributing to the loss of impulse control observed in drug addicts. The chemical 
composition of the street heroin sample was determined and the apoptotic mechanisms 
involved in the neurotoxicity of a concentration of street heroin that induced a moderate 
decrease in cell viability were studied. Street heroin was composed by 62% heroin, 
12% 6-monoacetylmorphine (6-MAM) and 1% morphine. In a concentration that 
induced 10% loss in cell viability without causing loss of membrane integrity, street 
heroin was shown to activate caspases through the mitochondrial apoptotic pathway. 
DNA fragmentation was also observed, and was prevented by the non-selective 
caspase inhibitor z-VAD-fmk. Caspase-3 activation was not prevented by μ-opioid 
receptor antagonists, ionotropic glutamate receptor antagonists or by antioxidants. The 
activation of caspases seemed to be mediated by mitochondrial dysfunction involving 
cytochrome c release, loss of mitochondrial potential and a decrease in Bcl-2/Bax ratio. 
Pure heroin, in the same concentration found in street heroin, only induced a small 
increase in caspase-3 activation, suggesting that caspase-3 activation is enhanced by 
the presence of the cocktail of compounds found in the street heroin sample. This also 
indicates that the use of impure heroin represents an increased neurotoxic risk. 
These results show that the drugs of abuse cause neurotoxicity by several 
intracellular pathways, culminating in oxidative stress and mitochondrial dysfunction, 
which may represent important targets for future therapeutic strategies for drug 
addiction. 
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OUTLINE 
 
This thesis is divided into the following sections: 
 
• Part I – Introduction 
 
This section reviews the most relevant literature related with neuronal 
dysfunction in drug addiction. It also provides the rationale for the objectives of this 
thesis. 
 
 
• Part II – Material and Methods 
 
This section contains the descriprion of the materials and methods used to 
perform the studies presented in Part III 
 
 
• Part III – Results and Discussion 
 
This section includes the experimental data and the discussion of the results. 
 
 
 
• Part IV - Conclusions 
 
This section contains the general conclusions of the work presented in Part III. 
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1.1 Historical and geographical 
perspective of drug abuse 
 
Drugs with psychoactive properties have been used by humans for centuries. 
The use of plants containing hallucinogenic substances is thought to have played an 
important role in the development of philosophy and religious thought in early human 
cultures (Nichols, 2004). Plant derivatives have also been used medicinally in various 
cultures, as is the case of opium, which has been used for centuries to treat pain and 
other symptoms (von Zastrow and Evans, 2006). 
 
Cocaine was first isolated in 1855 by the german chemist Friedrich Gaedcke. 
This alkaloid is extracted from the plant Erythroxylum coca, which is cultivated in the 
South American countries Bolivia, Colombia and Peru. The natives of these countries 
chew the coca leaves in magical cerimonies and initiation rites. Cocaine was present in 
coca-cola, which was invented in 1886 and was removed from its formula in 1903.  
Cocaine may be processed in water soluble or insoluble forms. Water soluble 
forms include cocaine sulphate and cocaine hydrochloride. These forms are active by 
oral, intranasal and intravenous administrations. In contrast, water insoluble forms such 
as free base cocaine or crack are mainly active through smoking, a route of 
administration that enables immediate absorption into the blood and a rapid, short, but 
very intense euphoric effect. 
According to the United Nations Office on Drugs and Crime (2006), cocaine is 
mainly processed in its countries of origin, from where it is illegally transported to the 
rest of the world. 
 
Amphetamine was first synthesized in 1887 by Lazar Edeleano at the 
University of Berlin. This drug is a synthetic derivative of the plant alkaloid ephedrine, 
extracted from plants in the genus Ephedra. Ephedra sinica, also known as Ma Huang, 
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has been used in traditional Chinese medicine for 5000 years to treat several diseases, 
such as asthma and common cold. 
Amphetamines are still used medicinally to treat narcolepsy and attention-deficit 
hyperactivity disorder (ADHD). Amphetamine production occurs mainly in North 
America, East and South-East Asia and in Europe. 
 
Opium is extracted from the opium poppy (Papaver somniferum). Historically 
there are reports of cultivation of this plant in the Mesopotamia since 3400 BC (see: 
http://www.pbs.org/wgbh/pages/frontline/shows/heroin/etc/history.html). 
Nowadays, the opium poppy is mainly cultivated in Asia, and the countries 
responsible for the majority of opium production are Afghanistan, Union of Myanmar 
and Lao People’s Democratic Republic. More recently, since 1980, the opium poppy is 
also cultivated in the South American countries Colombia, Mexico and Peru. In 2004 
most of the laboratories of opium processing were dismantled in Russia, Moldova and 
Afghanistan, from where opium was distributed to the rest of the world. 
Opium contains about 40 alkaloids that make up 10-20% of total opium 
substances. The most abundant opium alkaloids are morphine (8-17%), codeine (0.7-
5%), thebaine (0.1-1.5%), papaverine (0.5-1.5%) and noscapine (narcotine, 1-10%) 
(Schiff, 2002). 
Morphine is purified from opium extracts and converted into heroin by 
acetylation. Heroin is more lipid soluble than morphine and is easily transported across 
the blood brain barrier, being 2-4 times more potent than morphine to treat acute pain 
(Sawynok, 1986). 
Heroin was first synthesized in 1874 by C.R. Alder Wright in England but it was 
only discovered by the medical community when it was independently re-synthesized, 
23 years later, by Felix Hoffmann, who worked for Bayer. From 1898 to 1910 heroin 
was commercialized by Bayer as a non-addictive morphine substitute and cough 
medicine for children (Figure 1.1.A). The use of heroin was thought to be a potential 
cure for morphine addiction until it was found that heroin is converted into morphine, 
when metabolized in the liver (Wikipedia, 2007). 
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A B 
  
Figure 1.1: Presentations of heroin. A) Heroin commercialized by Bayer in the beginning of the 20th 
century. B) Heroin in different purification forms (images from http://heroin.know-library.net/ 
(A) and http://www.druginfo.adf.org.au/article.asp?ContentID=heroin (B)). 
 
1.1.1 Present situation 
Nowadays, the use of drugs has become a complex issue, namely due to the 
development of purification procedures that enable an increase in the effective 
quantities of the active compounds consumed. Another factor that contributed to the 
increase in the deleterious effects of drug abuse was the invention of the hypodermic 
syringe, in the mid 19th century, which allowed the direct injection of purified active 
compounds into the blood stream. This also contributed to increase infections among 
drug addicts. 
 
Presently, drug addiction seriously affects public health and society worldwide. 
The Annual Report of the European Monitoring Centre for Drugs and Drug Addiction 
(2006) refers that the most abused drugs in Europe are cannabis, cocaine, ecstasy, 
amphetamines and opiates. Worldwide, cannabis is used by 3.9% of the world 
population, followed by the amphetamines (0.6%) cocaine (0.3%) and heroin (0.3%) 
(Table 1.1). 
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Although less consumed, opiates are the drugs that lead more people to seek 
treatment, due to their severe withdrawal effects and the increased risk for infections 
and, therefore, opiates have a strong negative economic impact.  
 
Table 1.1: Percentage of drug users in the last 12 months 
 % population (age 15-64) 
 Heroin Cocaine Amphetamines Cannabis 
Europe 0.6 0.7 0.5 5.6 
West and Central Europe 0.5 1.1 0.7 7.4 
South East Europe 0.2 0.1 0.2 2.3 
East Europe 1.2 0.1 0.2 3.8 
Americas 0.3 1.5 0.8 6.4 
North America 0.4 2.3 1.1 10.3 
South America 0.1 0.7 0.4 2.6 
Asia 0.2 0.1 0.6 2.1 
Oceania 0.2 0.9 3 15.3 
Africa 0.2 0.2 0.4 8.1 
Global 0.3 0.3 0.6 3.9 
 
Global users 11,250,000 13,358,000 24,880,000 162,400,000 
Source: United Nations Office on Drugs and Crime, World Drug Report, 2006 
1.2 Polydrug use  
Polydrug use is an increasingly important issue in Europe (European Monitoring 
Centre for Drugs and Drug Addiction, 2006). A relatively common combination of drugs 
is the speedball, which consists in concurrent administration (by injection) of cocaine 
and heroin. Speedball has been reported to cause more rewarding effects in rats than 
cocaine or heroin alone (Ranaldi and Munn, 1998). This may be explained by the 
reduction of the unwanted side-effects of one drug by the other, which has different 
mechanisms of action, or by the fact that one drug enhances the effect of the other 
(Leri et al., 2003). When injected together, the different effects of the combination of 
drugs, when compared to the drugs alone, can be also due to chemical interactions 
between the molecules of the two different drugs (Garrido J. et al., unpublished 
results). If the molecules of cocaine and heroin (or morphine) interact, this may confer 
different behavioural properties to the speedball, when compared to the drugs alone. 
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Ethanol is frequently combined with other drugs of abuse. When ethanol and 
cocaine are co-consumed, the euphoric effects of cocaine are enhanced. However, this 
combination also increases the toxic effects of both drugs, because the drugs are 
combined in the liver to form a very toxic metabolite – cocaethylene (see Figure 1.7). 
Cocaethylene is a very lipophilic compound and is able to cross the blood brain barrier. 
The effects of cocaethylene are similar to those of cocaine but the metabolite has a 
longer half live, prolonging the acute effects of cocaine (Henry, 2007). 
1.3 Adulterants and contaminants  
A critical issue associated with drug abuse is the fact that the drugs available in 
the streets are illegally synthesized, usually under poor conditions. Deficient purification 
and low quality of the reagents used often leave some impurities in the final products. 
Frequently, adulterants are also intentionally added to the drugs to increase profit.  
Heroin is a semi-synthetic drug, obtained from acetylation of morphine. Heroin 
possesses little or no opioid activity (White and Irvine, 1999) but its metabolism, which 
may occur in vivo and in vitro (Hutchinson and Somogyi, 2002), generates 6-
monoacetylmorphine (6-MAM) and morphine, two μ-opioid receptor agonists (White 
and Irvine, 1999) – see section 1.5.2.2.2 (Opiates and reward).  
Street heroin may contain different quantities of heroin and other components 
depending on its origin and on the method of illicit synthesis. Street heroin is illegally 
synthesized from morphine purified from opium extracts (Figure 1.1.B). Upon illicit 
purification, morphine is often contaminated with other alkaloids, which may also suffer 
synthetic acetylation during heroin manufacture.  
 
Depending on the purification procedure, street heroin may contain some 
impurities (Moore et al., 1984), namely morphine and 6-MAM (heroin metabolites), 
codeine and acetylcodeine (Soine, 1986, for review). Heroin in seized samples may 
also contain various inert diluents (starch, lactose, fructose, sucrose, mannitol, 
powdered milk) and active adulterants (caffeine, paracetamol, strychnine, 
acetylsalicylic acid, barbiturates, quinine and amphetamines) (Chiarotti et al., 1991; 
Introduction 
 
 8 
Sharma et al., 2005). These and other frequent additives are presented in Table 1.2. 
Common additives of cocaine are shown in Table 1.3. 
 
 
Table 1.2: Frequent heroin additives (adapted from  Roth et al., 1998; Shesser et al., 1991) 
Opium alkaloids Other pharmacologically active compounds Inert Volatile 
Thebaine Tolemectin Starch Rosin 
Codeine Quinine Sugar Toluene 
Acetylcodeine Phenobarbital Calcium tartarate Methanol 
Papaverine Methaqualone Calcium carbonate Acetaldehyde 
Noscapine Lidocaine Sodium carbonate Ethanol 
Narceine Phenolphtalein Sucrose Acetone 
 Caffeine Dextrine Diethyl ether 
 Dextromoramide Magnesium sulphate Chloroform 
 Chloroquine Dextrose Acetic acid 
 Diazepan Lactose  
 Nicotinamide Barium sulphate  
 N-phenyl-2-naphtylamine Silicon dioxide  
 Phenacetin Vitamin C  
 Acetaminophen   
 Fentanyl   
 Doxepin   
 Naproxen   
 Promazine   
 Piracetam   
 Procaine   
 Diphenhydramine   
 Aminopyrine   
 Allobarbital   
 Indomethacin   
 Glutethimide   
 Scoopolamine   
 Sulfonamide   
 Arsenic   
 Strychnin   
 Cocaine   
 Amphetamine   
 Methamphetamine   
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Table 1.3: Frequent cocaine additives (adapted from  Roth et al., 1998; Shesser et al., 1991). 
Pharmacologically active compounds Inert Volatile 
Lidocaine Inositol Benzene 
Cyproheptidine Mannitol Methyl ethyl ketone 
Diphenhydramine Lactose Ether 
Benzocaine Dextrose Acetone 
Mepivacaine Starch  
Aminopyrine Sucrose  
Methapyrilene Sodium bicarbonate  
Tetracaine Barium carbonate  
Nicotinamide Mannose  
Ephedrine   
Phenylpropanolamine   
Acetaminophen   
Procaine base   
Caffeine   
Acetophenetidin   
1-(1 Phenylcyclohexyl)pirrolidine   
Methaqualone   
Dyclonine   
Pyridoxin   
Codeine   
Stearic acid   
Piracetam   
Rosin (colophonum)   
Fencafamine   
Benzoic acid   
Phenothiazines   
L-Threonin   
Boric acid   
Aspirin   
Dibucaine   
Propoxyphene   
Heroin   
Amphetamine   
Methamphetamine   
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1.4 Drug addiction 
There are several reasons that lead teenagers to experiment drugs. In Portugal 
about one half of the teenagers that experimented drugs started using them at the age 
of 12-13 (Matos et al., 2007). 
Drug use usually starts due to curiosity or by the need to have fun, becoming 
part of a group or to escape from physical and/or psychological problems. The acute 
effects of drugs induce pleasurable feelings that lead the individuals to take drugs 
again. Although some regular users are able to cease drug use, about 8-32% of them 
lose control over drug consumption, becoming drug addicts (Madras, 2006). The 
factors that trigger the transition from controlled drug use to addiction are drug-specific 
and are not completely understood.  
 
The main characteristic of drug addiction is the compulsive drug use despite 
serious negative consequences. Drugs become more important than other goals and 
all activities are directed towards obtaining and consuming the drugs (Hyman et al., 
2006). Drug addiction is associated with a reduction in life-sustaining activities that has 
both medical and social consequences.  
When addiction develops, changes in the brain occur in order to adapt to the 
presence of the drug. Abstinence from the drug triggers physiological and 
psychological withdrawal, which are negative consequences of drug use.  During 
withdrawal the brain is hyper-reactive and requires the drug for its proper function. 
Withdrawal symptoms include anxiety, stress, irritability, insomnia or hypersomnia, 
aches, craving, among other effects. Upon prolonged abstinence, intense craving can 
develop, suppressing the individual’s will to control the compulsive drug-seeking, and 
often leading to relapse. The transition between these states is cyclic, as illustrated in 
Figure 1.2. 
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Figure 1.2: Cycle of addiction, as described by Madras (2006). Genotype, phenotype and 
neurodevelopment contribute to the first experience with drugs. The acute effects of the drugs 
lead to toxicity and adaptations that induce drug addiction and physical dependence. When 
the drug is absent, withdrawal symptoms appear leading to craving and relapse. During 
withdrawal, medications may be useful to prevent relapse. 
 
Addiction is considered a chronic disease (Leshner, 1997), often accompanied 
by cognitive dysfunction with loss of impulse control towards drug consumption (Pau et 
al., 2002). 
 
1.4.1 Characteristics of psychoactive drugs 
Drugs with psychoactive effects can be divided into several groups, according 
to their specific actions. The most common illicit drugs of abuse are the 
psychostimulants (include the psychomotor stimulants amphetamines and cocaine), 
depressants (include the opiate narcotic analgesics) and hallucinogens (include 
mescaline and lysergic acid - LSD). The properties of these groups of drugs are 
summarized in Table 1.4. 
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Table 1.4: Principal effects of the main illicit drugs-of-abuse (based on Roth et al., 1998). 
 
Effects Acute Chronic Withdrawal Drugs 
Psychostimulants 
Euphoria, 
tachycardia, 
hypertension, 
hyperthermia, 
increased mental 
alertness, seizures. 
Psychosis, 
paranoia, reduced 
appetite, weight 
loss, heart failure, 
nervousness, 
insomnia 
Severe 
depression 
(sometimes), 
headache 
Cocaine, 
amphetamine, 
ecstasy 
Depressants 
Pain relief, euphoria, 
drowsiness/nausea, 
constipation, 
confusion, sedation, 
respiratory 
depression and 
arrest, hypothermia, 
unconsciousness, 
seizures, coma, 
death. 
Depressed sexual 
drive, lethargy, 
general physical 
debilitation, 
infections, 
hepatitis, 
tolerance, 
addiction. 
Anxiety, 
Insomnia, 
nausea, 
vomiting, 
diarrhea, 
anorexia, 
tachycardia, 
lacrimation, 
sweating, severe 
back pains, 
stomach cramps, 
muscle spasms. 
Opium, 
morphine, 
heroin 
Hallucinogens 
Altered states of 
perception and 
feeling. 
Persisting 
perception 
disorder 
(flashbacks) 
No typical 
symptoms 
Mescaline, LSD, 
psilocybin, 
ecstasy 
 
Some drugs of abuse have effects that are common to more than one group. 
For example, ecstasy (or 3,4-methylenedioxymethamphetamine - MDMA) belongs to 
the class of psychedelic drugs, which share stimulant and hallucinogenic effects. These 
drugs are also known by empathogens or entactogens, because they induce feelings of 
empathy (Riedlinger and Riedlinger, 1994). Another example is cannabis, which shares 
properties of all the groups described (Murray, 1986). 
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1.5 Brain circuits affected by the drugs 
of abuse 
 
Drugs of abuse interact with the brain, affecting brain systems that respond to 
physiological stimuli such as food, water and social interaction, which are critical to 
survival. Imaging studies, such as positron emission tomography (PET) and functional 
magnetic resonance imaging (fMRI), have implicated the involvement of different brain 
circuits in drug addiction (reviewed by Volkow et al., 2003). The interaction of the drugs 
with these circuits may be different in the different phases of drug addiction: 
intoxication, withdrawal and craving. 
 
The main brain circuits implicated in the effects of the drugs are the ones that 
mediate reward, memory, motivation/drive and control, and are mainly composed by 
the following brain areas:  
(a) reward- nucleus accumbens (NAc) and ventral pallidum;  
(b) motivation/drive- orbitofrontal cortex (OFC) and subcallosal cortex;  
(c) memory and learning- amygdala and hippocampus;  
(d) control- the prefrontal cortex and anterior cingulate gyrus (CG) 
 
 
 
Figure 1.3: Interaction between brain circuits in addiction. The brain circuits that mediate reward, 
motivation/drive, learning/memory and control are interconnected and the interactions 
between these circuits change with experience. In drug addiction, the drug over-activates the 
reward, motivation and memory circuits, overcoming the inhibitory control exerted by the 
prefrontal cortex (based on Volkow et al., 2003). 
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For drug-addicted individuals, reward, motivation and memory circuits are over-
activated by the drug. This over-activation is accompanied by the loss of inhibitory 
control of the prefrontal cortex, which no longer regulates the activation of the other 
circuits, perpetuating the cycle of addiction (Figure 1.3). 
Imaging studies (PET and fMRI) have shown that drug-associated cues 
activate cortical regions (such as the anterior cingulate cortex and the orbitofrontal 
cortex) and the insula. The function of the insula, which is involved in conscious 
emotional feelings, seems to be essential to mediate relapse (Naqvi et al., 2007). 
 
The brain areas involved in the circuits affected by drug addiction are 
innervated by dopaminergic and glutamatergic projections, and modifications in these 
projections mediate many of the adaptations involved in drug addiction. The reward 
pathway is an important dopaminergic circuit involved in the reinforcing effects of the 
drugs of abuse. 
 
1.5.1 The reward pathway 
The reward pathway in the brain is acutely activated by all the drugs of abuse. 
This pathway consists in the projection of dopaminergic neurons in the ventral 
tegmental area (VTA) to several structures involved in emotions, thoughts, memories 
and planning and executing behaviours (Figure 1.4). One of these structures, 
implicated in the addictive effects of the drugs, is the NAc, in the ventral striatum. This 
structure is involved in reward and addiction, but also in motivation and learning (Di 
Chiara et al., 1999). Another brain structure receiving projections from VTA neurons is 
the prefrontal cortex, which coordinates executive functions.  
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Figure 1.4: Representation of the reward pathway in the human brain. This pathway is composed by 
neurons that project from the VTA to several structures, including the NAc, in the ventral 
striatum and the prefrontal cortex. Reprinted, with permission, from the Annual Review 
of Neuroscience, Volume 29 © 2006 by Annual Reviews  www.annualreviews.org” (Hyman et 
al., 2006). 
 
 
1.5.2 Molecular mechanisms involved in the 
effects of the drugs of abuse in the 
brain 
 
Drugs of abuse affect brain functions mainly due to structural similarities with 
neurotransmitters (Figure 1.5). Cocaine, amphetamine and ecstasy have structures 
that are similar to the monoamine neurotransmitters dopamine and noradrenaline.  
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Figure 1.5: Chemical structures of some neurotransmitters and psychoactive drugs. Ecstasy and LSD 
resemble the neurotransmitter serotonin. Amphetamine and cocaine are similar to dopamine 
and noradrenaline. 
 
 
The structures of ecstasy and LSD resemble the neurotransmitter serotonin 
(Figure 1.5), whereas morphine and heroin have some structure overlap with the 
neuropeptides enkephalins and endorphins (Figure 1.6). 
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Figure 1.6: Structural similarities between endogenous opioids and morphine (adapted from Romero, 
2005). 
 
 
 
The drugs of abuse may be administered in several ways, depending on the 
drug and on the desired effect. Upon administration, the drugs are usually metabolized 
and therefore the metabolites can contribute to the effects of the drugs. 
 
Cocaine is usually self-administered by nasal insuflation (snorting), smoking, 
genital application and injection (Jenkins and Cone, 1998). Cocaine may be 
metabolized by several pathways (Figure 1.7):  
• Plasma and liver cholinesterases produce the inactive metabolite ecgonine methyl 
ester 
• The second major metabolite, benzoylecgonine, is spontaneously produced at 
physiological pH.  
• N-demethylation of cocaine in the liver produces the active metabolite norcocaine. 
• When cocaine and ethanol are co-administered, the toxic metabolite cocaethylene 
is produced in the liver by transesterification. Cocaethylene is a lipid soluble 
molecule and crosses the blood brain barrier. 
• Smoking of cocaine may produce the pyrolysis compound anhydroecgonine methyl 
ester, which can be used as a marker of this route of administration. 
 
Introduction 
 
 18 
 
 
Figure 1.7 Metabolism of cocaine. Plasma and liver cholinesterases convert cocaine in ecgonine methyl 
ester. Benzoylecgonine is spontaneously produced at physiological pH. N-demethylation of 
cocaine in the liver produces norcocaine. Transesterification of cocaine and ethanol produces 
cocaethylene. Smoking of cocaine results in the pyrolysis product anhydroecgonine methyl 
ester (adapted from Jenkins and Cone, 1998). 
 
Heroin is normally administered by intramuscular or intravenous injection, 
snorting or smoking. Heroin is rapidly deacetylated to the active metabolite 6-MAM 
(Figure 1.8), which is then converted into morphine. The formation of 6-MAM may 
occur spontaneously in aqueous media. Heroin may be considered as a pro-drug, 
because it does not have intrinsic activity, but, due to its high lipophilicity it facilitates 
the distribution of the active metabolites, 6-MAM and morphine (Sawynok, 1986). 
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Figure 1.8 Heroin and its main metabolites 
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Amphetamines may be self-administered by oral, intravenous or smoked 
routes. d-Amphetamine is metabolized by deamination, oxidation and hydroxylation 
(Figure 1.9). Deamination produces the inactive metabolite phenylacetone, which is 
oxidized to benzoic acid and excreted as hippuric acid. Oxidation of amphetamine 
produces norephedrine, which is pharmacologically active.  Hydroxylation of 
amphetamine and norephedrine respectively produces hydroxyamphetamine and 
hydroxynorephedrine, which have pharmacologic activity. Methamphetamine may be 
hydroxylated to hydroxymethamphetamine or N-demethylated to amphetamine 
(Jenkins and Cone, 1998).  
 
 
Figure 1.9 Metabolism of amphetamine and methamphetamine. Deamination of amphetamine produces 
phenylacetone, which is further oxidized to benzoic acid and excreted as hippuric acid. 
Oxidation of amphetamine produces norephedrine. Hydroxylation of amphetamine and 
norephedrine produces hydroxyamphetamine and hydroxynorephedrine, respectively. 
Methamphetamine may also be hydroxylated to hydroxymethamphetamine or N-demethylated 
to amphetamine (adapted from Jenkins and Cone, 1998). 
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1.5.2.1 Neurotransmitter systems affected in drug 
addiction 
1.5.2.1.1 Monoamine neurotransmitters 
Psychostimulant drugs share structural similarities with monoamines (Figure 
1.5) and thereby interfere with the activity of these neurotransmitters.  
Monoamine neurotransmitters include the catecholamines dopamine and 
noradrenaline and also serotonin. Dopamine and noradrenaline are synthesized from 
tyrosine by the highly regulated enzyme tyrosine hydroxylase (TH), giving rise to L-
dihydroxyphenylalanine (L-DOPA). L-DOPA is converted into dopamine by the enzyme 
L-aminoacid decarboxylase. In noradrenergic neurons, dopamine is converted into 
noradrenaline by the enzyme dopamine β-hydroxylase. Serotonin is synthesized from 
tryptophan by the enzyme tryptophan hydroxylase, originating 5-hydroxytryptophan, 
which is then converted into serotonin by the enzyme L-aminoacid decarboxylase. The 
monoamines are actively transported by vesicular monoamine transporters (VMATs) 
into synaptic vesicles where they are stored. When the neurons depolarize, the 
synaptic vesicles fuse with the plasma membrane releasing the neurotransmitters into 
the synaptic cleft, where they interact with pre- and post-synaptic receptors. The 
neurotransmitters are then reuptaken by the pre-synaptic neuron for further release, or 
metabolized, in order to terminate their synaptic activity. Reuptake is performed by 
specific transporters in the plasma membrane of the synaptic terminal. Dopamine 
transporter (DAT), noradrenaline transporter (NET) and serotonin transporter (SERT) 
are the specific proteins involved in the reuptake of monoamines. 
Enzymatic metabolism of monoamines is mainly mediated by the enzymes 
monoamine oxidases (MAOA and MAOB) and catechol-O-methyl-transferase (COMT). 
Monoamine oxidases are mitochondrial enzymes that catalyse the oxidative 
deamination of biogenic amines in the brain and in peripheral tissues (see also section 
1.6.2.1). The two isoforms of MAO have different substrate specificities. MAOA 
preferentially oxidizes serotonin and noradrenaline and MAOB has a preference for 
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phenylethylamine and benzylamine. Both isoforms oxidize dopamine but in humans 
dopamine is preferentially oxidized by MAOB, whereas in rodents it is predominantly 
oxidized by MAOA (Shih et al., 1999). The other enzyme involved in catecholamine 
inactivation, COMT, may be either cytoplamatic or in a membrane-bound form present 
in the synaptic cleft and may inactivate cytoplasmic or synaptic catecholamines. 
 
 
1.5.2.1.1.1 Dopaminergic pathways 
The reward circuit (Figure 1.4) is composed by dopaminergic pathways, and is 
a key mediator of the reinforcing effects of the drugs. All the drugs of abuse acutely 
induce large and fast increases in dopamine in this and other brain circuits. Dopamine 
is synthesized by a subset of neurons that express tyrosine hydroxylase. These 
neurons are present in specific regions in the brain, namely in the VTA, the substantia 
nigra and the arcuate and periventricular nuclei of the hypothalamus (Venero et al., 
2002).  
Dopamine mediates physiologic processes including reward, movement and 
lactation. There are four dopaminergic pathways: the mesolimbic, mesocortical, nigro-
striatal and tuberoinfundibular pathways (Figure 1.10). The first two of these pathways 
are part of the reward circuit activated by virtually all the drugs of abuse (Di Chiara and 
Imperato, 1988). The mesolimbic pathway is mainly involved in motivated behavior, 
whereas the mesocortical pathway, which projects to the prefrontal cortex, is involved 
in learning and memory. The nigrostriatal pathway is involved in the control of 
movement and the tuberoinfundibular pathway is involved in the stimulation of milk 
production. Blocking of dopamine neurotransmission in the tuberoinfundibular pathway 
may cause increases in blood prolactin levels, causing abnormal lactation, disruption of 
the menstrual cycle, and sexual dysfunction. 
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Figure 1.10: Dopaminergic pathways in the rat brain.  There are four dopaminergic pathways in the brain. 
The mesolimbic pathway is composed by neurons projecting from the VTA to the NAc, 
olfactory tubercle and parts of the limbic system. The mesocortical pathway originates in the 
VTA and projects to the prefrontal cortex. The nigrostriatal pathway projects from the 
substantia nigra to the caudate-putamen and globus pallidus. The tuberoinfundibular pathway  
(not represented) originates in the periventricular and arcuate nuclei of the hypothalamus and 
projects to the capillary plexus of the hypothalamic-hypophyseal portal system (Vallone et al., 
2000) (image adapted from  Salinas, 2006). 
 
 
 
As it was described in the previous sections, drugs of abuse interfere with the 
molecular and cellular pathways involving some neurotransmitters that are structurally 
similar to the drugs. The molecular targets of the drugs are the transporters or 
receptors that mediate the physiological actions of the neurotransmitters, activating 
specific intracellular signalling pathways. However, the drugs do not completely mimic 
the action of the neurotransmitters because the molecular machinery involved in the 
removal of the neurotransmitters from the synapse does not recognize the drugs, which 
are able to interfere with neurotransmission for a longer period of time (Madras, 2006). 
Specific interactions of these drugs of abuse with the neurotransmitter 
receptors/transporters are described in section 1.5.2.2.  
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1.5.2.1.2 Opioid neuropeptides 
The prediction that opioid receptors would be the target of opiate drugs of 
abuse led to the search of a natural agonist of the receptors. Enkephalins (Hughes et 
al., 1975), β-endorphin (Li and Chung, 1976) and dynorphin (Goldstein et al., 1979) 
were the first opioid neuropeptides discovered. Endomorphins were later discovered in 
the search for a more selective μ-opioid receptor agonist (see Figure 1.14) (Zadina et 
al., 1999, for review). The aminoacid sequences of the main endogenous opioids are 
represented in Table 1.5. 
 
Table 1.5: Aminoacid sequences of endogenous opioids 
 
Name Amino acid sequence 
Leucine-enkephalin Tyr-Gly-Gly-Phe-Leu-OH 
Methionine-enkephalin Tyr-Gly-Gly-Phe-Met-OH 
β-Endorphin Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln- 
 Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile- 
 Val-Lys-Asn-Ala-His-Lys-Gly-Gln-OH 
α-Neoendorphin Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Pro-Lys 
Dynorphin Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys- 
 Leu-Lys-Trp-Asp-Asn-Gln-OH 
Endomorphin-1 Tyr-Pro-Trp-Phe-NH2 
Endomorphin-2 Tyr-Pro-Phe-Phe-NH2 
 
β-Endorphin is a cleavage product of the proopiomelanocortin peptide (POMC) 
(Figure 1.11.A) and is expressed in the pituitary gland and in the arcuate nucleus of the 
hypothalamus. Enkephalins are cleavage products of the proenkephalin A peptide 
(Figure 1.11.B) and are the most widely distributed opioids in the central nervous 
system (CNS), with the highest concentration found in the globus pallidus.  
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Figure 1.11: Proteolytic processing of the pre-propeptides (A) pre-proopiomelanocortin and (B) pre-
proenkephalin A. The maturation of the pre-propeptides involves cleaving the signal sequence 
and other proteolytic processing. This results in the production of several neuroactive peptides 
such as adrenocorticotropic hormone (ACTH), γ-lipotropin, and β-endorphin (A), or multiple 
copies of the same peptide, such as met-enkephalin (B) (based on Purves et al., 2001). 
 
The distribution of opioid neuropeptides in the brain depends on the expression 
of the precursor proteins and on the distribution of specific proteases responsible for 
cleavage of the precursors. 
1.5.2.2 Short-term (acute) effects 
1.5.2.2.1 Psychostimulants and reward 
The stimulant drugs amphetamine and cocaine directly increase extraneuronal 
dopamine levels through different mechanisms (Figure 1.12).  
Amphetamine induces an increase in extracellular monoamines, by interacting 
directly with monoaminergic cells. Although amphetamine has comparable effects in 
neurons containing serotonin, noradrenaline and dopamine, the effects implicated in its 
reinforcing properties are mainly mediated by dopamine (Fleckenstein et al., 2007).  
Due to its structural similarity with dopamine, amphetamine is a substrate for 
the DAT (Sitte et al., 1998). In low concentrations amphetamine is transported by the 
DAT to the cytosol and increases the intracellular binding sites of the DAT for 
dopamine, resulting in the exchange of extracellular amphetamine by intracellular 
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dopamine, and leading to an increase in extracellular dopamine (Jones et al., 1999). 
When present in higher extracellular concentrations, amphetamine may diffuse into the 
cell, due to its lipophilicity (Sulzer et al., 1995; Kahlig et al., 2005). 
Intracellular amphetamine also induces reverse transport by the DAT because it 
contributes to increase the intracellular dopamine concentration. Amphetamine 
interferes with VMAT-2 function, impairing the active transport of the monoamines into 
synaptic vesicles, where they are stored. In addition, amphetamine may enter in the 
vesicles by diffusion, due to its weak base properties (Sulzer et al., 2005, for review). 
Since amphetamine is a weak base, at acidic pH it accepts protons leading to 
alkalinization inside the vesicles. A low pH inside the vesicles is essential to maintain 
the proton gradient used by VMAT-2 for active transport of monoamines into the 
vesicles. Therefore, amphetamine induces the release of vesicular dopamine to the 
cytosol and impairs the storage of dopamine in the vesicles. Cytosolic dopamine is 
then released to the extracellular space via reverse-transport by the DAT. 
 
Amphetamine also interferes with dopamine synthesis by inhibiting tyrosine 
hydroxylase (TH) (Ellison et al., 1978) and with dopamine metabolism, by inhibiting  
MAO (Ramsay and Hunter, 2002). 
 
Figure 1.12: Direct effects of amphetamine 
and cocaine in dopaminergic nerve 
terminals. Both drugs increase extracellular 
dopamine accumulation by different 
mechanisms. Briefly, amphetamines inhibit 
the storage of dopamine in synaptic 
vesicles, inducing an increase in cytosolic 
dopamine concentration and reversal of the 
DAT. Cocaine blocks the reuptake of 
dopamine by the DAT. 
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Cocaine inhibits the DAT (Brown et al., 2001), preventing the reuptake of 
dopamine into the nerve terminal. The inhibition of the DAT results in increased levels 
of dopamine in the synaptic cleft. Cocaine also inhibits the monoamine transporters 
NET and SERT (Gatley et al., 1998). However, as it happens with amphetamine, 
reinforcing effects of cocaine are largely dependent on its effect in dopaminergic 
neurotransmission (Ritz et al., 1987).  
Cocaine also interacts with the VMAT-2, favoring the storage of catecolamines 
inside synaptic vesicles (Brown et al., 2001). It was suggested that cocaine-induced 
inhibition of the DAT and increased vesicular sequestration of dopamine, causes a shift 
in the ratio of cytoplasmic to vesicular dopamine increasing the amount of 
neurotransmitter packaged in each vesicle before its release. This effect on the VMAT 
would contribute to further increase in synaptic dopamine, upon a depolarizing stimulus 
(Brown et al., 2001). 
 
 
1.5.2.2.2 Opiates and reward 
In contrast with the stimulant drugs, opiates induce an increase in dopamine in 
the NAc by an indirect mechanism.  
The major targets of opiates are the opioid receptors, which mediate the 
endogenous effects of the opioid neuropeptides. The drug of abuse morphine shares 
structural similarities with the opioid peptides and, therefore, is recognized by the 
opioid receptors, activating them (Figure 1.13). 
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Figure 1.13. Functional similarity between morphine and endogenous opioids. Due to its structural 
similarities with endogenous opioids, morphine is recognized by the opioid receptors and 
activates them (adapted from Romero, 2005). 
 
Opioid receptors are G-protein-coupled receptors that respond to endogenous 
opioids. There are 3 subtypes of opioid receptors, with different pharmacological 
selectivities (Figure 1.14): mu (μ), delta (δ) and kappa (κ) receptors. Morphine is a 
specific agonist of μ-opioid receptors, with binding potencies (Ki) of 14 nM for μ-opioid 
receptors, 538 nM for κ –receptors and above 1000 nM for δ –receptors (Figure 1.14) 
(Raynor et al., 1994). 
Binding of the specific ligands to any of the opioid receptors induces the 
activation of Gi/o proteins, resulting in the inhibition of adenylyl cyclase, activation of 
potassium conductance, inhibition of calcium conductance and the inhibition of 
neurotransmitter release (Williams et al., 2001).   
 
 
 
Figure 1.14: Selectivity windows of morphine and endogenous opioid peptides for the subtypes of opioid 
receptors. Met-enkephalin (Met Enk) and β endorphin preferentially bind to μ and δ opioid 
receptors. Dynorphin is selective for κ opioid receptors. Morphine selectively binds to μ opioid 
receptors (adapted from Williams et al., 2001). 
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Upon the activation of the opioid receptor, the alpha subunit of the G protein 
inhibits the enzyme adenylyl cyclase (Figure 1.15), which is responsible by the 
production of cyclic AMP (cAMP). cAMP normally activates protein kinase A (PKA), 
which is responsible for the phosphorylation of several proteins, involved in numerous 
cellular processes. One of these proteins is the transcription factor cAMP response 
element-binding protein (CREB).  
It has also been reported that acute exposure to opiates may lead to the 
activation of protein kinase (PKC), release of calcium from intracellular stores and 
activation of mitogen-activated protein kinase (MAPK) cascade (Williams et al., 2001). 
These effects seem to be mediated by the beta/gamma subunits of the G protein. 
 
 
 
Figure 1.15: Intracellular signalling 
mediated by G-protein coupled 
receptors. Binding of the agonist to 
the receptor activates heterotrimeric 
G proteins composed of α,β and γ 
subunits. Stimulatory α subunits 
activate the enzyme adenylyl 
cyclase, which produces cAMP. 
Inhibitory α subunits inhibit this 
pathway. cAMP activates PKA that 
is translocated to the nucleus. PKA 
is active in the cytosol and in the 
nucleus, phosphorylating several 
proteins such as the transcription 
factor CREB, which is activated by 
this phosphorylation. Activated 
CREB binds to CREB-binding 
protein (CBP) and activates 
transcription of its target genes, 
leading to the expression of new 
proteins (adapted from Alberts et al., 
2002). 
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Figure 1.16 summarizes the actions of opiates and other reinforcing drugs of 
abuse in the neurons of the reward pathway, which culminate in an increase in 
dopamine in dopaminergic synapses of the NAc.  
VTA neurons (represented in the bottom left of Figure 1.16) project to the NAc 
(bottom right). The activity of these projections is regulated by interneurons, which 
interact with VTA or NAc neurons.  
Due to the inhibitory actions of opiates described above, opiate drugs of abuse 
bind to μ-opioid receptors present in gamma aminobutyric acid (GABA)-releasing 
interneurons in the VTA, inhibiting the release of GABA, an inhibitory neurotransmitter 
that acts on dopaminergic neurons to inhibit dopamine release (Figure 1.16). Thus, the 
action of the opiate drugs in the GABAergic interneurons results in an increase of 
dopamine release by the dopaminergic neurons of the VTA.  Opiates also interact 
directly with NAc neurons and produce reward in a dopamine-independent manner. 
Other drugs induce dopamine release in the NAc by different mechanisms. 
Nicotine causes dopamine release by interacting with nicotinic acetylcholine receptors 
in the VTA. Ethanol interacts with GABAA receptors in the VTA.  Some drugs of abuse 
may also interact directly with NAc neurons.  
 
Figure 1.16: Effects of psychoactive drugs in the reward pathway. All the drugs of abuse induce an 
increase in the synaptic concentration of dopamine (DA) in the NAc. Stimulants act directly in 
the synaptic terminals of dopaminergic neurons projecting from the VTA. Opiates, nicotine and 
alcohol affect the activity of interneurons that regulate this pathway. Opiates, alcohol, 
cannabinoids and phenylcyclidine (PCP) may also directly affect NAc neurons. Reprinted, with 
permission, from the Annual Review of Neuroscience, Volume 29 © 2006 by Annual Reviews  
www.annualreviews.org” (Hyman et al., 2006). 
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1.5.2.3 Long-term homeostatic adaptations 
Upon chronic drug abuse and during withdrawal, dopamine function in the brain 
is markedly decreased. Several adaptations to the drugs occur, leading to the 
development of drug addiction. Chronic exposure to the drugs of abuse in humans 
induces long-lasting changes in gene expression, and some of these changes may be 
correlated with the development of the compulsive behaviour associated with drug 
addiction (Rhodes and Crabbe, 2005, for review). Changes in gene expression induced 
by chronic drug exposure may also underlie changes in the cellular responses to 
stress. These alterations are in the basis for the development of sensitization or 
tolerance, in human drug abusers, in which the response to the same dose of a drug is 
increased or decreased, respectively. These processes are responsible for the 
withdrawal symptoms and increased motivation to drug abuse (Nestler, 2004b).  
Opiates have the most evident addictive effects, involving tolerance, withdrawal 
and a high rate of relapse. Binding of opioids to their receptors activates intracellular 
signalling pathways that regulate gene expression.  
 
Figure 1.17: Activity of the cAMP pathway 
upon acute or chronic exposure to opiates. 
Acute exposure to opiates inhibits the cAMP 
pathway (lower line: cAMP and phosphorylated 
PKA levels). Upon repeated exposure to 
opiates the activity of the cAMP pathway 
recovers to normal levels. When an antagonist 
of the opiate receptors is present (withdrawal) 
the activity of the cAMP pathway increases far 
above control levels. These changes are due 
to induction of adenylyl cyclase and PKA 
expression during chronic exposure to the 
opiates (upper line: adenylyl cyclase and PKA 
protein levels) (adapted from Nestler, 2004a) 
 
Physical dependence develops when the physiology of cells, and circuits, is 
changed by the drugs in such a way that, when the drug is absent, withdrawal 
symptoms appear. It was demonstrated that acute morphine exposure decreases the 
levels of cAMP in the locus coeruleus, the major brain noradrenergic nucleus. 
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However, upon continued exposure to morphine, compensatory upregulation of the 
cAMP pathway occurs, with increase in adenylyl cyclase expression and cAMP 
recovery to normal levels (Figure 1.17 and Figure 1.18). During withdrawal or in the 
presence of an opioid receptor antagonist (such as naloxone), the upregulation of the 
cAMP pathway results in the increase in the levels of cAMP, which can rise several 
times above normal levels. The expression of other signalling molecules is also 
affected upon chronic exposure to morphine. These phenomena were also 
demonstrated to occur in NAc neurons (Chieng and Williams, 1998), which are 
implicated in the motivational aspects of drug addiction. 
 
Figure 1.18: Long-term effects of opiate drugs of abuse due to changes in gene expression. Intracellular 
signalling mediated by the activation of opioid receptors is changed upon chronic exposure to 
morphine. Several components of the cAMP pathway are upregulated, such as adenylyl 
cyclase (AC), PKA, TH and CREB, contributing to increased electrical excitability which 
underlies tolerance, dependence and withdrawal observed upon chronic exposure to opiates. 
C- catalytic subunit of PKA (adapted from Nestler, 2004a). Reprinted with permission from 
AAAS. 
 
The molecular mechanisms involved in the upregulation of the cAMP pathway 
seem to be partially mediated by the transcription factor CREB. Chronic opiate 
exposure induces CREB expression and activity, which is thought to mediate the 
expression of some of the components of the cAMP pathway. Cocaine and 
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amphetamine also induce CREB activation due to increase in the stimulation of 
dopamine (D1) receptors (Hyman et al., 2006, for review). 
 
Figure 1.19: Induction of dynorphin peptides by dopamine. One of the target genes of CREB is dynorphin, 
which is expressed in NAc neurons and regulates the activity of VTA neurons, decreasing 
dopamine release. Over-activation of CREB induced by chronic exposure to the drugs of 
abuse increases the expression of dynorphin, representing a negative-feedback loop. 
Reprinted, with permission, from the Annual Review of Neuroscience, Volume 29 © 2006 by 
Annual Reviews  www.annualreviews.org” (Hyman et al., 2006). 
 
CREB has many target genes, such as cFos, corticotropin-releasing factor 
(CRF), TH, brain derived neurotrophic factor (BDNF), adenylyl cyclase (isoform VIIII), 
enkephalins and dynorphin (Carlezon, Jr. et al., 2005). The upregulation of dynorphin 
seems to mediate the decrease in the rewarding properties of the drugs, mediated by 
CREB (Cole et al., 1995). Dynorphin acts on k-opioid receptors present on VTA 
neurons to decrease dopamine release (Figure 1.19) and represents a negative-
feedback loop.  
Upregulation of cAMP pathway by the opiates leads to decreased dopamine 
release in the VTA when opiates are present. When opiates are no longer present, the 
decrease in dopamine release mediated by dynorphin may contribute to anhedonia and 
dysphoria that characterize the early phases of opiate withdrawal. 
 
Another transcription factor involved in the chronic effects of drugs of abuse is 
ΔFosB, a member of the Fos family of transcription factors (McClung et al., 2004). 
Acute exposure to drugs of abuse transiently induces the expression of several 
members of the Fos family. However, chronic exposure to the drugs results in 
increasing accumulation of stable isoforms of ΔFosB, which persist in NAc neurons for 
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a long time after cessation of drug use (Nestler, 2004b). ΔFosB may be viewed as a 
“molecular switch”, initiating and maintaining long-lived adaptations associated with 
drug addiction. 
 
Opiates also induce changes in the synaptic activity of opiate receptors, by 
inducing desensitization, internalization and intracellular trafficking of these receptors, 
leading to decreased receptor availability or response (Figure 1.20).  
 
 
Figure 1.20: Effects of acute and prolonged activation of opioid receptors by opioid receptor agonists. 
Binding of the agonist (ag) to the G protein-coupled receptor triggers G protein activation (1) 
and phosphorylation of the receptor by G protein-coupled receptor kinases (GRK) (1), allowing 
the binding of arrestin (3), which targets the receptor to endocytosis (4). The receptor may be 
recycled to the cell membrane (5) or degraded in the lysosome (not shown) (based on Bailey, 
2007). 
 
As discussed in section 1.5.2.2.2, opioids are recognized by specific receptors, 
triggering an intracellular cascade of events. Acute exposure to opiate drugs activates 
the opioid receptors, inducing the activation of heterotrimeric G-proteins that mediate 
signal transduction events. However, upon prolonged exposure to endogenous opioids, 
the receptors are desensitized due to phosphorylation by G protein-coupled receptor 
kinases (GRKs) (Figure 1.20). This allows the binding of arrestin molecules, preventing 
the activation of G proteins, due to uncoupling of the receptor from the G protein. 
Arrestin-bound receptors are internalized by endocytosis in clatrin-coated vesicles, 
reducing the number of receptors available in the cell membrane. The internalized 
receptors may be either dephosphorylated and transported back to the plasma 
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membrane, inducing resensitization, or degradated by proteolysis in the lysosomes, 
inducing downregulation of the receptors, a permanent decrease in the number of 
receptors in the cell membrane. 
 
Studies performed in human embryonic kidney (HEK293) cells (Keith et al., 
1996), gut neurons (Sternini et al., 1996), cortical neurons (Keith et al., 1998) and 
spinal cord neurons (Trafton et al., 2000), showed that morphine was much less 
effective in inducing μ-opioid receptor internalization, when compared to endogenous 
opioids. However, in cultures of striatal neurons, representative of the GABAergic 
neurons of the NAc, μ-opioid receptors were recently shown to be internalized upon 
exposure to morphine, probably due to the presence of different isoforms of signalling 
molecules in these neurons (Haberstock-Debic et al., 2005). Two explanations for the 
tolerance induced by morphine have been reported. One possibility is that morphine 
does not trigger significant receptor internalization and the receptor remains coupled to 
the intracellular signalling systems for a long period of time, inducing tolerance due to 
adaptations in the intracellular signalling machinery (Finn and Whistler, 2001). Another 
possibility is that morphine-desensitized receptors accumulate at the cell surface and, 
in this case, tolerance may be caused by the fact that morphine-desensitized receptors 
are not efficiently internalized and resensitized (Schulz et al., 2004).  
The effect of morphine seems to be cell-specific but the end-result seems to be 
common to all systems - the cells decrease the number or the activity of receptors that 
respond to the opioids, in order to decrease the deleterious effects of the chronic 
presence of the drug. During abstinence, the amount of opiates decreases and the 
system becomes unbalanced due to adaptation to the excessive inhibitory signals, 
when the drugs are present. This may explain some of the withdrawal symptoms 
observed in opiate addicts. 
1.5.2.4 Learning and memory 
Long-term adaptations to drugs explain the withdrawal symptoms observed 
upon abstinence and the dependence on drugs, but do not completely explain the 
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persistence of relapse risk observed long time after the individuals stop consuming. It 
was suggested that the life-long risk of relapse may be explained by long-term 
associative memory processes triggered by the drugs (Hyman et al., 2006). This is 
highly suggested by the observation that most relapses occur after exposure to cues 
associated with previous drug use. These cues may be external, associated with 
sensory stimuli (persons, objects or places previously associated with drug use) or 
internal, as for example the withdrawal symptoms. Stress can also induce relapse, 
probably due to the activation of the reward pathway, resembling drug-exposure 
(Hyman et al., 2006). 
In relapse, drug-seeking is facilitated by impairment in the impulse control 
mediated by the prefrontal cortex, which is responsible for inhibiting harmful behaviours 
in non-addicts. 
An increase in synaptic dopamine induced by the drugs of abuse may be 
responsible for the activation of circuits involved in processing long-term associative 
memories because dopaminergic neurons project to several brain areas and innervate 
multiple targets (Hyman et al., 2006). 
 
 
1.5.2.5 Stress and drug addiction 
Stress also plays an important role in relapse to drug-taking behavior. The 
drugs of abuse activate the hypothalamic-pituitary-adrenal (HPA) axis, which mediates 
the stress response (Figure 1.21). The release of stress hormones begins in the brain, 
by the release of the hypothalamic neuropeptide CRF. Upon a stressful event CRF is 
released from the hypothalamus and acts in the pituitary gland, stimulating the release 
of β-endorphin and ACTH, which are derived from POMC (see section 1.5.2.1.2 and 
Figure 1.11). ACTH is secreted into the blood and triggers the release glucocorticoids, 
namely cortisol, from the adrenal glands. Cortisol acts in a negative feedback manner 
in the hypothalamus and in the pituitary to inhibit the production of CRF, ACTH and β-
endorphin. Endogenous opioids may be involved in the regulation of this axis. 
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Figure 1.21: Components of the stress-
response axis. The release of stress 
hormones begins in the brain, with the 
release of CRF to the anterior pituitary, 
stimulating the release of β-endorphin (β-end) 
and ACTH, which are derived from POMC. 
ACTH is secreted into the blood and triggers 
the release of cortisol, from the adrenal 
glands. Cortisol acts in a negative feedback 
manner in the hypothalamus and in the 
pituitary to inhibit the production of CRF, 
ACTH and β-endorphin. Endogenous opioids 
may be also involved in the regulation of this 
axis. Reproduced, with permission from 
Nature Reviews Drug Discovery (Kreek et al., 
2002) ©2002 Macmillan Magazines Ltd. 
 
 
The concentrations of glucocorticoids regulate the level of dopamine release in 
the NAc (Piazza and Le Moal, 1998). In basal conditions both glucocorticoid secretion 
and dopamine release are low. An acute stress leads to the increase in glucocorticoid 
secretion, which enhances dopamine release in the NAc and thereby increases the 
sensitivity to the reinforcing effects of the drugs of abuse, which can result in increased 
self-administration. However, since glucocorticoids activate a negative feedback that 
controls their own release, the system returns to basal levels within 2 hours. Upon 
repeated stress, the negative feedback loop becomes impaired, resulting in a long-
lasting increase in glucocorticoid secretion and, consequently, an increase in dopamine 
release in the NAc. These changes lead to a long-lasting increase in the sensitivity to 
the reinforcing effects of the drugs (Piazza and Le Moal, 1998).  
Introduction 
 
 37
During withdrawal, drugs of abuse increase the levels of CRF which may be 
responsible for stress-induced relapse (reviewed by Sarnyai et al., 2001; Kreek and 
Koob, 1998). 
As described above, drug addiction involves different cellular and molecular 
adaptations that are specific for each stage of the life cycle of addiction, which are 
summarized in Figure 1.22. 
 
 
Figure 1.22: Life cycle of addiction. Upper boxes show the processes associated with each stage of drug 
addiction. Lower boxes show the underlying cellular and molecular mechanisms involved. 5-
HT- serotonin.  (From Nestler and Aghajanian, 1997. Reprinted with permission from AAAS). 
 
1.6 Drugs of abuse and neurotoxicity 
Many drugs of abuse have been shown to induce toxicity in several tissues of 
the human body. Cytotoxicity was demonstrated for ecstasy (Capela et al., 2006), d-
amphetamine, methamphetamine (Cadet et al., 2003), cocaine (Zhang et al., 1999) 
and morphine (Bhat et al., 2004).  
Since addiction may be considered a brain disease (Leshner, 1997), 
neurotoxicity may underlie some of the effects of the drugs. The brain is one of the 
most metabolically active tissues. A continuous supply of glucose is essential for the 
energy-consuming neuronal functions such as axonal transport or synaptic 
transmission. Although new neurons may be formed by neurogenesis in the adult brain 
(see section 1.6.2.4) (Gage, 2002), the existing neurons do not divide and thus 
dysfunction or death of these cells may result in irreversible damage. Furthermore, the 
brain is highly sensitive to oxidative stress due to its high content in poly-unsaturated 
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fatty acids, low levels of antioxidants, the presence of transition metals and high levels 
of oxygen consumption. 
Moreover, there are evidences that chronic abuse of heroin (Fishbein et al., 
2007), cocaine (Bolla et al., 2000) and amphetamines (Barr et al., 2006) induces 
impairment of neurocognitive functions. 
1.6.1 Glutamate mediated effects of opiate 
drugs 
Many evidences suggest the involvement of glutamatergic neurotransmission in 
the mechanisms of drug dependence involving the dopaminergic reward circuit in the 
brain (Tzschentke and Schmidt, 2003).  
 
N-methyl-D-aspartate (NMDA) receptors are a subtype of ionotropic glutamate 
receptors that plays a key role in excitatory synaptic transmission. These receptors 
have been implicated in synaptic plasticity associated with learning and memory, and 
hypofunction of NMDA receptors produces memory dysfunction (Newcomer and 
Krystal, 2001). In contrast, hyperfunction of these receptors has been associated with 
acute CNS injury syndromes such as hypoxia, ischaemia, trauma and status 
epilepticus (Newcomer and Krystal, 2001). 
 
The biophysical and pharmacological properties of these receptors depend on 
their subunit composition. There are three different subtypes of NMDA receptor 
subunits, NR1, NR2 (A-D) and NR3 (A-B). NMDA receptors are heteromeric complexes 
composed of at least one NR1 subunit and one NR2 subunit. Heterotrimeric complexes 
composed of NR1/NR2 and NR3 have been also described (Cull-Candy et al., 2001).  
 
Glutamate binds to the NR2 subunits and the co-agonist glycine binds to the 
NR1 subunit. Several agonists and antagonists regulate the activity of NMDA receptors 
by interacting with different sites of the receptors (Figure 1.23). 
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Figure 1.23: Structure of NMDA receptor showing binding sites for agonists and antagonists (*). The 
extracellular portions of the subunits consist of two domains, the modulatory domain 
(Modulatory D) and the agonist binding domain (Agonist BD). The NR1 subunit contains the 
glycine-binding site and the NR2 subunit contains the glutamate-binding site. Reprinted, with 
permission, from the Annual Review of Pharmacology and Toxicology, Volume 47  ©2007 by 
Annual Reviews   www.annualreviews.org” (Hara and Snyder, 2007). 
 
Subunit composition of NMDA receptors in the brain varies during development. 
Before birth, NR2B subunits are found in most brain regions and NR2D subunits are 
found in the diencephalon and brain stem. After birth the levels of NR2A subunits 
increase in most brain regions and NR2C subunits appear in the cerebellum. Hence, 
NR2B subunit expression decreases during development, whereas NR2A subunit 
expression increases (Cull-Candy et al., 2001). However, subunit composition at the 
same age also differs among different brain regions. The levels of mRNA of the 
different NR2 subunits in specific brain areas in adult rats (Goebel and Poosch, 1999) 
are in the following order: 
 
           Cortex: NR2B >> NR2A  >  NR2C >> NR3A > NR2D 
Hippocampus: NR2A >> NR2B >> NR2C  > NR2D ≈ NR3A  
         Striatum: NR2B >> NR2A >> NR2C  > NR3A ≈ NR2D. 
 
It was previously suggested that glutamatergic neurotransmission involving the 
NMDA receptor contributes to opiate dependence in humans (Bisaga et al., 2001). 
NMDA receptor antagonists inhibit the development of physical dependence and 
tolerance (Trujillo, 2000). Memantine, an antagonist of the NMDA receptor, is capable 
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of preventing the acquisition of morphine-induced conditioned place-preference, 
suggesting that the glutamatergic system can modulate opiate reward (Ribeiro Do 
Couto et al., 2004). Moreover, the NMDA receptor antagonist MK-801 was shown to 
specifically block morphine-induced tolerance and neuronal apoptosis in the spinal cord 
(Mao et al., 2002).  
 
Morphine dependence reduces the affinity of glycine for NMDA receptors in the 
NAc (Siggins et al., 2003; Martin et al., 2004). Moreover, morphine-dependent rats 
show decreased NR1 and NR2A subunit expression in the frontal cortex and 
hippocampus and increased levels of NR1 and NR2A in the NAc, whereas NR2B is not 
affected (Murray et al., 2007). These data suggest that NR2A-containing NMDA 
receptors in the NAc probably contribute to the development of opiate dependence. 
Another study also suggested that chronic morphine induces an increase in NR2A 
subunit function in the NAc, and a decrease in the function of the NMDA receptor 
subunits NR2B and 2C, which could result in altered excitability and integrative 
properties (Martin et al., 2004). 
However, other authors showed that chronic morphine significantly increased 
the protein levels of NR1 and NR2B subunits in the NAc (Bajo et al., 2006). It was 
recently suggested that NR2B subunit-containing NMDA receptors may be involved in 
the rewarding effect of morphine (Kato et al., 2007; Ma et al., 2007). NR2B-containing 
NMDA receptors in the NAc and the dorsal hippocampus were proposed to play a 
significant role in mediating the reinstatement of rewarding responses to morphine (Ma 
et al., 2007). This effect seems to be specific for morphine because NR2B containing 
NMDA receptors are more involved in morphine reward rather than in natural rewards 
(Ma et al., 2006). Nevertheless, the acute exposure to opiates may have different 
effects on NMDA receptors when compared to the chronic exposure. 
NMDA receptors are highly permeable to calcium and, thus, hyperactivation of 
these receptors leads to excitotoxicity and cell death due to the activation of Ca2+-
dependent proteases. 
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These and other mechanisms of toxicity mediated by the drugs of abuse may 
involve the mitochondria, organelles with important functions in the life and death of 
cells. 
1.6.2 Mitochondria in cell life and death 
Mitochondria are the powerhouses in the cells, producing energy to supply the 
various energy-consuming cellular activities. Classically, mitochondria are composed of 
two compartments, separated by two different lipid membranes with different protein 
compositions (Figure 1.24). The outer mitochondrial membrane (OMM) separates the 
organelle from the cytoplasm, whereas the inner mitochondrial membrane (IMM) 
separates the matrix compartment - inside the mitochondria - from the intermembrane 
space (IMS). Recently, another compartment was shown to exist in the space between 
cristae, the intracristal space (ICS) (Mannella, 2006), surrounded by inner 
mitochondrial membrane. The ICS communicates with the IMS through bottleneck-like 
junctions that create a diffusion barrier. 
 
In these organelles, several important bioenergetic reactions take place. The 
goal of these reactions is to produce ATP. A series of oxidative reactions mediated by 
the electron transport chain allows the production of several ATP molecules for each 
molecule of energetic substrate consumed. 
 
 
 
Figure 1.24: Mitochondria and the electron transport chain. ICS: intracristal space, IMS: intermembrane 
space, VDAC: voltage dependent anion channel, ANT: adenine nucleotide translocator. 
 
The electron transport chain is composed by five protein complexes present in 
the IMM. NADH/H+ produced by several bioenergetic reactions (namely in the Krebs 
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cycle) serves as an electron donor, reducing a flavin mononucleotide (FMN) center in 
the mitochondrial NADH-ubiquinone reductase- the complex I of the mitochondrial 
electron transport chain. The reduction of FMN initiates a cascade of redox reactions in 
complex I that result in the reduction of a lipid-diffusible molecule of ubiquinone (or 
coenzyme Q). These redox reactions also result in the pumping of four protons from 
the matrix to the IMS.  
Complex II consists primarily of the Krebs cycle enzyme that converts 
succinate in fumarate (succinate dehydrogenase) and two iron-sulfur proteins. This 
redox reaction results in the reduction of a FAD center in the protein, ultimately 
resulting in the reduction of a lipid-soluble molecule of ubiquinone. 
The reduced lipid-soluble ubiquinone transfers the electrons to another protein 
complex in the IMM, the cytochrome c reductase or complex III. Ubiquinone reduces 
an iron-sulfur center in complex III, initiating a complex cascade of redox reactions that 
results in the reduction of two cytochrome c molecules and in the pumping of four 
protons from the matrix to the IMS. 
Reduced cytochrome c transfers one electron to a cupper center in complex IV 
(cytochrome oxidase). Complex IV uses 4 electrons transported by cytochrome c to 
reduce one oxygen molecule (O2) into two water molecules, pumping 4 protons to the 
IMS. The reduction of one O2 molecule requires the transfer of electrons from two 
electron carrier molecules. A total of ten protons are pumped across the IMM per 
electron pair donated by NADH. 
Pumping of protons by the mitochondrial electron transport chain generates a 
proton gradient across the IMM and also an electric potential (ΔΨm). This gradient is 
used by complex V (the ATP synthase) as energy to produce ATP in the mitochondrial 
matrix.  
ADP is transported into the matrix by the adenine nucleotide translocase (ANT) 
in exchange with ATP, transported into the IMS. Inorganic phosphate (Pi) is 
transported into the matrix by the Pi translocator, which also transports a proton into 
the matrix. For each ADP molecule phosphorylated by the ATP synthase in order to 
form ATP, 3 more protons are transported back to the matrix. Thus, the activity of the 
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electron transport chain is essential to maintain the proton gradient and also the 
electric potential. 
The oxidative reactions in the mitochondria are also generators of reactive 
oxygen species (ROS), making the mitochondria a site and a target of oxidative stress. 
1.6.2.1 Drug-addiction and oxidative stress 
Oxidative stress is defined as the imbalance in the production ROS (oxidants) 
versus the activity of the detoxifying systems (antioxidants) in the cells, towards an 
increase in the levels of oxidants. 
 
 
Figure 1.25: Oxidative metabolism of dopamine. A) Enzymatic deamination by MAO, B) Auto-oxidation. 
Both processes result in the production of H2O2. 
 
As described above, all the drugs of abuse induce an increase in the 
extracellular levels of the neurotransmitter dopamine in specific brain areas. Dopamine 
is easily oxidized, by enzymatic and non-enzymatic mechanisms (Figure 1.25) and may 
induce oxidative stress in dopaminergic and neighboring cells. This may contribute to 
the neurotoxicity of the drugs of abuse. Synaptic activity of dopamine is mainly 
regulated by two mechanisms: reuptake, responsible for 70-80% of dopamine 
recycling, and/or inactivation (metabolism). Dopamine may be metabolized 
intracellularly by MAO (see section 1.5.2.1.1), a mitochondrial enzyme, present in the 
cytoplasmic side of the outer membrane. MAO catalyses the deamination of dopamine 
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producing 3,4-dihydroxyphenylacetic acid (DOPAC) and hydrogen peroxide (H2O2). 
Dopamine auto-oxidation also produces H2O2. 
H2O2 may react with transition metal ions, via the Fenton/Haber-Weiss reactions 
(1, 2), originating the highly toxic hydroxyl radical (•OH). 
 
Fe2+ + H2O2 → Fe3+ + •OH + OH- (Fenton reaction - 1) 
 
O2-• + H2O2 → O2 + •OH + OH- (Haber-Weiss reaction - 2) 
 
Thus, dopamine is both a neurotransmitter and a neurotoxin, and changes in 
dopamine metabolism may induce oxidative stress and cell death in dopaminergic or 
surrounding cells (Jones et al., 2000), if the antioxidant systems are not able to deal 
with the increase in the levels of ROS. The increase in ROS levels may lead to cell 
death due to the oxidation of important cellular macromolecules such as aminoacids, 
phospholipids and nucleic acids (Cadet and Brannock, 1998). 
1.6.2.1.1 Detoxification of H2O2 
Cells have specific antioxidant systems (enzymatic and non-enzymatic) that 
respond to increases in H2O2. 
Glutathione (γ-L-Glutamyl-L-cysteinyl-glycine) is a tripeptide that can exist in 
the reduced (GSH) and oxidized (GSSG) forms. Glutathione is an antioxidant that 
reduces disulfide bonds in cytoplasmic proteins, by acting as an electron donor. When 
this happens, glutathione is oxidized and a disulfide bond is formed between two 
cysteines of two GSH molecules. The levels of GSH/GSSG are maintained by two 
enzymes: glutathione reductase (GRed) and glutathione peroxidase (GPx). The 
latter converts two molecules of GSH in GSSG and simultaneously detoxifies H2O2 
forming two water molecules. GRed reduces GSSG into 2 molecules of GSH by using 
NADPH/H+, which is converted into NADP+. NADPH/H+ is produced by glucose-6-
phosphate dehydrogenase in the pentose-phosphate pathway. This group of reactions 
is also known as the glutathione redox cycle (Figure 1.26). 
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Figure 1.26: Glutathione redox cycle. H2O2 is detoxified by glutathione peroxidase (GPx), producing water, 
using 2 molecules of GSH that are converted into GSSG. Glutathione reductase (GRed) 
converts GSSG back to GSH, using NADPH/H+, which is converted into NADP+. 
 
 
Another enzyme that detoxifies H2O2 is catalase, present in the peroxisomes, 
which catalyzes the reaction (3): 
2 H2O2 → 2 H2O + O2 (3) 
 
Superoxide dismutase (SOD), another antioxidant enzyme, contributes to 
increase H2O2 levels by detoxification of the superoxide anion (O2.-) (4). The H2O2 
produced by SOD has to be detoxified by the systems described above. 
 
2O2.- + 2H+ → O2 + H2O2 (4) 
 
The levels and the activity of these enzymes are regulated by the cells and are 
important to maintain cellular homeostasis. 
 
When continuously exposed to oxidants, cells may increase the levels of 
antioxidant systems in order to maintain homeostasis. Thus, the effects of chronic 
exposure to oxidants contrast with the effects of acute exposure. For example, acute 
exposure to H2O2 can induce apoptotic cell death in PC12 cells (Benedi et al., 2004; 
Jang and Surh, 2004), whereas cells chronically exposed to low concentrations of H2O2 
become resistant to the acute toxicity of this compound (Wiese et al., 1995; Davies, 
1999). Acute exposure to H2O2 may then be used as a model of cytotoxicity whereas 
chronic treatment of PC12 cells with a low concentration of H2O2 may be a model of 
cell adaptation (Jackson et al., 1994).  
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1.6.2.1.2 Amphetamines and oxidative stress 
Amphetamines were shown to induce neurotoxicity, both upon acute and 
chronic exposure. It is believed that the mechanisms involved in amphetamine toxicity 
are mediated by oxidative stress, due to an increase in the levels of H2O2 resulting from 
enzymatic and non-enzymatic oxidation of dopamine. Table 1.6 summarizes some of 
the recent studies investigating the role of oxidative stress in the effects of 
amphetamines in neurons.  
 
 
Table 1.6: Evidences for amphetamine-induced oxidative stress in the brain or in neuronal cells 
Drug Biological model Mechanisms Dose/time of exposure Reference 
Meth Human SH-SY5Y cell line 
↓ΔΨm 
↑ROS 
Protected by vitamin E 
Acute: 
0.17-1.68 mM, 
24-72h 
(Wu et al., 
2007) 
Meth Human caudate and frontal cortex 
↑4-HNE 
↑MDA -- 
(Fitzmaurice 
et al., 2006) 
Acute: ↑SOD prefrontal cortex for 1 
mg/kg 
Chronic: ↑SOD hippocampus; ↓SOD 
striatum for 1 and 4 mg/kg 
↑Catalase prefrontal cortex and 
hippocampus for 4 mg/kg 
↓Catalase hippocampus and striatum 
for 2mg/kg 
(Frey et al., 
2006b) d-
Amph 
In vivo- 
Wistar rats 
Prefrontal cortex, 
striatum, 
hippocampus 
Chronic exposure: ↑TBARS and 
↑Superoxide in prefrontal cortex and 
hippocampus 
1 mg/kg, 2 
mg/kg, or 4 
mg/kg 
Acute: 1 day 
Chronic: 7 
days 
(Frey et al., 
2006a) 
Meth 
Striatal 
synaptosomes 
(Wistar rat) 
↑ROS 
Protected by antioxidants 
Acute 
2h, 2 mM 
(Pubill et al., 
2005) 
Meth Human caudate ↑SOD ↑GSSG -- 
(Mirecki et al., 
2004) 
d-
Amph Rat brain 
↑GST – hypothalamus 
↑GPx – striatum, NAc and medial 
prefrontal cortex 
↑GRed - hypothalamus 
↑Catalase - medial prefrontal cortex 
↓GRed – medial prefrontal cortex 
Chronic (14 
days) 20 
mg/kg/day 
(Carvalho et 
al., 2001) 
Meth 
In vivo- Wistar rats 
Prefrontal cortex 
Striatum 
↑ SOD 
↑ TBARS 
Acute 
10-15 mg/kg 
(Acikgoz et 
al., 2000) 
 
Abbreviations: Meth- methamphetamine, d-amph- d-amphetamine, ΔΨm- mitochondrial potential; ROS- 
reactive oxygen species; HNE- hydroxynonenal; MDA- malondialdehyde; SOD- superoxide 
dismutase; TBARS- thio-barbituric acid reactive substances; GST- glutathione-S-transferase; 
GPx- glutathione peroxidase; GRed- glutathione reductase 
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Acute exposure to amphetamine induces an increase in ROS production and 
interferes with mitochondrial function, whereas chronic exposure induces changes in 
the activity or expression of antioxidant enzymes. The changes observed seem to be 
specific for each brain region studied. 
Amphetamines interfere with the mitochondrial function in several ways. 
Methamphetamine was shown to inhibit the mitochondrial respiratory chain (Burrows et 
al., 2000), and to inhibit ATP synthesis. Moreover, amphetamines may also increase 
ATP utilization, due to hyperthermia and hyperactivity (reviewed by Brown and 
Yamamoto, 2003).  
Since amphetamines are lipophilic weak bases, they may diffuse into the 
mitochondria and contribute to the alkalinization of the matrix (Sulzer and Rayport, 
1990), disrupting the mitochondrial membrane potential (Cunha-Oliveira et al., 2006a). 
1.6.2.1.3 Cocaine and oxidative stress 
Cocaine has been shown to induce oxidative stress in the brain. Some recent 
studies investigating the role of oxidative stress in cocaine neurotoxicity are 
summarized in Table 1.7. Both acute and chronic cocaine administrations affect the 
oxidative status of neurons, especially in the striatum, frontal cortex and hippocampus. 
 
Table 1.7: Evidences for cocaine-induced oxidative stress in the brain or neuronal cell cultures 
Biological model Mechanisms Dose/time of exposure Reference 
In vivo: prenatal exposure- rat 
hippocampus and cortex 
Nitric Oxide 
TBARS 
Repeated: 
20 mg/kg/day 
4 days 
(Bashkatova 
et al., 2006)  
Human neuronal progenitor cells 
Frontal cortex and striatum 
Protein carbonyl 
Protein HNE 
↓GSH 
Acute: 1 μM; 30 
min; analysed after 
6-96 h 
(Poon et al., 
2007) 
In vivo: Swiss mice, striatum and 
frontal cortex 
Low dose: ↓catalase in 
striatum 
High dose: ↓catalase activity 
in cortex and striatum 
Low dose: 10-30 
mg/kg 
High dose: 90 
mg/kg 
(Macedo et 
al., 2005) 
In vivo:  rat – frontal cortex and 
striatum 
↑H2O2 
Lipoperoxidation 
↓Complex I activity 
↑SOD, ↑GPx 
20 mg/kg/day 
Acute – 1 day 
Chronic- 10 days 
(Dietrich et 
al., 2005) 
In vivo: prenatal exposure – rat 
brain 
↓GSH 
↓reduced VitE 
↑oxidized Vit E 
Single (Lipton et al., 2003) 
Abbreviations: Vit E- vitamin E. For other abbreviations see legend of Table 1.6. 
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Cocaine was also shown to impair mitochondrial respiration (Devi and Chan, 
1997) and to disrupt mitochondrial potential (Cunha-Oliveira et al., 2006a; Yuan and 
Acosta, Jr., 1996). 
 
1.6.2.1.4 Opiates and oxidative stress 
Acute exposure to opiates was also reported to induce oxidative stress in 
neuronal tissues. Some recent studies showing changes in the levels of oxidants and 
antioxidants in neurons are summarized in Table 1.8. Acute morphine and heroin 
exposures affect the levels of antioxidants and increase damage to proteins, lipids and 
nucleic acids, in the brain. 
 
Table 1.8: Evidences of opiate-induced oxidative stress in neurons  
Drug Biological model Mechanisms Dose/time of exposure Reference 
Morphine Rabbit; brain and spinal tissues 
↑Lipid peroxidation 
↓GSH 
↓Unsaturated fatty 
acids 
6 mg/kg intraspinal (Ozmen et al., 2007) 
Heroin Mouse brain 
↓SOD 
↓CAT 
↓GPx 
↑Oxidative damage 
to DNA, lipids and 
proteins  
i.p. (Xu et al., 2006) 
Morphine Rat brain ↓GSH Single i.p. 3,6 or 12 mg/kg 
(Guzman et al., 
2006) 
Heroin Mouse brain 
↓GSH/GSSG 
↓SOD 
↓Catalase 
↓GPx 
↑8-OHdG 
↑Protein carbonyls 
↑MDA 
i.p. (Qiusheng et al., 2005) 
Abbreviations: GSH- reduced glutathione; SOD- superoxide dismutase; CAT- catalase; GPx- glutathione 
peroxidase; GSSG- oxidized glutathione; 8-OHdG- 8-hydroxy-2-deoxyguanosine; MDA- 
malondialdehyde, i.p.-intraperitoneal 
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1.6.2.2 Mitochondria in cell death 
Besides being essential for cell survival, mitochondria have been also shown to 
play a crucial role in cell death. The permeabilization of mitochondrial outer membrane, 
and disruption of mitochondrial function is a fundamental step in several pathways of 
cell death (Kroemer et al., 2007). The disruption of the OMM allows the release of 
soluble proteins that usually are only present in the IMS. 
Programmed cell death can occur through several tightly regulated pathways. 
One of the best characterized types of cell death is apoptosis. Apoptosis was firstly 
described in 1972 (Kerr et al., 1972) as a form of cell death morphologically distinct 
from necrosis. Morphological hallmarks of apoptotic cells are cell shrinkage, 
fragmentation into membrane-bound apoptotic bodies, chromatin condensation and 
fragmentation. 
Biochemically, apoptotic cells maintain membrane integrity and ATP levels, at 
least in the first steps. Apoptosis is characterized by three phases: initiation, 
integration/decision and execution/degradation. The signals that trigger apoptosis may 
come from out of the cell (extrinsic) of from inside (intrinsic). Two main molecular 
pathways of apoptosis have been characterized, one being activated by extrinsic 
signals, involving the activation of death-receptors in the cell membrane, and another 
activated by intrinsic stimuli and involving mitochondrial membrane permeabilization. 
Both these pathways involve the activation of cysteine aspartic proteases, named 
caspases, which are activated by proteolysis. 
The initiation phase in the extrinsic pathway involves the activation of death-
receptors, such as tumor necrosis factor (TNF) receptor 1, CD95/Fas or the TNF-
related apoptosis inducing ligand receptors 1 and 2 (TRAIL), and the consequent 
activation of the initiator caspases -8 or -10. The initiation phase in the intrinsic 
apoptotic pathway involves the permeabilization of the mitochondrial membrane, 
releasing apoptotic factors to the cytosol, such as cytochrome c, second mitochondria-
derived activator of caspases (Smac/DIABLO), Omi serine protease (Omi/HtrA2), 
apoptosis inducing factor (AIF) or endonuclease G (EndoG). Cytosolic cytochrome c 
reacts with deoxy ATP (dATP) and apoptotic protease activating factor 1 (APAF-1) in 
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the cytosol, inducing a change in APAF-1 conformation that enables the formation of 
the apoptosome, a complex composed by seven subunits of APAF-1/cytochrome 
c/dATP, which activates the initiator caspase-9. 
The initiator caspases of both pathways activate the effector caspase -3, 
initiating the degradation phase, which has common features for the two apoptotic 
pathways. Caspase-3 cleaves several substrates in the cell, including the effector 
caspase-6, poly-ADP-ribose polymerase (PARP) – a protein involved in DNA repair, 
and caspase-activated DNAse (DFF/CAD) – a nuclease that contributes to apoptotic 
DNA fragmentation.  
These mechanisms are involved in the appearance of the hallmarks of 
apoptosis, namely phosphatydylserine exposure, membrane blebbing, DNA 
fragmentation and condensation and the formation of apoptotic bodies. 
 
Caspase-independent apoptosis has also been described (Kroemer and Martin, 
2005). The mitochondrial factors AIF and EndoG, which are also released upon OMM 
permeabilization, induce apoptotic DNA fragmentation independently of caspase 
activity. 
1.6.2.2.1 Regulation of mitochondrial membrane 
permeabilization 
The integrity of mitochondrial membranes is essential to maintain different 
molecular environments. The IMM must be impermeable to protons, in order to allow 
the establishment of the proton gradient essential to the synthesis of ATP. The 
permeability of the OMM is also regulated, although it has been assumed that the 
presence of the voltage dependent anion channel (VDAC) makes this membrane freely 
permeable to molecules up to 5 kDa. However, VDAC has been shown to control and 
limit the diffusion of Ca2+ (Rizzuto and Pozzan, 2006). OMM permeabilization mainly 
occurs through a Bax/Bak-mediated mechanism. IMM permeabilization is still a 
controversial issue, although some authors defend that a mechanism involving the 
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permeability transition pore (PTP) could contribute to mitochondrial-mediated 
apoptosis.  
1.6.2.2.1.1 Bax/Bak mediated OMM permeabilization 
Proteins of the Bcl-2 family regulate the integrity of the OMM. This family of 
proteins can be divided into sub-families, according to the presence of different Bcl-2 
homology (BH) domains in their structure, which confer different functions (Figure 
1.27). Multi-domain antiapoptotic proteins with four different BH domains, referred as 
BH1234, include Bcl-2 and Bcl-XL. Proapoptotic proteins include the multi-domain 
proteins (BH123) such as Bax and Bak, and the BH3-only proteins, including Bid and 
Bad. In all sub-families there are members with a transmembrane domain that allows 
their insertion into lipid membranes. 
 
Examples of proteins 
 
BH1234: Bcl-2, Bcl-XL, Bcl-w, Mcl-1, A1, 
Boo 
 
 
 
 
BH123: Bax, Bak, Bok 
 
 
BH3-only: Bad, Bid, Bim, Noxa, PUMA, 
Bik 
Figure 1.27: Structure of typical members of the subclasses of the Bcl-2 family. 
 
 
BH1234 normally reside in the OMM, protecting the mitochondria against 
permeabilization, namely by binding and neutralizing the proapoptotic members of the 
Bcl-2 family, which induce OMM permeabilization. BH1234 proteins may also be 
present in the membrane of the endoplasmic reticulum (ER). 
Members of the BH123 proapoptotic proteins have different sub-cellular 
locations. Bak is normally associated with the OMM, whereas Bax resides in the 
cytosol, under normal conditions. Bax-mediated OMM permeabilization is initiated by 
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the translocation of Bax from the cytosol and insertion in the OMM, where it forms 
openings in the OMM, alone or in association with other pro-apoptotic proteins. These 
openings can result from the assembly of Bax homo-oligomeric pores or from the 
destabilization of the lipid bilayer. 
BH3-only proteins can exert their pro-apoptotic function either by facilitating or 
activating BH123 proteins, which initiate OMM permeabilization. Facilitators, such as 
Bad, interact with BH1234 proteins, dissociating them from other pro-apoptotic 
proteins, which become free to promote OMM permeabilization. The activators, such 
as tBid (which results from the cleavage of Bid by caspase-8), directly activate BH123 
proteins, either by stimulating the translocation of Bax to the OMM or by interacting 
with Bak. 
 
The expression of Bax or Bak has been shown to be required for OMM 
permeabilization in several models of apoptosis. Models of OMM permeabilization that 
do not require Bax or Bak can exhibit permeabilization through a VDAC mediated 
mechanism (reviewed by Kroemer et al., 2007). 
 
 
1.6.2.2.1.2 IMM permeabilization – the permeability transition pore 
The permeability transition pore (PTP) is a voltage-dependent, high-condutance 
channel located in the OMM, permeable to solutes with a molecular mass up to 1.5 
kDa. The molecular composition of the PTP is still controversial, but some consensus 
in found for the contribution of dynamic interactions between VDAC, ANT and 
cyclophylin D (CypD). Other proteins thought to be involved in the formation of the PTP 
are hexokinase, peripheral benzodiazepine receptor (PBR) and Bcl-2 family members, 
in the OM, creatine kinase, in the IMS, the ANT and CypD, in the IMM. Consequences 
of the opening of the PTP are mitochondrial swelling and loss of mitochondrial 
potential. These pores are inhibited by cyclosporin A, a CypD ligand and are activated 
by Ca2+ (Zamzami and Kroemer, 2001). 
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1.6.2.2.1.3 Reorganization of cristae 
The observation that most of the mitochondrial cytochrome c (~85%) is present 
in the recently described mitochondrial compartment, the ICS (Scorrano et al., 2002), 
implicates that an additional mechanism is needed to enable complete cytochrome c 
release upon OMM permeabilization. This mechanism involves remodelling of the 
cristae, resulting in the removal of the diffusion barrier and mobilization of the 
cytochrome c from the ICS to the IMS. Reorganization of cristae is mediated by 
proteins involved in mitochondrial dynamics, in the processes of mitochondrial fusion 
and fission. The junctions between the ICS and IMS were recently shown to be 
maintained by Opa1 (optic atrophia 1) (Frezza et al., 2006), an integral protein of the 
IMM involved in mitochondrial dynamics. The proteolytic activation of Opa1 by the 
presenilin-associated rhomboid like (PARL), an integral protease present in the IMM, 
releases truncated Opa1 to the IMS (Cipolat et al., 2006). The soluble and the 
truncated forms of Opa1 interact to maintain the diffusion barrier between the ICS and 
the IMS (Frezza et al., 2006). Cleavage of Opa1 by PARL is therefore important to 
maintain cytochrome c in the ICS and PARL dysfunction may represent a mechanism 
involved in the triggering of mitochondria-dependent apoptosis. 
Changes in mitochondrial dynamics towards an increase in mitochondrial fission 
have been shown to be associated with mitochondrial-dependent apoptosis (Youle and 
Karbowski, 2005). 
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1.6.2.3 Drugs of abuse and apoptosis in the 
Central Nervous System 
Induction of neuronal cell death by apoptosis by some drugs of abuse has been 
documented. Recent studies about amphetamine-induced neuronal apoptosis are 
presented in Table 1.9.  
Amphetamines induce apoptosis upon acute and repeated exposures. 
Apoptotic pathways induced by amphetamines in neurons seem to be mainly mediated 
by the mitochondrial apoptotic pathway, associated with a decrease in Bcl-2 levels and 
direct interference with mitochondrial potential. 
 
Table 1.9: Evidences of apoptosis induced by amphetamine or its derivatives in the brain or neuronal cells. 
Drug Biological model Mechanisms Dose/time of exposure Reference 
MDMA Rat cortical neurons 
Stimulation of serotonin 
2A-receptor 200 - 1600 μM 
(Capela et al., 
2006) 
Meth In vivo- mouse striatum TUNEL positive cells 
30 mg/kg, i.p. 
Tested 24h later (Zhu et al., 2006) 
d-Amph Rat cortical neurons 
Caspases -2, -9 and -3 
↓ΔΨm 
Acute (24 h) 
500 μM 
(Cunha-Oliveira 
et al., 2006a)  
d-Amph 
In vivo –mouse 
medium spiny 
striatal neurons 
Mitochondrial pathway 
Caspase-3, ↑p53, ↑Bax, 
↓Bcl-2 
Bax-KO mice are 
resistant 
Repeated: 10mg/kg, 
4 times, every 2h 
(Krasnova et al., 
2005) 
Meth, 
MDMA 
Rat cerebellar 
granule cells 
Caspase-3; ROS, 
cytochrome c Acute (48 h, 1-5 mM) 
(Jimenez et al., 
2004)  
d-Amph PC12 Caspase-3 Cytochrome c Acute (5h, 300 μM) 
(Oliveira et al., 
2003)  
d-Amph PC12 ↓ATP/ADP Acute (96h, 1mM) (Oliveira et al., 2002)  
Meth In vivo- mouse striatum ↑p53; ↓Bcl-2 
Repeated: 10mg/kg, 
4 times, every 2h 
(Imam et al., 
2001) 
d-Amph 
Meth 
MDMA 
Neocortical 
neurons 
Bcl-xL/s changes 
c-Jun 
Acute (1-96 h, 
125μM-1mM) 
Apoptosis evaluated 
at 96h, 500μM 
(Stumm et al., 
1999)  
Meth 
Immortalized 
neural cells from 
rat mesencephalon 
Apoptosis 
Protection by Bcl-2 
overexpression 
ROS? 
1-3 mM (24 h) (Cadet et al., 1997)  
Abbreviations: Meth- methamphetamine, d-Amph- d-amphetamine, MDMA- ecstasy, MDA-
malondialdehyde 
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Cocaine was also described to activate the mitochondrial apoptotic pathway. 
However, cocaine seems to be less toxic than amphetamine, and in some studies 
apoptotic neurons were not observed upon exposure to cocaine (Cunha-Oliveira et al., 
2006a; Dietrich et al., 2005). Recent studies on cocaine-induced neuronal apoptosis 
are presented in Table 1.10. 
 
Table 1.10: Evidences of cocaine-induced apoptosis in the brain or neuronal cells. 
Biological model Mechanisms Dose/time of exposure Reference 
Fetal locus coeruleus 
neurons 
Bax/Bcl-2 
Caspase-3 
Acute 
(30 min -24 h) 500 
ng/ml 
(Dey et al., 2007)  
Human neuronal 
progenitor cells 
Oxidative stress (48h) 
Cell death (72 h) Acute (30 min) (Poon et al., 2007)  
Rat cortical neurons 
Caspases -2,-9 and -3 
↓ΔΨm 
Mitochondrial apoptotic 
pathway 
No apoptotic morphology 
Acute (24 h) 
1 mM 
(Cunha-Oliveira et al., 
2006a)  
PC12 cells -rat 
Immediate early genes 
Transcription factors 
Caspases 
Acute (24h) 
50-2500 μM (Imam et al., 2005)  
In vivo – rat – 
dopaminergic brain 
structures 
No apoptosis 
20 mg/kg/day 
Acute – 1 day 
Chronic- 10 days 
(Dietrich et al., 2005)  
PC12 - rat Caspase-3 Cytochrome c Acute (5 h) 300 μM (Oliveira et al., 2003)  
Prenatal exposure – 
rat  brains 
c-Fos 
Caspases 
Acute (binge) 
3 x 15 mg/kg – 1h 
interval in the day 
before birth 
Evaluated 24 h after 
birth 
(Mitchell and Snyder-
Keller, 2003) 
Cerebral vascular 
muscle cells - dog TUNEL positive cells 
Acute (12-24 h) 1 μM-
1mM (Su et al., 2003)  
Abbreviations: TUNEL- terminal dUTP nick-end labelling, ΔΨm – mitochondrial potential. 
 
 
Although there are some studies reporting heroin (Fecho and Lysle, 2000) and 
morphine (Bhat et al., 2004) cytotoxicity, the molecular mechanisms of neurotoxicity 
induced by these opiate drugs is scarcely documented. However, a few studies have 
shown the involvement of apoptosis in neuronal dysfunction induced by opiates (Table 
1.11). 
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 Table 1.11: Evidences of apoptosis induced by opiates in neuronal cells. 
Drug Biological model Mechanisms Dose/time of exposure Reference 
Morphine Rat spinal cord Caspase-3, MAPK, PKA 
10μg, twice daily, 7 
days 
(Lim et al., 2005) 
Heroin PC12 cells Cytochrome c Caspase-3 
30 μM (without 
serum) – 5 h 
(Oliveira et al., 
2003) 
Heroin PC12 cells ↑Dopamine metabolism 300 μM – 4 days 
(Oliveira et al., 
2002) 
Morphine Rat spinal cord 
↑Caspase-3 
↑Bax 
↓Bcl-2 
NMDA receptors 
20 μg, twice daily 
for 7 days 
(Mao et al., 
2002) 
Morphine Fetal human neurons Caspase-3 1 μM (without serum) – 5 days 
(Hu et al., 2002) 
Abbreviations: MAPK- mitogen activated protein kinase, PKA- protein kinase A, NMDA- N-methyl-D-
aspartate 
1.6.2.4 Drugs of abuse and neurogenesis  
Besides being toxic to neurons, drugs of abuse have also been shown to induce 
a decrease in hippocampal neurogenesis (reviewed by Eisch and Harburg, 2006), 
compromising the capacity of the brain to generate new neurons.  
In the adult mammalian brain there are two main neurogenic regions (Figure 
1.28), the subventricular zone (SVZ) and the subgranular zone (SGZ) of the dentate 
gyrus (DG) in the hippocampus.  
 
Figure 1.28 Schematic diagram showing the two constitutively neurogenic regions of the adult mammalian 
CNS (SVZ/olfactory bulb and hippocampal dentate gyrus-DG). Reproduced with permission from 
Nature Reviews Neuroscience (Lledo et al., 2006) ©2006 Macmillan Magazines Ltd. 
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The first study showing that morphine and heroin induced a decrease in SGZ 
neurogenesis was published in 2000 (Eisch et al., 2000). Since then, cocaine 
(Yamaguchi et al., 2004; Mackowiak et al., 2005) and amphetamines (Teuchert-Noodt 
et al., 2000) were also reported to decrease hippocampal neurogenesis. 
Repeated or chronic exposure seems to be required to observe the inhibition in 
adult hippocampal neurogenesis induced by opiates or psychostimulants (Eisch and 
Harburg, 2006)  
Although the mechanisms involved in the decrease in neurogenesis induced by 
drugs of abuse are just starting to be investigated, they may be related with alteration 
of the proliferative environment, direct action of the drugs of abuse in the progenitor 
cells or alteration of the cell cycle of SGZ (Eisch and Harburg, 2006). 
The effect of drugs of abuse on neurogenesis seems to be selective for the 
SGZ, and does not seem to occur in the SVZ (Nixon and Crews, 2004). A decrease in 
hippocampal neurogenesis may result in long-lasting effects on learning, memory and 
cognition. 
1.7 Pharmacotherapies for drug 
addiction 
 
Some individuals that experiment drugs become addicted to them. The liability 
to addiction varies from drug to drug, being of 5-10% for cocaine and of 25-33% for 
opiates, depending not only on the effects of the drugs but also on genetic and 
environmental factors that lead to repeated drug use (reviewed by Kreek et al., 2002). 
 
Treatment for drug addiction is generally directed to alleviating the withdrawal 
symptoms, normalizing any physiological functions that were disrupted by drug use, 
and preventing craving and relapse. 
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There are three main time points for the pharmacological intervention in drug 
addiction (Figure 1.29):  
1) during active use of the drug of abuse 
2) during withdrawal (detoxification) 
3) during abstinence (or chronic maintenance or replacement treatment) - 
relapse prevention 
 
 
 
Figure 1.29: Stages of drug addiction and importance of medications. Primary prevention may be useful to 
stop the whole process of addiction, preventing the initial use of a drug. Vaccines and some 
medications may be useful to prevent sporadic intermittent use of drugs. Once addiction is 
established medications are useful and needed, because less than 20% of the addicted 
individuals sustain abstinence without medications Adapted, with permission from Nature 
Reviews Drug Discovery (Kreek et al., 2002) ©2002 Macmillan Magazines Ltd. 
 
 
 
Opiates are the drugs of abuse that induce a higher number of individuals to 
search treatment because they induce very severe symptoms. Substitution therapies 
are needed because more than 80% of the addicted individuals that do not receive 
medications are not able to sustain abstinence and eventually relapse to drug use. 
There are three effective substitution therapies for the long-term treatment of opiate 
addiction: methadone, levo-alpha-acetyl-methadol (LAAM) - two opioid receptor 
agonists, and buprenorphine - a partial opioid receptor agonist - alone or combined 
with naloxone, an antagonist of opioid receptors. The molecular mechanisms and the 
main characteristics of these treatments are described in Table 1.12. 
Introduction 
 
 59
 
Table 1.12: Substances currently used to treat opiate addiction (based on: Pouletty, 2002; Kreek et al., 
2002). 
  
Substance Characteristics 
Methadone μ-opioid receptor agonist  
Prevents withdrawal symptoms without showing opiate-like effects  
Reduces or eliminates drug craving  
Behavioural treatment needed 
LAAM μ-opioid receptor agonist  
Analogue of methadone 
Buprenorphine μ-opioid receptor partial agonist  
Slow onset and long duration of action  
It’s more difficult to overdose unintentionally 
(antagonistic effect prevails in overdosage)  
Partial agonism may  limit maximum effectiveness 
Naloxone μ-opioid receptor antagonist  
Combined with buprenorphine to prevent its abuse liability  
(naloxone is only bioavailable when injected, blocking the buprenorphine 
agonist effect) 
Naltrexone μ-opioid receptor antagonist  
Little effectiveness in the treatment of opiate addiction  
Prevents endogenous opioid activity 
 
 
Treatment with methadone consists in the substitution of one opioid for another, 
but it can improve the physical and psychological health and social functioning. It also 
reduces illicit drug use, criminality and the risk for contracting infectious diseases (Kaye 
et al., 2003). 
However, susbstitution therapy with methadone has a high initial dropout rate 
(30-90%) and an early relapse rate (Kaye et al., 2003). Combination of methadone with 
clonidine, an α2-receptor agonist, may improve treatment success. α2-Receptors are 
G-protein coupled adrenergic receptors that inhibit adenylyl cyclase. α2-Receptor 
agonists are thus helpful to suppress noradrenergic hyperactivity observed during 
withdrawal, which results in symptoms such as nausea, vomiting, cramps, sweating, 
tachycardia and hypertension. 
 
Another possible treatment is the ultrarapid detoxification, which involves the 
treatment with opioid receptor antagonists, to eliminate the withdrawal symptoms (Kaye 
et al., 2003). The withdrawal syndrome is precipitated by the administration of opioid 
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receptor antagonists (naloxone and/or naltrexone – see Table 1.12), under general 
anaesthesia. This treatment has the advantage of being a very short detoxification 
process, lasting 4 to 6 hours. However, this treatment only prevents further withdrawal 
symptoms and does is not effective in preventing relapse. 
 
Other pharmacotherapies for drug addiction are being developed (reviewed by 
Kreek et al., 2002). These are mainly directed against μ-opioid receptor and their 
endogenous ligands (β-endorphin and enkephalin peptides), the stress-responsive 
axis, components of the dopaminergic system (dopamine receptor antagonists, partial 
agonists or high efficacy agonists and monoamine reuptake inhibitors) and k-opioid 
receptor and dynorphin peptides (k-opioid receptor antagonists, partial agonists and 
high efficacy, selective agonists).  
Vaccines against the drugs of abuse could also be useful to decrease the 
kinetics of entry of the drugs into the brain and reduce their acute effects. 
Other therapeutic targets could be explored in the future, namely 1) preventing 
the toxicity and destruction of synapses, 2) enhancing cognition and improving 
decision-making capacities and 3) reducing the development of drug-associated 
memories coupled to conditional cues, which lead to relapse.  
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OBJECTIVES 
Substance abuse and addiction are the most costly of all neuropsychiatric 
disorders (Madras, 2006). 
In the last decades, much progress has been achieved in the understanding the 
effects of the drugs of abuse on the brain. However, efficient treatments that prevent 
relapse have not been developed. 
Understanding the mechanisms that underlie brain dysfunction observed in 
these individuals may contribute to improve the treatment of drug addiction, which may 
have social and economic consequences. 
 
The main objective of the work presented in Part III, is to study the neuronal 
dysfunction and neurotoxicity induced by the drugs of abuse cocaine, amphetamine 
(Chapter 1) and heroin (Chapter 2). 
 
 
The specific objectives were: 
 
1) To study the dysfunction of dopaminergic cells upon chronic exposure to 
cocaine, amphetamine – Manuscripts 1 (Chapter 1) - and street heroin- Manuscript 2 
(Chapter 2), compared to H2O2 
 
2) To analyse the contribution of NMDA receptor subunits (NR1/NR2A or 
NR1/NR2B) to street heroin toxicity – Manuscript 3 (Chapter 2) 
 
3) To investigate the mechanisms of neurotoxicity of street heroin in cortical 
neurons – Manuscript 4 (Chapter 2) 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
2 PART II - MATERIAL AND METHODS 
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2.1 Materials 
Optimem medium, Neurobasal medium and B27 supplement were supplied by 
Gibco (Paisley, UK). RPMI, DMEM, Chymostatin, leupeptin, antipain, pepstatin A, N-
Acetyl-Ile-Glu-Pro-Asp-p-nitroaniline (Ac-IEPD-pNA), N-Acetyl-Val-Asp-Val-Ala-Asp-p-
nitroanilide (Ac-VDVAD-pNA), N-Acetyl-Val-Glu-Ile-Asp-p-nitroanilide (Ac-VEID-pNA) 
and N-Acetyl-Leu-Glu-His-Asp-p-nitroanilide (Ac-LEHD-pNA) trypsin, Soybean Trypsin 
Inhibitor (SBTI), 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide 
(MTT), anti-microtubule associated protein 2 (MAP-2), ifenprodil and glutathione ethyl 
ester (GSH-EE) were supplied by Sigma Chemical Co (St Louis, MO, USA). Anti-
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), trolox and N-Acetyl-Asp-Glu-
Val-Asp p-nitroanilide (Ac-DEVD-pNA) were supplied by Calbiochem (Darmstadt, 
Germany). PC12 cells and HEK293 cells were obtained from ATCC (Manassas, VA, 
USA). NT-2 cells were a kind gift from Dr. Russell Swerdlow (University of Virginia 
Health System, VA, USA). The superfect transfection reagent was obtained from 
Qiagen (Hilden, Germany). The rat NR1 (NR1a), NR2A and NR2B cDNA clones 
inserted respectively in pEGFP-N3, pcDNAI, or pDP3 were a generous gift from Dr. 
John Woodward (Medical University of South Carolina, Charleston, SC, USA). The 
antibodies anti-caspase 3, anti-caspase 9, anti-Bax and anti-cleaved poly(ADP-ribose) 
polymerase (PARP) were supplied by Cell Signaling (Beverly, MA, USA); ECF and 
anti-rabbit IgG were obtained from Amersham Biosciences (Piscataway, NJ, USA); 
MitoTracker Green, Hoechst 33342, Alexa anti-rabbit IgG 488, Alexa anti-mouse IgG 
594 and rhodamine 123 were supplied by Molecular Probes (Eugene, OR, USA). 
Antibodies against the native and denatured forms of cytochrome c were obtained from 
PharMingen (San Diego, CA, USA). MK-801 was a kind gift from Merck Sharp & 
Dohme Research Laboratories (Merck & Co. Inc., Whitehouse Station, NJ, USA). 
Idebenone was a kind gift from Seber (Odivelas, Portugal). Clocinnamox, D-Phe-Cys-
Tyr-D-Trp-Orn-Thr-Pen-Thr amide (CTOP), 2,3-dioxo-6-nitro-1,2,3,4-tetrahydro-
benzoquinoxaline-7-sulfonamide (NBQX), d-2-amino-5-phosphono-pentanoic acid (d-
AP-5) and naltrindole were purchased from Tocris (Bristol, UK). Anti-Bcl-2 was 
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obtained from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Amphetamine, 
May-Grünwald and Giemsa solutions were obtained from Merck (Darmstadt, 
Germany). Cocaine and a sample of seizure street heroin was provided by the Instituto 
da Droga e da Toxicodependência (IDT, Lisbon, Portugal). Morphine and codeine 
hydrochlorides were obtained from Uquipa (Lisbon, Portugal).  
 
2.2 Methods 
2.2.1 Cell culture 
2.2.1.1 Culture and incubation of PC12 cells 
 PC12 cells were cultured in 75 cm2 flasks, in RPMI 1640 medium 
supplemented with 10% (v/v) horse serum, 5% (v/v) bovine serum, 50 U/mL penicillin, 
and 50 mg/mL streptomycin. Cultures were maintained at 37ºC in a humidified 
incubator containing 95% air and 5% CO2. In one study, the cells were plated on poly-
L-lysine coated multiwells at a density of 50,000 cells/cm2 for MTT studies and 160,000 
cells/cm2 for HPLC analysis.  
For chronic treatment, PC12 cells were cultured for 7-12 months in RPMI 
medium supplemented with non-toxic concentrations of cocaine (30 μM), amphetamine 
(30 μM), street heroin (10 μM) or H2O2 (10 μM). Toxicity studies revealed similar 
responses in cells chronically exposed to the drugs or H2O2 from 7 to 12 months (data 
not shown). For acute treatment, the cells were exposed to toxic concentrations of 
cocaine (3 mM), amphetamine (1 mM), street heroin (300 μM) or H2O2 (50-75 μM), for 
24-96 h. Concentrations of the stimulant drugs (Oliveira et al., 2002) or H2O2 (data not 
shown) for chronic or acute experiments were previously established in the PC12 cells. 
Street heroin was dissolved in DMSO and the maximal concentration of DMSO (0.2 %) 
used in the experiments was not toxic per se. 
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For the study of the activity of antioxidant enzymes, the cells were grown in 
suspension, and passed twice a week, in culture medium (control) or in culture medium 
supplemented with non-toxic concentrations of cocaine (30 μM), amphetamine (30 μM) 
or H2O2 (10 μM), for 1 to 4 weeks.   
2.2.1.2 Culture and transfection of HEK293 cells  
HEK 293 cells were obtained from the American Type Culture Collection 
(Manassas, VA, U.S.A.) and were grown in Dulbecco’s modified Eagle’s medium 
(DMEM; Sigma Chemical Co., St. Louis, MO, U.S.A.) supplemented with 10% fetal 
bovine serum (Biochrom  AG, Berlin, Germany), penicillin (100 U/ml) and streptomycin 
(100 µg/ml). Cells were grown to 50-75% confluence in poly-L-lisine coated multiwells 
and transfected using the superfect transfection reagent (Qiagen, Hilden, Germany) 
according to the manufacturer’s instructions. In co-transfections the NR1:NR2 plasmid 
ratio was 1:4. Cells were transfected with the DNA-superfect mixture for 4 h and further 
incubated for 24 h with 10- 1000 μM heroin (provided by the Instituto da Droga e da 
Toxicodependência, Lisbon, Portugal) and/or 10 μM MK-801, in fresh culture media. 
The rat NR1 (NR1a), NR2A, and NR2B cDNA clones inserted respectively in pEGFP-
N3, pcDNAI or pDP3 were a generous gift from Dr. John Woodward (Medical 
University of South Carolina, Charleston, U.S.A.). NR1 is expressed as a fusion protein 
with EGFP and is referred in the manuscript as NR1-GFP. 
2.2.1.3 Culture of cortical neurons  
The frontal cortices of rat embryos (16-17 days) were dissected and the cells 
washed with isolation medium (in mM: 120.9 NaCl, 4.83 KCl, 1.22 KH2PO4, 25.5 
NaHCO3, 13.0 glucose, 10.0 HEPES) containing 0.3% BSA. The cells were 
sedimented at 1000 rpm and dissociated with isolation medium, supplemented with 
0.02% trypsin and 0.04 mg/mL DNAse for 10 min at 37ºC. Trypsin was inactivated by 
adding 0.075% SBTI (trypsin inhibitor) and the cells were centrifuged at 1000 rpm for 5 
min. The cells were then mechanically dissociated in isolation medium containing 
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0.012% SBTI and centrifuged at 1000 rpm for 5 min. The resulting pellet was 
ressuspended in Neurobasal medium with B27 supplement, 0.2 mM glutamine, 0.1 
mg/mL streptomycin and 100 U/mL penicillin (in 5% CO2/ 95% air), and plated on poly-
L-lysine (1 mg/mL) coated multiwells or coverslips. Cortical cultures contained a small 
percentage of glial cells (less than 10%) as assessed by immunofluorescence using 
anti- MAP2 and anti-glial fibrillary acidic protein (GFAP) (not shown). After 6 days in 
culture, the cells were incubated with street heroin (4.3- 1280 μg/mL), pure heroin (215 
or 840 μM), morphine (4.5 or 17.6 μM) or 6-MAM (47 or 183 μM), for 24 h, unless 
otherwise specified. Street heroin was dissolved in DMSO and the maximal 
concentration of DMSO (0.2 %) used in the experiments was not toxic per se (not 
shown). Where specified, 1 μM z-VAD-fmk, 1 μM naloxone, 1 μM clocinnamox, 1 μM 
CTOP, 1 μM naltrindole, 2 μM MK-801, 3 μM ifenprodil, 100 μM d-AP-5, 10 μM NBQX, 
3 μM idebenone, 100 μM trolox or 100 μM GSH-EE were preincubated for 30-60 min 
and were present in the culture media throughout all the experiments. The 
concentrations of the compounds tested were chosen based on previous studies (Gil et 
al., 2003; Araujo et al., 2003; Williams et al., 2001).  
2.2.1.4 Culture of NT-2 cells  
The production of the NT2 rho0 cell line used in these experiments was 
previously described (Swerdlow et al., 1997). NT-2 rho+ and rho0 cells were grown 
routinely in 75 cm2 tissue culture flasks in Optimem Medium, supplemented with 10% 
heat inactivated fetal calf serum, penicillin (50 U/mL), and streptomycin (50 µg/mL). 
Uridine (50 µg/mL) and pyruvate (200 µg/mL) were also added to rho0 cell growth 
medium. The cells were grown and maintained at 37°C in a humidified incubator 
containing 95% air and 5% CO2. The cells were plated at 0.1×106 cm-2 for cell viability 
assay and incubated with street heroin (128 μg/mL) for 24 h. 
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2.2.2 Assessment of cell viability 
2.2.2.1 MTT assay  
 Metabolic cell viability was measured using the MTT reduction assay, at 570 
nm (Mosmann, 1983). The cells were incubated with 0.5 mg/mL MTT in Na+ medium 
(in mM: 140 NaCl, 5 KCl, 1 MgCl2, 1 NaH2PO4, 1.5 CaCl2, 5.6 glucose, 20 HEPES, pH 
7.4) for 2 h and the precipitated salt was dissolved with 0.04 M HCl in isopropanol. The 
capacity of treated cells of reducing the tetrazolium salt was expressed as a 
percentage of absorbance (at 570 nm) in control cells. 
2.2.2.2 LDH assay  
The integrity of the plasma membrane of cortical neurons was determined by 
monitoring the leakage of lactate dehydrogenase (LDH), by following the rate of 
conversion of NADH to NAD+ at 340 nm, according to Bergmeyer and Bernt (1974). 
Alterations in membrane integrity were expressed as a percentage of LDH release, 
over the total LDH, compared to control cells. 
2.2.3 Measurement of dopamine and DOPAC 
levels 
The intracellular levels of dopamine and dihydroxyphenylacetic acid (DOPAC) 
were determined after cell extraction with 0.1 M perchloric acid (0-4ºC). The cells were 
centrifuged at 15,800 xg for 10 min, and the pellet was solubilized with 1 M NaOH for 
total protein analysis using the Sedmak method (Sedmak and Grossberg, 1977). The 
resulting supernatants, stored at –80ºC, were extracted with alumina, using 
dihydroxybenzylamine (DHBA) as an internal standard, and assayed for dopamine and 
DOPAC analysis by HPLC with electrochemical detection, as described previously 
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(Warnhoff, 1984). Dopamine accumulated in the cultured media upon acute exposure 
to cocaine or amphetamine was determined using the same procedure. 
2.2.4 Morphological analysis of PC12 cells 
Cell morphology was evaluated by staining cell smears with May-Grünwald-
Giemsa staining procedure. Naïve cells and cells chronically exposed to the stimulant 
drugs or to H2O2 (1x106 cells), before or after an acute exposure to 50 μM H2O2, were 
centrifuged at 200 xg for 5 min, ressuspended in 30 μl of FBS and placed on a slide for 
analysis at the microscope. Cell smears were stained with May-Grünwald and Giemsa 
solutions. Cell morphology was analysed by optic microscopy using a Leitz Dialux 20 
microscope associated with a digital camera. 
2.2.5 Measurement of intracellular ATP 
levels 
Intracellular ATP, ADP and AMP levels were determined after cell extraction 
with 0.3 M perchloric acid (0-4ºC). The cells were centrifuged at 15,800 xg for 10 min, 
and the pellet was solubilized with 1 M NaOH for total protein analysis using the Biorad 
protein assay (Biorad). The supernatants were neutralized with 3 M KOH in 1.5 M Tris, 
and centrifuged at 15,800 xg for 10 min. The resulting supernatants, stored at –80ºC, 
were assayed for adenine nucleotide determination, by separation in a reverse-phase 
HPLC, as described previously (Rego et al., 1997). 
2.2.6 Evaluation of the activity of 
antioxidant enzymes 
PC12 cells were centrifuged at 1000 x g for 10 minutes and then ressuspended 
in 200 μl of a lysis buffer containing 10 mM HEPES, 10 mM NaCl, 3 mM MgCl2, 1 mM 
EGTA, 0.1% Triton X-100, 2 mM DTT, 1:1000 of a protease inhibitor cocktail 
(chymostatin, leupeptin, antipain- serine and cysteine protease inhibitors and pepstatin 
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A - potent inhibitor of acid proteases; 1mg/mL each); 0.1 mM PMSF, 50 mM NaF, pH 
7.5. The cells were allowed to lyse on ice, for 40 minutes, and then the samples were 
centrifuged at 2300 x g for 12 min, 4ºC. The supernatants were collected and stored at 
-20ºC. 
2.2.6.1 Glutathione peroxidase (GPx) activity 
assay 
A reaction mixture containing 5 mM K2HPO4, 5 mM KH2PO4, 0.1 mM EDTA, 
1mM GSH, 0.24 U/mL glutathione reductase and 0.25 mM NADPH was freshly 
prepared from stock solutions. Five μl of sample were added to 175 μl of the reaction 
mixture and tested for GPx activity by initiation with 1.1 mM tert-butyl hydroperoxide 
(20 μl). The oxidation of NADPH was monitored at 340 nm for 5 minutes, against 
blanks prepared without NADPH, at 25ºC in a Spectramax Plus 384 microplate reader 
(Molecular Devices). The acitivity of GPx was calculated and normalized in percentage 
of the control. 
2.2.6.2 Glutathione reductase (GRed) activity 
assay 
A reaction mixture containing 100 mM K2HPO4, 1 mM EDTA and 0.1 mM 
NADPH was freshly prepared from stock solutions. Twenty μl of sample were added to 
170 μl of the reaction mixture and tested for GRed activity by initiation with 1 mM 
GSSG (10 μl). The oxidation of NADPH was monitored at 340 nm for 5 minutes, at 30 
ºC, against blanks prepared without GSSG, in a Spectramax Plus 384 microplate 
reader (Molecular Devices). The acitivity of GRed was calculated and normalized in 
percentage of the control. 
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2.2.6.3 Superoxide dismutase (SOD) activity 
assay 
A reaction mixture containing 43.75 mM KH2PO4, 0.088 mM EDTA and 0.025 
mM hypoxanthine, 0.025% triton X-100 and 0.1 mM NBT was freshly prepared from 
stock solutions. 10 μl of sample were added to 187 μl of the reaction mixture and 
tested for SOD activity by initiation with 0.025 U/mL Xanthine Oxidase (3 μl). The 
reduction of NBT was monitored at 560 nm for 5 minutes at 25ºC, against blanks 
prepared without hypoxanthine, in a Spectramax Plus 384 microplate reader (Molecular 
Devices). The maximum rate of NBT reduction mediated by the superoxide radical was 
determined in wells prepared without any test sample. The activity of SOD in the test 
samples was proportional to the percentage of inhibition of the maximum NBT 
reduction. The acitivity of superoxide dismutase was calculated and normalized in 
percentage of the control. 
 
2.2.7 Chemical analysis 
A street heroin sample was analysed in order to quantify diacetylmorphine, 
morphine, 6-MAM, codeine and acetylcodeine content. HPLC analyses were 
conducted on an HPLC system (Merck/Hitachi–LaChrom) equipped with a diode-array 
detector (DAD). The analytical column was a commercially prepacked reverse phase 
(RP-18) column (250 × 4.0 mm i.d., 5 μm) with precolumn (Waters, Watford, UK). An 
isocratic elution was performed at a flow rate of 1.5 mL min-1 and the absorbance was 
measured at 216 nm. The analysis was carried out, at room temperature, using a 
solution of 60% 10 mM aqueous ammonium acetate (pH 3) plus 40% acetonitrile as 
mobile phase. Prior to use, the solutions were filtered and subsequently sonicated for a 
minimum of 15 min. The volume of sample injected was 20 μL. A calibration curve of 
six standards was prepared for each of the compounds (heroin, morphine, 6-MAM, 
codeine and acetylcodeine). Compounds on seizure street heroin samples were 
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identified by comparison of their retention times with those of known standards. For this 
study heroin and analogs were synthesized due to the nonavailability of the 
compounds from commercial sources. Heroin and acetylcodeine were synthesized by 
the classic method of acetylation, using acetic anhydride and pyridine (Garrido et al., 
2004b; Garrido et al., 2004a) at room temperature. 6-Monoacetylmorphine was 
obtained by deacetylation of the phenolic group of heroin under mild conditions 
(Garrido et al., 2004b). Qualitative and quantitative analysis of the seizure street heroin 
was accomplished using HPLC with UV detection. Street heroin maintained the same 
composition throughout the experiments. Qualitative thin-layer chromatography was 
used to detect the presence of caffeine and sugars (Moffat, 1986; Chiarotti et al., 1991; 
Sharma et al., 2005).  
2.2.8 Immunocytofluorescence 
2.2.8.1 Cytochrome c  
 The cells were incubated with MitoTracker Green (1 μM) in Na+ medium for 1 h. 
After fixation in 4% paraformaldehyde containing 4% sucrose in saline buffer (PBS, in 
mM: NaCl 137, KCl 2.7, K2HPO4 1.4, KH2PO4 4.3 at pH 7.4), the cells were incubated 
with 20 mM glycine. After cell permeabilization in the presence of saponin (0.1% in 20 
mM glycine), the cells were incubated with a specific antibody against the native form 
of cytochrome c (PharMingen, 1:100 in 0.1% saponin), which was detected by using a 
secondary antibody Alexa Fluor 594 anti-mouse IgG (1:200 in 0.1% saponin). The cells 
were visualized in a confocal microscope (Bio-Rad MRC 600). 
2.2.8.2 Cleaved PARP 
The cells were fixed in 4% paraformaldeyde, permeabilized in 0.2% Triton X-
100, for 2 min, and blocked in 3% BSA for 30 min. The fragment resulting from the 
cleavage of PARP by caspase-3 was detected by using a specific primary antibody 
Materials and Methods 
 
 74 
(1:100 in 3% BSA) and a secondary Alexa anti-rabbit 488 antibody (1:200 in 3% BSA). 
The nuclei were stained by using Hoechst 33342 (1 µg/mL) and the cells were 
visualized in an epifluorescence microscope (Zeiss Axioscope). 
2.2.9 Fluorimetric evaluation of rhodamine-
123 cellular retention 
The cells were loaded with 1 μM rhodamine-123 for 10 min, in the dark, at 37ºC. 
The fluorescence (λex 505nm and λem 525nm) was recorded for 10 min, before and 
after permeabilization with 0.5% Triton X-100, in a SPEX Fluorolog spectrometer 
equipped with a thermostatic water bath. Rhodamine-123 retention was determined by 
the difference between total fluorescence (after permeabilization) and the initial value 
of fluorescence. Because positively charged rhodamine-123 is retained by the 
mitochondria under normal conditions, corresponding to a high mitochondrial 
membrane potential (ΔΨm), a decrease in cellular retention of rhodamine-123 was 
associated with a decrease in ΔΨm (Palmeira et al., 1996). 
2.2.10 Colorimetric evaluation of caspases-
like activity 
The cells were dissociated in lysis buffer [in mM: 25 HEPES, 2 MgCl2, 1 EDTA, 
1 EGTA, 2 DTT, 0.1 PMSF and 1 µg/mL of protease inhibitor cocktail. The resulting 
extracts were frozen and thawed three times, centrifuged at 15,000 g for 10 min (4ºC), 
and the protein (supernatant fraction) was quantified by the Bio-Rad protein assay. The 
supernatant was tested for the activity of caspases 2, 3, 6, 8 and 9, at 405 nm, after 
reaction with the respective substrates Ac-VDVAD-pNA, Ac-DEVD-pNA, Ac-VEID-pNA, 
Ac-IEPD-pNA and Ac-LEHD-pNA (100 μM, for 2 h at 37ºC) as described by Gurtu et al 
(1997). The results were normalized over the control absorbance value, using the 
same amount of protein (25-40 μg/assay). 
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2.2.11 Western blotting 
2.2.11.1 Sample preparation  
For the analysis of caspases activation by western blotting, the cells were 
treated as for the caspases activity assay. For the analysis of Bcl-2 and Bax levels, 
total extracts were obtained using total extraction buffer (in mM: 20 Tris (pH 7); 100 
NaCl; 2 EDTA; 2 EGTA, 50 NaF; 1 sodium orthovanadate; 0.1 PMSF) supplemented 
with 100 nM okadaic acid, 1 µg/mL of protease inhibitor cocktail, 0.5% SDS and 0.5% 
Triton X-100. For the analysis of cytochrome c release, cell lysates were homogenized 
in sucrose buffer (in mM: 250 sucrose; 20 HEPES, 10 KCl; 1.5 MgCl2; 1 EDTA; 1 DTT; 
0.1 PMSF) supplemented with 1 µg/mL of protease inhibitor cocktail. The mitochondrial 
fraction (P2) was separated by centrifugation at 500 x g for 12 min (4ºC) followed by 
centrifugation of the resulting supernatant at 12,000 x g for 20 min (4ºC). Cytosolic 
fraction (P3) was obtained upon protein precipitation of the resulting supernatant with 
5% trichloroacetic acid, followed by centrifugation at 15,800 x g for 10 min and pH 
neutralization with KOH. 
2.2.11.2 Immunoblotting procedures  
Proteins (30-50 μg/sample) were denatured and separated by SDS-PAGE 
(12%), and then transferred to a PVDF membrane, which was then incubated with 
rabbit anti-caspase-3 (1:1000), rabbit anti-caspase-9 (1:1000), mouse anti-Bcl-2 
(1:500), rabbit anti-Bax (1:1000), mouse anti-cytochrome c (1:500) and mouse anti-
GAPDH (1:2500) antibodies. The secondary detection was performed using anti-
mouse IgG or anti-rabbit IgG alkaline-phosphatase-bound antibodies (1:20000). The 
bands were developed with ECF, visualized in a VersaDoc imaging system (Bio-Rad) 
and quantified using the Quantity One software (Bio-Rad). 
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2.2.12 Statistical analysis 
Data are the mean ± SEM from at least three independent experiments, 
performed in duplicate or triplicate. Statistical analysis was performed by one-way 
ANOVA with Bonferroni post hoc test or by the Student’s t-test, when comparing two 
Gaussian populations (a P<0.05 was considered significant). 
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3.1.1 MANUSCRIPT 1- Differential cytotoxic 
responses of PC12 cells chronically 
exposed to psychostimulants or to 
hydrogen peroxide 
 
 
 
 
 
Based on: Teresa Cunha-Oliveira, A. Cristina Rego, M. Teresa Morgadinho, 
Tice Macedo and Catarina R. Oliveira, Differential cytotoxic responses of PC12 cells 
chronically exposed to psychostimulants or to hydrogen peroxide, Toxicology (2006) 
217: 54-62 and unpublished results. 
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3.1.1.1 Abstract 
Repeated abuse of the stimulant drugs cocaine and amphetamine, is 
associated with extraneuronal dopamine accumulation in specific brain areas. 
Dopamine may be cytotoxic through the generation of ROS, namely H2O2, resulting 
from dopamine oxidative metabolism. In this work we studied the cytotoxicity in PC12 
cells (a dopaminergic neuronal model) chronically and/or acutely exposed to cocaine or 
amphetamine, as compared to H2O2 exposure. Chronic cocaine treatment induced 
sensitization to acute cocaine insult and increased cocaine-evoked accumulation of 
extracellular dopamine, although no changes in DOPAC levels were observed. 
Moreover, dopamine was depleted in cells chronically exposed to amphetamine and 
acute amphetamine toxicity persisted in these cells, indicating that dopamine was not 
involved in amphetamine cytotoxicity. PC12 cells chronically treated with H2O2 were 
totally resistant to acute H2O2, but not to acute cocaine or amphetamine exposure, 
suggesting that the toxicity induced by these stimulant drugs is unrelated to adaptation 
to oxidative stress. Interestingly, chronic cocaine treatment largely, but not completely, 
protected the cells against a H2O2 challenge, whilst a decrement in intracellular ATP 
was observed. H2O2 resistance of cells chronically exposed to H2O2 appears to involve 
changes in the activity of GPx, GRed and SOD, whereas chronic cocaine increased 
GPx activity only, possibly explaining the incomplete resistance to acute H2O2. PC12 
cells chronically exposed to amphetamine initially exhibited changes in GPx, GRed and 
SOD activities that returned to control levels after 4 weeks of exposure. This biphasic 
effect may be explained by dopamine depletion evoked by amphetamine, and may 
explain the lower level of resistance to acute H2O2 of cells chronically exposed to 
amphetamine, in comparison with cells chronically exposed to cocaine. Together, these 
results indicate that cellular adaptations of PC12 cells to cocaine and amphetamine are 
associated with changes in dopamine levels and in the activity of antioxidant enzymes, 
suggesting the involvement of oxidative stress in the chronic effects of these drugs of 
abuse. 
Keywords: Amphetamine, cocaine, drug abuse, neurotoxicity, oxidative stress 
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3.1.1.2 Introduction 
The continuous abuse of drugs is sustained by the activation of the reward 
circuits in the brain, which is mainly associated with changes in dopaminergic activity 
(Di Chiara and Imperato, 1988). The stimulant drugs amphetamine and cocaine are 
known to increase extraneuronal dopamine levels through different mechanisms. 
Amphetamine can redistribute the dopamine stored in vesicles to the cytoplasm (Sulzer 
et al., 1995), inducing non-vesicular release of dopamine, which is mediated by the 
plasma membrane DAT (Kahlig et al., 2005). Amphetamine induces an increase in 
cytosolic dopamine that may contribute to its increased intracellular metabolism by the 
mitochondrial enzyme MAO. On the other hand, cocaine inhibits DAT (Brown et al., 
2001), preventing the reuptake of dopamine to the nerve terminal, thereby increasing 
the levels of dopamine in the synaptic cleft.  
Dopaminergic cells are particularly sensitive to oxidative stress because 
dopamine is easily oxidized by MAO or by auto-oxidation, resulting in the production of 
H2O2. Although amphetamine may inhibit MAO (Ramsay and Hunter, 2002), it was 
previously demonstrated that amphetamine-induced H2O2 production is MAO-
dependent (Duarte et al., 2004). Another source of intracellular H2O2 is the enzyme 
SOD, which detoxifies the radical O2.-, with consequent formation of H2O2. H2O2 is 
detoxified by the antioxidant enzymes GPx and catalase. GPx reduces H2O2 into water, 
and simultaneously oxidizes two molecules of GSH, forming GSSG. GSSG is 
converted back to GSH by GRed. Catalase also converts H2O2 into water. However, 
while GPx is present in the brain mainly in the cytosol and mitochondria, catalase is 
restricted to the peroxisomes and has a modest activity in the brain (Mavelli et al., 
1982). 
ROS have been frequently associated with neuronal cell death due to the 
oxidation of amino acids, phospholipids and nucleic acids (reviewed by Cadet and 
Brannock, 1998). Accordingly, acute exposure to H2O2 has been reported to induce 
apoptotic cell death in PC12 cells (Benedi et al., 2004; Jang and Surh, 2004). In 
contrast, cells chronically exposed to low concentrations of H2O2 become resistant to 
H2O2-induced toxicity (Wiese et al., 1995; Davies, 1999). Thus, acute H2O2 can be 
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used as a model of cytotoxicity, whereas chronic treatment of PC12 cells with H2O2 is a 
model of cellular adaptation (Jackson et al., 1994).  
Chronic exposure to the drugs of abuse in humans induces long-lasting 
changes in gene expression, and some of these changes may be correlated with the 
development of the compulsive behaviour associated with drug addiction (Rhodes and 
Crabbe, 2005, for review). Changes in gene expression induced by chronic drug 
exposure may underlie changes in the cellular responses to stress. These alterations 
are also in the basis for the development of sensitization or tolerance, in human drug 
abusers, in which the response to the same dose of a drug is increased or decreased, 
respectively. These processes contribute to the withdrawal symptoms and to increased 
motivation to drug abuse (Nestler, 2004b). Thus, we hypothesize that chronic drug 
exposure may also be involved in altered responses to cytotoxic insults, such as an 
acute exposure to the same drug or to other cytotoxic stimuli, such as oxidative stress.  
Psychostimulant drugs of abuse have been suggested to induce oxidative 
stress in the brain, upon chronic exposure. Moreover, there are evidences of 
adaptations to oxidative stress upon psychostimulant exposure in vivo (Frey et al., 
2006b; Carvalho et al., 2001; Acikgoz et al., 2000). Chronic d-amphetamine exposure 
has been shown to induce changes in the activity of GPx, GRed (Carvalho et al., 
2001), SOD and catalase (Frey et al., 2006b) in the rat brain. Changes in the activity of 
SOD, GPx and in the levels of GSH and hydroperoxides in the rat brain were also 
observed upon chronic exposure to cocaine (Dietrich et al., 2005). However, it has not 
been previously demonstrated if adaptation to oxidative stress occurs upon direct 
exposure of dopaminergic cells to amphetamine and cocaine. 
Taking into account our previous studies with PC12 cells exposed to the 
stimulant drugs (Oliveira et al., 2002), we analyzed the toxicity of cocaine, 
amphetamine or H2O2 (acute exposure) in PC12 cells chronically exposed to non-toxic 
concentrations of cocaine, amphetamine or H2O2 for 7-12 months, as compared to 
PC12 cells non-exposed to the drugs of abuse (naïve cells). We also evaluated the 
intracellular ATP/ADP levels and the activity of the antioxidant enzymes GPx, GRed 
and SOD upon continuous exposure of PC12 cells to cocaine, amphetamine and H2O2 
in the initial phases of cell adaptation, at 1 to 4 weeks.  
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Our data suggest that the cytotoxic responses of PC12 cells are modified 
depending on the chronic exposure to cocaine, amphetamine or H2O2. In particular, 
increased toxicity of cocaine in cells chronically exposed to this stimulant drug may 
contribute to the behavioural sensitization of drug addicts after acute cocaine exposure. 
Furthermore, changes in energy metabolism and in the activity of antioxidant enzymes 
are involved in the chronic effects of cocaine, amphetamine and H2O2. 
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3.1.1.3 Results 
3.1.1.3.1 Chronic cocaine treatment sensitizes PC12 cells 
to acute cocaine  
The toxicity of acute exposure to stimulant drugs was analyzed in naïve PC12 
cells and cells chronically exposed to cocaine, amphetamine or H2O2, by following the 
MTT reduction assay (Figure 3.1).  
 
 
Figure 3.1: Acute effect of cocaine, amphetamine or H2O2 on the viability of PC12 cells chronically 
exposed to the stimulant drugs of abuse or H2O2. Naïve PC12 cells or PC12 cells chronically 
exposed to cocaine, amphetamine or H2O2 for 7-12 months were incubated with 1 mM 
amphetamine (amph) or 3 mM cocaine for 4 days or 75 μM H2O2 for 24 h. Cell viability was 
determined by the MTT reduction assay. Data were normalized in percentage of the 
respective controls, typically with absorbance values (at 570 nm) of 0.42 (naïve), 0.84 
(cocaine), 0.83 (amphetamine) and 0.90 (H2O2). Data are the means ± SEM of at least 3 
experiments performed in triplicate. Statistical significance: ***P<0.001 as compared with the 
respective control; ###P<0.001 compared to naïve cells. 
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The effect of long-term exposure to cocaine, amphetamine or H2O2 in cell 
viability was not possible to assess using the MTT assay because cells chronically 
exposed to these agents revealed an increased capacity to reduce MTT (about 2 fold), 
which can result from an increase in cell proliferation and/or an increase in cell viability. 
Exposure of dividing mammalian fibroblasts to low concentrations of oxidants (3-15 µM 
H2O2) was previously reported to stimulate cell growth and proliferation (Davies, 1999). 
Thus, it is possible that the increase in MTT reduction observed in cells chronically 
exposed to H2O2 or to the stimulants is due to an increase in cell proliferation rather 
than a direct effect in cellular reduction systems or in cell viability. Therefore, MTT 
reduction data were normalized as a percentage of control for each sub-cell line to 
evaluate the susceptibility induced by acute exposure to the agents, after different long-
term pre-treatments. Acute cocaine exposure (3 mM, for 96 h) decreased the viability 
of naïve cells by about 40%, whereas in cells previously exposed to cocaine the 
decrement in cell viability was about 60%. Thus, chronic cocaine sensitized PC12 cells 
to acute cocaine toxicity by about 20%. In contrast, acute incubation with amphetamine 
(1 mM, for 96 h) induced the same decrease in cell viability (about 40%) in naïve cells 
or in cells previously exposed to amphetamine (Figure 3.1).  
Since cocaine and amphetamine are known to interfere with the dopaminergic 
system, we evaluated the effects of chronic and acute exposure to these 
psychostimulants in the accumulation of extracellular dopamine (Figure 3.2 A,B), 
intracellular dopamine levels (Figure 3.2 C,D) and the endogenous levels of its 
metabolite, DOPAC (Figure 3.2.E,F).  
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Figure 3.2: Dopamine and DOPAC levels upon an acute exposure to cocaine or amphetamine, of naïve 
cells or cells chronically exposed to cocaine (A,C,E) or amphetamine (B,D,F), for 7-12 
months. The cells were acutely exposed to cocaine (3 mM) or amphetamine (1 mM), for 24 h. 
Intra and extracellular dopamine and DOPAC levels were determined by HPLC with 
electrochemical detection. Data are the means ± SEM of at least 3 experiments performed in 
triplicate. Statistical analysis: *P<0.05,**P<0.01 and ***P<0.001, compared with the respective 
control; ##P<0.01 compared to naïve cells. n.d. - non-detectable levels. 
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Acute cocaine (3 mM) or amphetamine (1 mM) exposure for 24 h in naïve PC12 
cells, increased extracellular dopamine accumulation, by about 7.6-fold and 5.6-fold, 
respectively (Figure 3.2.A,B). Concordantly, under these conditions, a decrease in 
intracellular dopamine levels was observed in the presence of cocaine (decreased by 
3.5 fold) or amphetamine (decreased by 8.3-fold) (Figure 3.2.C,D). Moreover, acute 
amphetamine treatment largely decreased DOPAC levels, compared to the control, by 
4.7-fold (Figure 3.2.F), whereas no significant changes were observed in cells exposed 
to cocaine (Figure 3.2.E). The decrement of DOPAC levels in cells exposed to 
amphetamine is consistent with the ability of amphetamine to inhibit MAO (Ramsay and 
Hunter, 2002). 
In cells chronically treated with cocaine, further exposure to cocaine evoked a 
significant increase in extracellular dopamine by about 18.5% (Figure 3.2.A), when 
compared to naïve cells. This increase can be related with a non-statistical increase 
(by 2.2-fold) in intracellular dopamine levels in cells chronically exposed to cocaine, 
when compared to naïve cells (Figure 3.2.C). DOPAC levels were not significantly 
changed upon incubation with cocaine in cells chronically treated with the same drug, 
indicating that the extra dopamine was not metabolized by MAO (Figure 3.2.E). These 
data suggested that cocaine sensitization in cells chronically exposed to cocaine 
(Figure 3.1) was related with an increase in cocaine-evoked extracellular dopamine 
accumulation. 
Interestingly, no detectable levels of extracellular or intracellular dopamine 
(Figure 3.2.B,D) or intracellular DOPAC (Figure 3.2.F) were observed in cells 
chronically exposed to amphetamine. Thus, amphetamine toxicity in cells chronically 
exposed to amphetamine (Figure 3.1) can not be attributed to changes in extracellular 
or intracellular dopamine. Amphetamine-induced depletion of endogenous dopamine 
can be explained by long-term inhibition of tyrosine hydroxylase, the rate-limiting 
enzyme in the synthesis of dopamine (Bowyer et al., 1998). On the other hand, 
amphetamine is also known to decrease DAT activity (Kahlig et al., 2004), decreasing 
the reuptake of released dopamine. 
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3.1.1.3.2 Cells chronically exposed to cocaine are partially 
resistant to H2O2  
Repeated exposure to H2O2 is known to induce cellular adaptation to acute 
H2O2 in PC12 cells (Jackson et al., 1994) and in other cell types (Wiese et al., 1995; 
Seong et al., 2002). In this study, we compared the toxicity of H2O2 in cells chronically 
exposed to the drugs of abuse or to H2O2. In naïve cells, acute exposure to H2O2 (75 
μM, for 24 h) induced a decrease in cell viability by about 80% (Figure 3.1). In contrast, 
in cells chronically exposed to H2O2 the same acute exposure did not significantly 
change cell viability, indicating that these cells are completely resistant to H2O2-induced 
toxicity and thus adapted to oxidative stress injury. Moreover, upon chronic exposure to 
H2O2, the toxicity of cocaine or amphetamine was similar to the toxicity observed in 
naïve cells (Figure 3.1), suggesting that acute toxic effects mediated by the stimulant 
drugs were independent of adaptive changes induced by oxidative stress.  
Interestingly, cells chronically exposed to cocaine were more resistant to acute H2O2 
than naïve cells, showing a decrease in cell viability by about 25% only (Figure 3.1). In 
contrast, cells chronically exposed to amphetamine were only slightly more resistant to 
acute exposure to H2O2, (cell viability decreased by about 70%), in comparison with 
naïve cells. No significant changes in Bcl-2/Bax were observed in PC12 cells 
chronically exposed to cocaine, amphetamine or H2O2 (data not shown), thus not 
explaining the different susceptibility of these cells. 
Since chronic cocaine appeared to mediate some resistance to H2O2 toxicity 
(Figure 3.1), we also analyzed the morphology of PC12 cells and the intracellular levels 
of ATP upon an acute exposure to H2O2 in cells chronically treated with cocaine, which 
were compared to cells adapted to H2O2. Exposure of naïve cells to H2O2 (50 μM, for 
24 h) induced a decrease in cell viability by about 70% (data not shown), similar to 75 
µM H2O2 (Figure 3.1). Under these conditions, the cells showed membrane blebbing 
and cell shrinkage (Figure 3.3.A), indicating some degree of lesion, compatible with the 
viability assay. In contrast, cells chronically exposed to H2O2 or to cocaine, showed a 
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normal morphology after an acute exposure to H2O2 (Figure 3.3.A). These data were in 
accordance with data shown in Figure 3.1.  
 
Figure 3.3: Effect of an acute exposure to H2O2 in cells chronically exposed to cocaine or H2O2. (A) Cell 
morphology: cell smears were stained following May-Grunwald staining procedure and 
photographed under 100 x magnification in a Leitz Dialux 20 light microscope associated with 
a camera. Note the formation of blebs and cell shrinkage upon exposure of naïve cells to 50 
μM H2O2 for 24 h. Images are representative of 3 experiments performed in duplicate. (B) 
Intracellular ATP levels were detected by HPLC with UV detection, before or after incubation 
with 50 μM H2O2 for 24 h. Data are the means ± SEM of 4 experiments performed in triplicate. 
Statistical significance: *P <0.05 and **P <0.01 compared to the control.  
 
Acute exposure of naïve cells to H2O2 induced a decrease in intracellular ATP 
levels, by about 23%, whereas in cells chronically exposed to H2O2, ATP levels were 
maintained after an acute exposure to H2O2 (Figure 3.3.B), indicating a complete 
adaptation to oxidative stress-mediated changes in energy metabolism. However, in 
cells chronically exposed to cocaine, ATP levels were decreased by about 28% after 
exposure to H2O2. Thus, although cells chronically exposed to cocaine were more 
resistant to H2O2, intracellular ATP levels were still affected, suggesting that this may 
account for the increased susceptibility of cells chronically treated with cocaine, 
compared to cells treated with H2O2, when submitted to an acute H2O2 challenge 
(Figure 3.1). Endogenous levels of ADP were not significantly affected by acute 
exposure to H2O2 in naïve cells or in cells chronically exposed to cocaine or H2O2 (data 
not shown), suggesting a decrease in ATP synthesis. The apparent lack of correlation 
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between the high toxicity of acute H2O2 (Figure 3.1) and the moderate decrease in ATP 
levels (Figure 3.3), under similar experimental conditions, can be explained by the 
normalization of ATP levels over the protein content, which is not taken into 
consideration in the MTT reduction assay.  
 
 
3.1.1.3.3 Chronic exposure to cocaine or amphetamine 
induces changes in the activity of antioxidant 
enzymes  
The involvement of oxidative stress in the chronic effects of cocaine and 
amphetamine was further evaluated in PC12 cells exposed to cocaine (30 μM), 
amphetamine (30 μM) and H2O2 (10 μM) in the initial phases of cell adaptation, for 1 - 4 
weeks, by analyzing the activity of the antioxidant enzymes GPx (Figure 3.4.A), GRed 
(Figure 3.4.B) and SOD (Figure 3.4.C). Results in this section are presented as 
unpublished data, which are complementary to the results previously described. 
 
GPx detoxifies H2O2 producing water, by using GSH which is converted into 
GSSG. Chronic exposure to cocaine induced an increase in the activity of GPx (136.6 
%) in PC12 cells, upon 4 weeks exposure (Figure 3.4.A). In the case of chronic 
exposure to amphetamine, the activity of GPx was increased in PC12 cells upon 3 
weeks exposure (159.3 %), and returned to control levels upon 4 weeks exposure to 
amphetamine. Chronic exposure to H2O2 induced an increase in GPx activity in PC12 
cells, upon 3 (172.3 %) and 4 (157.8 %) weeks of exposure, which compensates for 
the increased need of the cells to detoxify H2O2. 
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Figure 3.4: Time course of glutathione peroxidase (A), glutathione reductase (B) and (C) superoxide 
dismutase activities and ATP/ADP levels (D) upon continuous exposure to cocaine, 
amphetamine or H2O2 for 1-4 weeks. PC12 cells were incubated with cocaine (30 μM), 
amphetamine (30 μM) or H2O2 (10 μM). The activity of antioxidant enzymes and the ATP/ADP 
ratio were normalized over the values of the respective controls. Data are the mean ± SEM of 
5 experiments performed in duplicate. *P< 0.05 **P< 0.01 ***P< 0.001 when compared to 
control PC12 cells. 
 
GRed reduces GSSG, regenerating GSH. Chronic exposure to cocaine did not 
significantly affect GRed activity whereas chronic exposure to amphetamine induced a 
decrease in GRed activity (59.2 %) after 3 weeks of exposure, returning to control 
levels upon 4 weeks of exposure to amphetamine (Figure 3.4.B). H2O2 initially induced 
an increase in GRed activity (141.3 %) upon 1 week exposure, returning to control 
levels upon 2 weeks of exposure of PC12 cells to H2O2. 
Manuscript 1: Chronic effects of psychostimulants 
 
 95
 
SOD converts the superoxide anion into H2O2, a less toxic molecule. SOD 
activity was not significantly affected by chronic exposure to cocaine (Figure 3.4.C). In 
contrast, chronic exposure to amphetamine induced a decrease in SOD activity (46.0 
%) upon 3 weeks of exposure, returning to control levels upon 4 weeks exposure to 
amphetamine. H2O2 induced a decrease in SOD activity in PC12 cells, upon 3 (62.7 %) 
and 4 (52.9 %) weeks exposure. 
 
Oxidative stress induces changes in cell metabolism. We have previously 
shown that acute exposure to H2O2 induces a decrease in ATP levels in PC12 cells, 
whereas chronic (7-12 months) exposure showed no significant changes in cellular 
ATP (Figure 3.3.B). Therefore, earlier stages of exposure to H2O2 may involve changes 
in energy metabolism. In this context, we analyzed the intracellular levels of ATP/ADP 
in PC12 cells exposed to cocaine, amphetamine and H2O2 for 1-4 weeks (Figure 
3.4.D). We observed a decrease in ATP/ADP levels in comparison with the controls, 
upon 2 weeks of exposure to cocaine (49.1 %), amphetamine (57.2 %) or H2O2 (56.1 
%). Interestingly, the levels of ATP/ADP returned to control levels upon 3 weeks of 
exposure to the drugs of abuse or to H2O2. 
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3.1.1.4 Discussion 
3.1.1.4.1 Cocaine sensitization and dopamine toxicity 
In this study we showed that chronic cocaine increases the susceptibility of 
PC12 cells to acute cocaine toxicity, occurring concomitantly with enhanced cocaine-
evoked dopamine release. PC12 cells chronically exposed to cocaine showed a non-
statistical increase (by 2.2-fold) in intracellular dopamine levels, which could help to 
explain the increase in cocaine-evoked extracellular dopamine accumulation observed 
in Figure 3.2.A, since dopamine release induced by cocaine is dependent on the 
vesicular pool of the neurotransmitter (Pifl et al., 1995). Repeated cocaine 
administration has been described to increase tyrosine hydroxylase activity, the rate-
limiting enzyme in the biosynthesis of dopamine, in brain areas affected by cocaine, 
such as the ventral tegmental area (Sorg et al., 1993) or the substantia nigra (Vrana et 
al., 1993). Since reuptake of dopamine is inhibited by cocaine (Brown et al., 2001), 
increased intracellular levels of dopamine could be due to increased dopamine 
biosynthesis. Furthermore, under control conditions, extracellular dopamine levels in 
cells chronically exposed to cocaine were not statistically different from those in naïve 
cells (Figure 3.2A). This observation could be due to an increase in expression of 
plasma membrane DAT, as reported previously in cells subjected to low concentrations 
of cocaine (Kahlig and Galli, 2003, for review). Thus dopamine uptake during chronic 
treatment with cocaine could be preserved. Dopamine has been described to be 
cytotoxic to PC12 cells, inducing oxidative stress and apoptosis (Wang et al., 2005), in 
a process occurring through activation of NF-kB (Panet et al., 2001) or the SAPK/JNK 
pathway (Luo et al., 1998). Nevertheless, no evidences of changes in dopamine 
metabolization by MAO were found, as examined by the maintenance of DOPAC levels 
in cells exposed to cocaine (Figure 3.2.E). Importantly, the observed increase in 
cocaine-evoked dopamine release may be related to the behavioral sensitization 
induced by this drug (Williams and Steketee, 2005), which is defined by increased 
motor activity after repeated administration. 
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3.1.1.4.2 Amphetamine-induced dopamine depletion and 
amphetamine toxicity 
Chronic exposure to amphetamine induced dopamine depletion (Figure 
3.2.B,D). Nevertheless, acute amphetamine toxicity persisted in cells lacking dopamine 
(Figure 3.1), indicating that dopamine is not involved in amphetamine toxicity. In vivo 
studies demonstrated that amphetamine toxicity is associated with a decrease in 
striatal dopamine levels (Wagner et al., 1980), decreased tyrosine hydroxylase activity 
(Ellison et al., 1978) and loss of dopamine transporter activity (Saunders et al., 2000). 
Although toxic mechanisms caused by amphetamine have been largely associated with 
the dopaminergic system, a more general mechanism of toxicity for amphetamine was 
also described, which involves disruption of the mitochondrial potential due to the net 
positive charge of amphetamine (Davidson et al., 2001). In accordance, we have 
previously observed that acute exposure of PC12 cells to amphetamine (1 mM, for 96 
h) resulted in a decrease in intracellular ATP/ADP ratio (Oliveira et al., 2002).  
Moreover, increasing evidence suggest that amphetamine, or amphetamine 
derivatives, can have toxic effects in non-dopaminergic cells, such as cerebellar 
granule cells exposed in vitro to 4 mM methamphetamine or methylenedioxy-
methamphetamine (Jimenez et al., 2004) and rat medium spiny projection neurons in 
the striatum, upon in vivo exposure to 4 times 10 mg/kg d-amphetamine (Krasnova et 
al., 2005).  
 
3.1.1.4.3 Cocaine and amphetamine-induced partial 
resistance to H2O2 
Chronic cocaine treatment was shown to partially protect PC12 cells against 
H2O2-induced toxicity, despite the decrease in ATP (by ~28%), which reflects metabolic 
dysfunction. In contrast, chronic treatment with H2O2 completely prevented H2O2 acute 
toxicity, as evaluated by MTT reduction (Figure 3.1), cell morphology (Figure 3.3.A) 
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and ATP levels (Figure 3.3.B). Several mechanisms have been proposed to explain 
cellular adaptation to H2O2. Moderate concentrations of H2O2 (0.25 mM, for 24 h) 
increase the capacity of oxidant degradation by antioxidant enzymes, whereas lower 
concentrations (0.05 mM, for 24 h) block the signalling pathways triggered by toxic 
concentrations of H2O2 (1 mM) (Lee and Um, 1999). 
3.1.1.4.3.1 Involvement of antioxidant enzymes 
Our results showed that changes in energy metabolism and in the activity of 
antioxidant enzymes are involved in the chronic effects of cocaine and amphetamine 
and also H2O2.  
Chronic exposure to H2O2 induced an increase in GPx activity, statistically 
significant upon 3 and 4 weeks of exposure (Figure 3.4.A). This was expected because 
of the increased need to detoxify H2O2. Upon 1 week exposure to H2O2, GRed activity 
was also increased (Figure 3.4.B), decreasing to normal levels upon 2 weeks of 
exposure. This may be explained by an initial need to convert GSSG into GSH. The 
restoration of GRed activity suggests the maintenance of GSH/GSSG by other 
mechanisms. One possibility is the increase in GSH synthesis, which could account for 
the GSH needed to supply the increased activity of GPx observed at a later time point.  
Repeated exposure to H2O2 also caused a decrease in SOD activity (Figure 
3.4.C), upon 3 and 4 weeks of exposure, in agreement with what was described by 
Ramasarma (1990). This decrease paralleled the increase in GPx, suggesting that 
increased levels of H2O2 are then reduced to water. 
Energy levels, measured by the ratio ATP/ADP, were decreased upon 2 weeks 
of exposure (Figure 3.4.D), returning to normal levels upon 3 weeks. This may be 
explained by an increased need for ATP upon 2 weeks of exposure to support the 
changes in cellular activity that are mainly manifested upon 3 weeks of exposure to 
H2O2. After this initial energy-requiring phase, the cells became adapted to the 
presence of H2O2, which may account for the restoration of the energy levels. 
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Repeated exposure to cocaine induced an increase in GPx activity in PC12 
cells (Figure 3.4.A), statistically significant upon 4 weeks of exposure, one week later, 
compared with cells exposed to H2O2. GRed activity showed a tendency for a decrease 
upon 3 and 4 weeks of exposure to cocaine (Figure 3.4.B), in contrast with cells 
exposed to H2O2. Stimulation of GPx activity without a concomitant increase in GRed 
activity suggests an impairment of GSH regeneration by GRed. In this case, if GSH 
synthesis does not increase, stimulation of GPx activity may lead to GSH depletion. In 
accordance, total GSH was shown to decrease in the prefrontal cortex and in the 
striatum upon in vivo exposure to cocaine (Dietrich et al., 2005; Poon et al., 2007). 
Furthermore, the activity of SOD was not affected by cocaine (Figure 3.4.C). Together, 
these findings suggest that repeated exposure to cocaine is accompanied by the 
generation of H2O2, which activates GPx, thus helping to decrease endogenous levels 
of intracellular H2O2. Because SOD activity is not affected, intracellular H2O2 levels 
should be lower than the levels achieved upon direct exposure of cells to 10 μM H2O2. 
The differential effect of chronic exposures to cocaine or H2O2 in the activity of 
antioxidant enzymes may explain the partial resistance of cells chronically exposed to 
cocaine, when acutely exposed to H2O2. 
It was previously reported that in vivo cocaine exposure induced an increase in 
GPx activity in the prefrontal cortex and in the striatum (Dietrich et al., 2005). However, 
these authors also observed an increase in SOD activity in the same brain regions. 
These observations may be explained by the fact that the structures analysed are 
composed by several types of neurons, which may respond to the drugs in different 
ways. PC12 cells synthesize only dopamine, noradrenaline and acetylcholine (Shafer 
and Atchison, 1991) and, thus, the effects of the drugs of abuse in PC12 cells may only 
be mediated by these neurotransmitters.  
 
Repeated exposure to amphetamine induced an increase in GPx activity 
(Figure 3.4.A) and a decrease in GRed (Figure 3.4.B) and SOD (Figure 3.4.C) 
activities, after 3 weeks of exposure. However, upon 4 weeks of exposure to 
amphetamine, the activities of these enzymes returned to control levels. Similarly to the 
effects described for cocaine, these results may represent an initial increase in H2O2 
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production from dopamine metabolism, via MAO or auto-oxidation, which may explain 
increased activity of GPx. An increase in GPx activity and a concomitant decrease in 
GRed activity suggest GSH depletion and a decrease in GSH/GSSG. In accordance, 
an increase in GSSG was observed in the dopamine-rich caudate of human 
methamphetamine abusers (Mirecki et al., 2004).  
The fact that, upon 4 weeks of exposure to amphetamine the activities of GPx, 
GRed and SOD returned to control levels, suggests a decrease in H2O2 production 
upon 4 weeks of exposure to amphetamine. This may be explained by the inhibition of 
TH by amphetamine, decreasing the intracellular levels of dopamine (as observed in 
PC12 cells exposed to amphetamine for 7-12 months - Figure 3.2) and thus also 
decreasing H2O2 produced by dopamine oxidation. Amphetamine inhibition of MAO 
(Ramsay and Hunter, 2002) may also be more evident upon 4 weeks of exposure to 
amphetamine, further decreasing the H2O2 produced by MAO. The biphasic effect of 
amphetamine may explain the lower level of resistance of cells chronically exposed to 
amphetamine to acute H2O2 toxicity upon 7-12 months of exposure (Figure 3.1), in 
comparison with cells chronically exposed to cocaine. 
It was previously reported that exposure to amphetamine in vivo induced an 
increase in GPx in the striatum, NAc and prefrontal cortex (Carvalho et al., 2001). The 
same authors reported an increase in catalase and a decrease in GRed in the 
prefrontal cortex. Other authors reported that amphetamine exposure induced a 
decrease in SOD in the striatum and an increase in catalase in the prefrontal cortex 
and hippocampus (Frey et al., 2006b). The results of these studies are in accordance 
with the results of the present study. However, in the same studies, the reverse 
changes were observed in other brain regions such as the hypothalamus (Carvalho et 
al., 2001) and hippocampus (Frey et al., 2006b). Thus, drugs of abuse may induce 
changes in antioxidant enzymes through different mechanisms in distinct brain regions. 
 
Interestingly, the decrease in ATP/ADP observed upon 2 weeks of exposure to 
cocaine or amphetamine (Figure 3.4.D), was restored to control levels upon 3 weeks of 
exposure to the drugs of abuse or H2O2. This may be explained by an increase in 
energy demanding cellular activities upon 2 weeks of exposure, which may underlie 
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cellular adaptation to these stress conditions. Moreover, changes in the activity of 
antioxidant enzymes may help to recover the energy levels. 
 
3.1.1.4.3.2 Involvement of intracellular signalling pathways and energy 
metabolism 
H2O2 adaptation may involve increased translocation of NF-kB to the nucleus, 
which contributes to increased cell survival (Kim et al., 2001a), not involving an 
increase in Bcl-2 or Bcl-XL (Lee and Um, 1999). Another signalling pathway regulated 
by H2O2 is the SAPK/JNK pathway, which is activated by high concentrations of H2O2 
and suppressed by low adaptive concentrations of H2O2 (Kim et al., 2001b). The 
interference with these signalling pathways may confer increased cell resistance to 
H2O2, independently of an increase in the capacity of degrading H2O2 (Lee and Um, 
1999). Moreover, H2O2 adaptation induces cross-resistance to serum withdrawal and 
C2-ceramide by blocking their ability to activate the SAPK/JNK pathway (Kim et al., 
2001b). Acute H2O2 toxicity has been reported to involve the inhibition of ADP 
phosphorylation, namely through the inhibition of glyceraldehyde-3-phosphate 
dehydrogenase, in glycolysis, and the ATP-synthase complex, at the mitochondrial 
respiratory chain (Hyslop et al., 1988). This could account for the decrease in 
intracellular ATP levels observed in naïve PC12 cells and in cells chronically exposed 
to cocaine, following acute exposure to H2O2 (Figure 3.3.B). 
Furthermore, proteomic analysis showed that adaptation to low concentrations 
of H2O2 may induce upregulation of proteins involved in energy metabolism, such as 
ATP synthase and glyceraldehyde-3-phosphate dehydrogenase (Seong et al., 2002), 
which may explain the maintenance of intracellular levels of ATP (Figure 3.3.B). In 
addition, proteomic analysis also suggests that upregulation of translation and RNA 
processing, chaperoning and redox regulation may also be in the basis for adaptation 
to H2O2 (Seong et al., 2002).  
In cells chronically exposed to cocaine, H2O2 toxicity seemed to affect cell 
metabolism (Figure 3.3.B). Thus, the mechanism involved in the partial resistance of 
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these cells to acute H2O2 is certainly not related to stimulation of energy metabolism. 
Similarly to H2O2, chronic cocaine was also reported to induce the activation of NF-kB 
(Ang et al., 2001) and AP-1 (Lee et al., 2001), two transcription factors described to be 
activated under oxidative stress conditions. Thus the mechanism of partial resistance 
to H2O2 toxicity in cells chronically exposed to cocaine may possibly be explained by 
the activation of intracellular signalling pathways involved in the adaptation to H2O2, by 
low concentrations of cocaine. Nevertheless, high concentrations of cocaine induced 
toxicity in H2O2-treated cells, suggesting that toxic effects mediated by high 
concentrations of cocaine are unrelated to adaptive changes induced by oxidative 
stress. 
 
In conclusion, this study provides further data confirming functional alterations 
in dopaminergic cells chronically exposed to amphetamine or cocaine. We showed that 
chronic treatment with amphetamine induced dopamine depletion, which did not affect 
amphetamine or H2O2 cytotoxicity in these cells. Furthermore, exposure to cocaine 
increased the sensitivity to an acute cocaine exposure, along with cocaine-evoked 
extracellular dopamine accumulation, which may be related with increased motor 
activity after repeated administration of this drug of abuse (Williams and Steketee, 
2005). Moreover, in contrast to prolonged exposure to H2O2, chronic cocaine induced a 
partial resistance to H2O2-mediated cytotoxicity, which was not correlated with the 
maintenance of energy levels. These data suggest that distinct cellular mechanisms 
operate during prolonged exposure to cocaine or H2O2, implicating major changes in 
cell susceptibility. Moreover, oxidative stress, probably mediated by H2O2, is involved in 
the effects of exposure to sub-toxic concentrations of cocaine and amphetamine in a 
catecholaminergic cell line. Amphetamine seems to have a biphasic effect on oxidative 
stress, which may be due to the downregulation of TH and MAO activities. 
Furthermore, H2O2 resistance of PC12 cells chonically exposed to H2O2 involves 
adaptation to oxidative stress. 
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3.2.1.1 Abstract 
The repeated use of opiates and other drugs of abuse leads to drug 
dependence. The most studied mechanism involved in this process is the activation of 
the dopaminergic neurotransmission in the mesolimbic/ mesocortical pathway. 
Dopamine is potentially neurotoxic, due to the generation of ROS, namely H2O2, 
following its oxidative metabolism. In this work we evaluated the effect of chronic 
exposure of PC12 cells to street heroin or H2O2 upon an acute exposure to these 
compounds, in comparison with naïve PC12 cells. Cells chronically exposed to heroin 
or H2O2 were partially or totally resistant to an acute exposure to H2O2, respectively. 
This effect was related to the maintenance of ATP levels upon acute exposure to H2O2. 
Moreover, the viability of cells chronically exposed to heroin and H2O2 was highly 
affected by an acute heroin exposure. This sensitization may be related to the increase 
in extracellular dopamine accumulation induced by these compounds. On the other 
hand, acute exposure to heroin in cells chronically exposed to this drug was more 
cytotoxic than in cells chronically exposed to H2O2. This observation may be related to 
the decrease in intracellular levels of ATP and ADP induced by chronic exposure to 
street heroin. In summary, chronic exposure to street heroin induces changes in 
cellular energy levels, in extracellular dopamine levels and in the response to cytotoxic 
stimuli. Together, these observations reflect the harmful effects of repeated heroin 
abuse. 
 
Keywords: adenine nucleotides, cytotoxicity, dopamine, heroin, oxidative 
stress 
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3.2.1.2 Introduction 
The repeated abuse of drugs of abuse is responsible for the development of 
drug dependence. The most studied brain circuit involved in drug dependence, which is 
shared by the majority of the drugs of abuse, is the reward pathway. In this pathway 
dopamine neurons of the mesolimbic/mesocortical structures play a major role in 
mediating the effects of the drugs of abuse. The drugs interact directly or indirectly with 
these dopaminergic neurons, increasing dopaminergic neurotransmission (Di Chiara 
and Imperato, 1988). Dopamine is both a neurotransmitter and a neurotoxin. Oxidative 
metabolism of dopamine generates ROS, namely H2O2, which can originate the highly 
reactive •OH in the presence of transition metal ions. Thus, dopamine metabolism 
causes oxidative stress and cell death in dopaminergic and surrounding cells (Jones et 
al., 2000). In this context, acute exposure to H2O2 induces apoptotic cell death in PC12 
cells (Benedi et al., 2004; Jang and Surh, 2004), whereas cells chronically exposed to 
low concentrations of H2O2 become resistant to the acute toxicity of this compound 
(Wiese et al., 1995; Davies, 1999). Thus, H2O2 chronic treatment of PC12 cells with 
H2O2 has been considered to be a model of cell adaptation (Jackson et al., 1994). 
In this work we investigated the effect of chronic exposure of PC12 cells to sub-
toxic concentrations of street heroin or H2O2, in comparison with non-chronically 
exposed PC12 cells (naïve cells). The cells were subsequently treated with toxic 
concentrations of street heroin or H2O2 (acute exposure), in accordance with our 
previous work (Oliveira et al., 2002; Cunha-Oliveira et al., 2006b). The results suggest 
that chronic exposure to street heroin changes the capacity of PC12 cells to respond to 
cytotoxic stimuli, namely due to a compromise of the energy metabolism, induced by 
this drug. 
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3.2.1.3 Results 
In order to compare the effects of street heroin and H2O2 in the metabolic 
viability of naïve and chronically exposed PC12 cells we evaluated the capacity to 
reduce MTT. We observed that incubation with street heroin (300 μM) induced a 
decrease in cell viability, by about 30% in naïve cells, as previously observed (Oliveira 
et al., 2002). In cells previously exposed to street heroin, the same acute concentration 
of street heroin induced a decrease in cell viability by about 70% (Figure 3.5.A), 
suggesting a higher susceptibility of cells chronically exposed to street heroin, when 
exposed to a toxic concentration of the same drug. In cells previously exposed to H2O2, 
street heroin induced a decrease in cell viability by about 50% (Figure 3.5.A), reflecting 
a lower degree of sensitization to the toxic effects of street heroin, in comparison with 
cells chronically exposed to street heroin. As described in Chapter 3.1 in cells exposed 
to cocaine in these conditions, we could not compare the controls of chronically 
exposed cells by the MTT assay, since there were differences in cell proliferation along 
the time of cell adaptation to H2O2 or street heroin. Exposure to H2O2 (50 μM, for 24 h) 
induced a decrease in cell viability by about 70% in naïve cells, whereas in cells 
chronically exposed to street heroin the decrease in cell viability was of just about 40% 
(Figure 3.5.A). However, the increase in H2O2 concentration to 75 μM induced a 
decrease in metabolic activity of naïve cells by about 80%, in comparison with the 
control, whereas in cells chronically exposed to street heroin the decrease was of 
about 60% (Figure 3.5.A). The fact that in cells chronically exposed to H2O2 the acute 
exposure to the same compound did not induce a significant change in metabolic cell 
viability appears to represent a cellular adaptation to H2O2 in cells chronically exposed 
to a sub-toxic concentration of this compound. Interestingly, cells chronically exposed 
to street heroin are partially resistant to acute H2O2 (Figure 3.5.A).  
The acute exposure to H2O2 induced changes in cell morphology, as evaluated 
by May-Grunwald-Giemsa staining (Figure 3.5.B), leading to loss of membrane integrity 
and to the appearance of membrane blebs. In cells chronically exposed to H2O2, and 
subsequently exposed to acute H2O2, the morphology was similar to the controls, 
confirming the total resistance of these cells to H2O2. In cells chronically exposed to 
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street heroin, acute exposure to H2O2 induced some changes in cell morphology, when 
compared to the control (Figure 3.5.B). These changes were less evident than the 
changes observed in naïve cells, which is in accordance with the partial resistance 
suggested by the MTT assay. 
 
 
 
Figure 3.5: Analysis of cell viability of PC12 cells chronically exposed to street heroin and H2O2, before and 
after acute exposure to cytotoxic concentrations of these compounds. Naïve PC12 cells and 
PC12 cells chronically exposed to street heroin or H2O2 (for 7-12 months) were incubated with 
street heroin (0.3 mM, for 96 h) or H2O2 (50 or 75 μM, for 24 h). A) Cell viability was evaluated 
by the MTT reduction assay. Data were normalized in percentage of the respective controls. 
Data are mean ± SEM of at least 3 experiments performed in triplicate. ***P<0.001, compared 
with the respective control, ###P<0.001, compared with the same exposure in naïve cells. B) 
Cell morphology was analysed by staining cell smears using the May-Grünwald-Giemsa 
technique. Note the formation of membrane blebbings and cell shrinkage in naïve cells and in 
cells chronically exposed to street heroin, upon acute exposure to H2O2 (50 μM, for 24 h). 
Images are representative of 3 experiments performed in duplicate. 
3.2.1.3.1 Street heroin induced changes in energy 
metabolism 
Since H2O2 interferes with energy metabolism, we investigated if the partial 
resistance to H2O2 in cells chronically exposed to street heroin or the total resistance in 
cells chronically exposed to H2O2, would be related to changes in intracellular levels of 
the adenine nucleotides ATP (Figure 3.6.A) and ADP (Figure 3.6.B). We observed that 
acute exposure of naïve cells to H2O2 (50 μM) induced a decrease in intracellular ATP 
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levels (Figure 3.6.A). However, this decrease was not compensated by an increase in 
intracellular ADP (Figure 3.6.B) or AMP (not shown). Chronic exposure to street heroin 
induced a decrease in intracellular ATP (Figure 3.6.A) and ADP (Figure 3.6.B) levels, 
suggesting an energetic compromise induced by this drug of abuse. In these cells, 
acute exposure to H2O2 did not induce significant alterations in ATP levels, as 
observed in naïve cells, possibly explaining the partial resistance of these cells to H2O2, 
observed in Figure 3.5.A. In addition, and in accordance with the total resistance to 
H2O2, we did not observe significant alterations in intracellular ATP or ADP levels in 
cells cronically exposed to H2O2, before or after incubation with 50 μM H2O2 (Figure 
3.6). 
 
 
Figure 3.6: Analysis of intracellular ATP (A) and ADP (B) levels, before and after acute exposure to H2O2. 
Naïve cells and cells chronically exposed to street heroin or H2O2 were incubated with H2O2 
50 μM, for 24 h. The levels of adenine nucleotides were determined by HPLC with UV 
detection. Data correspond to mean ± SEM of 4 independent experiments, performed in 
triplicate. *P<0.05 and **P<0.01, compared to control naïve cells. 
3.2.1.3.2 Role of dopamine in heroin sensitization 
Because PC12 cells are a catecholaminergic cell line and dopamine is 
potentially neurotoxic, we investigated whether street heroin sensitization observed in 
cells chronically exposed to street heroin would be related with changes in intra- or 
extracellular dopamine levels (Figure 3.7). We observed that acute exposure to street 
heroin induced a decrease in intracellular dopamine levels (Figure 3.7.A) and in 
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parallel, an increase in extracellular accumulation of this neurotransmitter (Figure 
3.7.B), in all sub-cell lines tested. Moreover, chronic exposure to street heroin and 
H2O2 induced an increase in extracellular dopamine accumulation (Figure 3.7.B). Upon 
acute exposure to street heroin, extracellular dopamine accumulation in cells 
chronically exposed to H2O2 was significantly increased, when compared to naïve cells 
(Figure 3.7.B). This increase can be related to the increase (although non-statistically 
significant) of intracellular dopamine in these cells (Figure 3.7.A). No significant 
alterations in intracellular DOPAC levels were observed in any of the experimental 
conditions tested (data not shown). 
 
Figure 3.7: Analysis of intracellular (A) and extracellular (B) dopamine levels, before and after acute 
exposure to street heroin. Naïve cells and cells chronically exposed to street heroin and to 
H2O2 were incubated with street heroin (0.3 mM), for 96 h. Intra- and extracellular dopamine 
levels were analysed by HPLC with electrochemical detection. Data are the mean ± SEM of 3 
experiments performed in triplicate. *P<0.05 **P<0.01 and ***P<0.001 compared to the 
respective control. #P<0.05 and ###P<0.001 compared to naïve cells. n.s.= not significant. 
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3.2.1.4 Discussion 
In this work we showed that chronic treatment of PC12 cells with street heroin 
or H2O2 induced, respectively, a partial or total resistance to the acute H2O2 cytotoxicity, 
accompanied by maintenance of intracellular ATP levels, upon exposure to H2O2. Cells 
chronically exposed to street heroin showed higher susceptibility to an acute exposure 
to the same drug, in comparison with cells chronically exposed to H2O2. This fact can 
be related to the changes in energy metabolism in cells chronically exposed to street 
heroin, as evidenced by the decrease in intracellular ATP and ADP levels. In addition, 
extracellular dopamine accumulation seems to contribute to the susceptibility of cells 
chronically exposed to street heroin or H2O2, upon acute street heroin exposure, 
suggesting a cytotoxic role for dopamine.  
Cellular adaptation to H2O2 can be explained by two mechanisms. When 
present in low concentrations (0.25 mM for 24 h), H2O2 induces an increase in cellular 
antioxidant capacity, namely an increase in glutathione peroxidase expression (Lee 
and Um, 1999). Moreover, when present in low concentrations (0.05 mM for 24h), H2O2 
induces an adaptive process that may not to be associated with an increase in cellular 
antioxidant capacity. In these conditions, a blockade of cell signalling pathways 
involving nuclear factor kB (Kim et al., 2001a) or the stress activated protein kinase 
(SAPK/JNK) pathway (Kim et al., 2001b) can occur, which are usually activated by 
toxic concentrations of H2O2 (1 mM) (Lee and Um, 1999). Cellular adaptation induced 
by low concentrations of H2O2 may also be related with an increase in the expression 
of proteins involved in energy metabolism, such as ATP synthase (at the mitochondrial 
respiratory chain) and glyceraldehyde-3-phosphate (GAPDH, at the glycolytic 
pathway), as demonstrated by proteomic analysis (Seong et al., 2002). The increase in 
the expression of these enzymes may explain the maintenance of intracellular ATP 
levels and the consequent cellular resistance upon acute exposure to H2O2, in cells 
chronically exposed to H2O2 (Figure 3.6.A), but not in cells chronically exposed to street 
heroin, since these cells showed a decrease in the intracellular levels of adenine 
nucleotides (Figure 3.6). Proteomic analysis also suggests that H2O2 adaptation can 
Manuscript 2: Chronic effects of street heroin 
 
 114
induce an increase in the expression of proteins associated with RNA processing, 
chaperones and proteins involved in redox regulation (Seong et al., 2002). The acute 
toxicity of H2O2 can be related to the inhibition of ADP phosphorylation, namely by 
inhibition of ATP synthase or GAPDH (Hyslop et al., 1988). These data could explain 
the decrease in intracellular ATP levels observed in naïve cells upon acute exposure to 
H2O2 (Figure 3.6.A), similar to what was previously observed by other authors 
(Milusheva et al., 2003). In addition, the decrease in intracellular energy levels induced 
by street heroin may be related to the inhibition of oxidative phosphorylation, since 
previous studies reported that the heroin metabolite morphine inhibits ATP synthase 
and the ATPase from the inner mitochondrial membrane (Gegenava and Chistyakov, 
1975).  
Previous studies demonstrated that H2O2 exposure induces dopamine release 
in rat striatal slices (Milusheva et al., 2005). These authors suggested that H2O2 may 
interfere with dopamine reuptake and/or storage of dopamine in presynaptic vesicles. It 
was also demonstrated that H2O2 induces a reversible inhibition of the activity of the 
DAT present in the plasma membrane of dopaminergic cells, via a calcium-dependent 
redox regulation (Huang et al., 2003). Taking this into account, in our conditions the 
increase in extracellular dopamine accumulation upon chronic exposure to H2O2, may 
be explained by H2O2-induced inhibition of DAT. We have previously observed that 
chronic exposure to cocaine (a classic DAT inhibitor) in PC12 cells induced similar 
effects in extracellular and intracellular dopamine levels, when compared to chronic 
exposure to H2O2 (Figure 3.2). 
Interestingly, chronic exposure to street heroin also induced an increase in the 
extracellular levels of dopamine. Moreover, acute exposure to this drug reinforced the 
accumulation of extracellular dopamine in cells chronically exposed to H2O2, in 
comparison with cells chronically exposed to street heroin (Figure 3.7.B). Heroin 
exposure has been reported to cause oxidative stress when intraperitoneally injected in 
mice (Pan et al., 2005; Qiusheng et al., 2005). In previous studies, we observed that 
acute treatment of PC12 cells with street heroin induced a non-statistical increase in 
intracellular hydroperoxides that was correlated with an increase in intracellular 
DOPAC levels (Oliveira et al., 2002). These data suggested that the cytotoxic effects of 
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street heroin could involve an unbalance between the cellular levels of oxidants and 
antioxidants. Thus, the partial resistance to H2O2 observed upon chronic exposure to 
street heroin, as well as the increase in extracellular dopamine, may be due to some 
degree of adaptation to oxidative stress. 
Together, the present results show that prolonged exposure to 
catecholaminergic cells to street heroin induces an energetic compromise in these cells 
and an increase in the sensitivity to high concentrations of the same drug. However, 
these cells are more resistant to H2O2, suggesting adaptation to oxidative stress. These 
data are important may contribute to increase our knowledge on the molecular and 
cellular mechanisms involved in drug addiction. 
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3.2.2.1 Abstract 
Repeated use of drugs of abuse, namely opiates, has been shown to affect 
glutamate-releasing neurons. Moreover, blockade of NMDA receptors prevents cell 
death by apoptosis induced by morphine, a heroin metabolite. Thus, in this study we 
investigated the involvement of different NMDA receptor subunits in street heroin 
cytotoxicity. HEK293 cells, which do not express native NMDA receptors, were 
transfected with NR1/NR2A or NR1/NR2B subunits. As a control, cells were 
transfected with NR1 alone, which does not form functional channels. Incubation with 
street heroin for 24 h induced a dose-dependent decrease in cell viability both in NR1-
transfected and non-transfected cells. The loss of membrane integrity induced by street 
heroin was more evident in cells transfected with NR1/NR2B than in cells transfected 
with NR1 alone or NR1/NR2A. This decrease in cell viability was blocked by MK-801, a 
selective and non-competitive antagonist of NMDA receptors. Nevertheless, no 
significant changes in intracellular ATP were observed in cells treated with street 
heroin. These data implicate NR2B-composed NMDA receptors as important mediators 
of street heroin neurotoxicity.  
 
Keywords: cytotoxicity, drugs of abuse, HEK293 cells, heroin, NMDA receptors 
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3.2.2.2 Introduction 
The abuse of opiates and other drugs of abuse is associated with severe 
physical and mental health problems. These drugs interact with the CNS, inducing 
changes in the release of neurotransmitters, namely in the dopaminergic system. Many 
evidences also suggest the involvement of glutamatergic neurotransmission in the 
mechanisms of drug dependence involving the dopaminergic reward circuit in the brain 
(Tzschentke and Schmidt, 2003). On the other hand, some drugs of abuse, such as 
methamphetamine, are responsible for neurodegenerative mechanisms that lead to the 
irreversible loss of neurons, with the involvement of dopaminergic and/or glutamatergic 
systems (Ohmori et al., 1996). Under this perspective, street heroin is able to induce 
cell death in PC12 cells (Oliveira et al., 2002; Oliveira et al., 2003) and morphine, a 
heroin metabolite, induces cell death by apoptosis in the spinal cord (Mao et al., 2002) 
and in human cerebrocortical neurons (Hu et al., 2002).  
Among the processes leading to cell death, the excitotoxic mechanism, which 
involves the hyperactivation of ionotropic glutamate receptors, has been largely studied 
due to its involvement in ischemia and several neurodegenerative diseases (Rego and 
Oliveira, 2003). NMDA receptors have an outstanding role in excitotoxic processes, 
due to their high permeability to calcium, which is responsible for the activation of 
several intracellular enzymes, leading to mitochondrial dysfunction and cell death. 
NMDA receptors are composed by NR1 subunits which can interact with NR2 (A-D) 
subunits, and less frequently with NR3 (A,B). NR1 subunits contain the glycine-binding 
site, whereas the NR2 subunits contain the glutamate-binding site, conferring 
heterogeneity to these receptors. Previous studies demonstrated that NR2B subunits, 
which are mainly localized in extra-synaptic sites, are associated to increased toxicity 
in comparison with NR2A synaptic subunits (Hardingham et al., 2002).  
It was previously suggested that glutamatergic neurotransmission involving the 
NMDA receptor contributes to opiate dependence in humans (Bisaga et al., 2001). 
Moreover, the NMDA receptor antagonist MK-801 was shown to specifically block 
morphine tolerance and neuronal apoptosis in the spinal cord (Mao et al., 2002). In this 
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context, in this work we analysed the involvement of NR1/NR2A and NR1/NR2B 
subunits in street heroin cytotoxicity. 
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3.2.2.3 Results and Discussion 
Previously, we showed that street heroin induces a dose-dependent decrease 
in cell viability in PC12 cells (Oliveira et al., 2002) and in primary cortical neurons 
(unpublished results). In the present study we observed a dose-dependent decrease in 
metabolic viability after 24 h exposure to street heroin in both untransfected and NR1-
GFP transfected HEK293 cells (Figure 3.8).  
 
 
Figure 3.8: Analysis of cell viability in HEK293 cells exposed to street heroin. The viability of untransfected 
HEK293 cells and cells transfected with NR1-GFP was evaluated upon exposure to increasing 
concentrations of street heroin (10-1000 μM) for 24 h, by using the MTT reduction assay. Data 
presented as mean ± SEM of at least three experiments, performed in triplicate, were 
normalized in percentage of non-treated untransfected cells (control). Statistical analysis: 
*P<0.05 and ***P<0.001 compared to the respective untreated cells. 
 
The decrease in metabolic viability was statistically significant for both 
populations at a high street heroin concentration (1 mM). A decrease in cell viability 
was also observed in untransfected (p<0.05) and NR1-GFP transfected (non-
statistically significant) HEK293 cells exposed to 100 μM street heroin. This 
concentration of street heroin was used in the following experiments, because a 
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moderate decrease in cell viability was observed under these conditions. These results 
demonstrated that street heroin is toxic to HEK293 cells. Furthermore, expression of 
non-functional NMDA receptors (NR1) did not affect street heroin toxicity.  
 
Next we evaluated the effect of functional NMDA receptors, composed of 
NR1/NR2A or NR1/NR2B, on street heroin-induced toxicity. NMDA receptor expression 
in the non-neuronal cell line per se led to a non-statistical increase (approximately 5-
10%) in LDH release, indicative of some loss of membrane integrity (Figure 3.9).  
 
 
Figure 3.9: Analysis of plasma membrane integrity in HEK293 cells transfected with different subunits of 
the NMDA receptor upon acute exposure to street heroin. The cells were transfected with 
NR1/NR2A or NR1/NR2B subunits of the NMDA receptor or with NR1-GFP (transfection 
control) and exposed to 100 μM street heroin and/or 10 μM MK-801 for 24 h. The integrity of 
the plasma membrane was evaluated by the LDH leakage assay. Data were expressed as a 
percentage of total LDH and presented as mean±SEM of at least 3 experiments, performed in 
triplicate. Statistical significance: **P<0.01 as compared to NR1-GFP, #P<0.05 compared to 
the respective untreated cells and £££P<0.001 compared to street heroin-treated cells 
expressing NR1/NR2B. 
 
 
Exposure to street heroin (100 μM, for 24 h) did not significantly change 
membrane integrity of NR1-GFP or NR1/NR2A-expressing cells (Figure 3.9). However, 
NR1/NR2B transfected cells showed a significant increase in membrane permeability in 
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the presence of the drug (p<0.05), and this effect was completely prevented by the 
NMDA receptor antagonist MK-801 (Figure 3.9). The protective effect of MK-801 
suggests that activation of NR1/NR2B receptor is necessary for street heroin-induced 
increase in membrane permeability, because MK-801 is an open-channel blocker of 
NMDA receptors. Interestingly, NR1/NR2B subtype was previously linked to cellular 
demise that occurs both in an excitotoxic paradigm (Hardingham et al., 2002) and in 
Huntington´s disease (Zeron et al., 2002).  
Cellular energy deficits are often associated with NMDA receptor-mediated 
excitotoxicity. Overactivation of NMDA receptor leads to an excessive increase in 
intracellular calcium concentration, which is exacerbated by a dysfunction of calcium 
extrusion mechanisms. This has been suggested to occur as a consequence of 
mitochondrial dysfunction and resulting decrement in ATP production (Rego and 
Oliveira, 2003). Nevertheless, neither the presence of street heroin nor the expression 
of functional NMDA receptor subtypes, NR1/NR2A or NR1/NR2B, affected ATP 
intracellular levels significantly (Figure 3.10).  
 
Figure 3.10: Measurement of intracellular ATP levels in HEK293 cells transfected with different subunits of 
the NMDA receptor upon acute exposure to street heroin. Cells transfected with NR1-GFP 
(transfection control) or with the different subunits of the NMDA receptor (NR1/NR2A or 
NR1/NR2B) were treated as described in Figure 3.9. Intracellular ATP levels were analysed 
by HPLC with UV detection. Data were expressed as pmol/μg protein and presented as mean 
± SEM of at least 3 experiments, performed in triplicate. 
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Because intact cellular energy levels are needed for the prosecution of 
apoptotic cell death (Nicotera and Melino, 2004), we hypothesize that NR1/NR2B-
mediated increase in street heroin cytotoxicity is initially mediated through apoptosis, 
rather than necrosis. Later stages of apoptosis also involve an increase in membrane 
permeability (Schwab et al., 2002), explaining the loss of membrane integrity observed 
in Figure 3.9. However, the occurrence of necrotic cell death cannot be excluded 
because, as ATP levels are normalized over the protein content in each sample, 
intracellular ATP can be over-estimated due to the detachment of necrotic cells from 
the multiwells. Therefore, it is possible that a decrease in intracellular ATP occurs in 
the total population of cells, but not in the cells that remain attached to the multiwell 
and contribute to the determination of intracellular ATP levels. 
Taken together our results indicate that the NR1/NR2B subtype of NMDA 
receptors is a mediator of street heroin-induced cytotoxicity. Previously, chronic 
exposure to morphine, a heroin metabolite that can coexist in heroin solutions 
(Hutchinson and Somogyi, 2002), was reported to alter NMDA receptor subunit 
composition in rat NAc neurons. Neuroadaptation to chronic morphine exposure was 
shown to increase NR2A activity and decrease NR2B activity (Martin et al., 2004). In 
the present work we hypothesize that overactivation of NR2B-composed receptors is 
responsible for the deleterious cellular effects induced by street heroin. It is possible 
that the decrease in the activity of NR2B-composed NMDA receptors observed by 
Martin et al. (2004) is due to selective cell death of neurons exhibiting higher 
expression levels of this NMDA receptors subunit. In this case, these neurons may be 
more susceptible to toxic insults, similarly to what was reported in Huntington´s disease 
(Zeron et al., 2002). 
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mitochondrial dysfunction and 
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3.2.3.1 Abstract  
 Cortical function has been suggested to be highly compromised by repeated 
heroin self-administration. We have previously showed that street heroin induces 
apoptosis in neuronal-like PC12 cells. Thus, we analyzed the apoptotic pathways 
involved in street heroin neurotoxicity using primary cultures of rat cortical neurons. Our 
street heroin sample was shown to be mainly composed by heroin, 6-
monoacetylmorphine and morphine. Exposure of cortical neurons to street heroin 
induced a slight decrease in metabolic viability, without loss of neuronal integrity. Early 
activation of caspases involved in the mitochondrial apoptotic pathway was observed, 
culminating in caspase-3 activation, PARP cleavage and DNA fragmentation. Apoptotic 
morphology was completely prevented by the non-selective caspase inhibitor z-VAD-
fmk, indicating an important role for caspases in neurodegeneration induced by street 
heroin. Ionotropic glutamate receptors, opioid receptors and oxidative stress were not 
involved in caspase-3 activation. Interestingly, street heroin cytotoxicity was shown to 
be independent of a functional mitochondrial respiratory chain, as determined using 
NT-2 rho0 cells. Nonetheless, in street heroin treated cortical neurons, cytochrome c 
was released, accompanied by a decrease in mitochondrial potential and Bcl-2/Bax. 
Pure heroin hydrochloride similarly decreased metabolic viability but only slightly 
activated caspase-3. Altogether, our data suggest an important role for mitochondria in 
mediating street heroin neurotoxic effects.  
 
Keywords: Apoptosis, cell death, heroin, mitochondrial dysfunction  
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3.2.3.2 Introduction  
Heroin abuse has been associated with loss of impulse control (Pau et al., 
2002), a function of the frontal cortex associated with drug dependence. Furthermore, 
downregulation of μ-opioid receptors was reported to occur in the prefrontal cortex in 
human heroin addicts, as detected by post-mortem analysis (Ferrer-Alcon et al., 2004). 
Street heroin may contain different quantities of heroin and other components 
depending on its origin and on the method of illicit synthesis. Heroin is a semi-synthetic 
drug, obtained from acetylation of morphine. Heroin possesses little or no opioid 
activity (White and Irvine, 1999) but its metabolism, which may occur in vivo and in vitro 
(Hutchinson and Somogyi, 2002), generates 6-MAM and morphine, two μ-opioid 
receptor agonists (White and Irvine, 1999). Street heroin is illegally synthesized from 
morphine purified from opium extracts. Opium contains about 40 alkaloids that make 
up 10-20% of total opium substances. The most abundant opium alkaloids are 
morphine (8-17%), codeine (0.7-5%), thebaine (0.1-1.5%), papaverine (0.5-1.5%) and 
noscapine (narcotine, 1-10%) (Schiff, 2002). Upon illicit purification, morphine is often 
contaminated with other alkaloids, which may also suffer synthetic acetylation during 
heroin manufacture. Depending on the purification procedure, street heroin may 
contain some impurities (Moore et al., 1984), namely morphine and 6-MAM (heroin 
metabolites), codeine and acetylcodeine (Soine, 1986, for review). Heroin seized 
samples may also contain various inert diluents (starch, lactose, fructose, sucrose, 
mannitol, powdered milk) and active adulterants (caffeine, paracetamol, strychnine, 
acetylsalicylic acid, barbiturates, quinine and amphetamines) (Chiarotti et al., 1991; 
Sharma et al., 2005).  
Apoptotic cell death appears to be involved in the loss of neuronal function 
induced by opiates. We have previously shown that street heroin induces apoptosis in 
neuronal-like PC12 cells (Oliveira et al., 2002; Oliveira et al., 2003). Furthermore, 
morphine was described to induce apoptosis in neurons (Mao et al., 2002) and 
microglia (Hu et al., 2002).  
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Apoptosis may be initiated by the activation of the extrinsic and/or the intrinsic 
pathways. The extrinsic pathway is activated by death receptors in the cell membrane 
that further activate the initiator caspases 8 or 10 (Chen and Wang, 2002) and possibly 
caspase 2 (Zhivotovsky and Orrenius, 2005). The intrinsic pathway is initiated by an 
increase in mitochondrial membrane permeability, regulated by pro-apoptotic and anti-
apoptotic proteins of the Bcl-2 family, and associated with the loss of mitochondrial 
potential (ΔΨm) and the release of mitochondrial proteins to the cytosol (Scorrano and 
Korsmeyer, 2003). Among these proteins, the most studied is cytochrome c, which 
induces the formation of the apoptosome and the consequent activation of caspase-9. 
Caspase-2 may also trigger the intrinsic pathway (Enoksson et al., 2004). Initiator 
caspases activate effector caspases (such as caspases 3 or 6) that further induce 
degradation of cellular components (Fischer et al., 2003, for review). Caspase-3 
cleaves PARP, a protein involved in DNA repair, and activates DFF/CAD leading to 
apoptotic DNA fragmentation. However, apoptotic cell death may occur in a caspase-
independent manner (Kroemer and Martin, 2005). 
In this study we evaluate the neurotoxicity of street heroin in primary cultures of 
rat cortical neurons. As many drugs of abuse, such as amphetamines (Cunha-Oliveira 
et al., 2006a; Davidson et al., 2001, for review), cocaine (Cunha-Oliveira et al., 2006a; 
Nassogne et al., 1998, for review) or morphine (Mao et al., 2002; Hu et al., 2002), have 
been reported to induce neuronal apoptosis, we characterize the involvement of 
apoptotic pathways in the neurotoxicity of street heroin. Briefly, we show that street 
heroin, in a concentration that slightly decreases metabolic viability, promotes caspase-
dependent mitochondrial apoptosis, characterized by a downregulation of Bcl-2 and a 
loss of ΔΨm. The decrease in metabolic viability may be attributed to heroin itself, but 
caspase-3 activation may be due to drug-drug interaction in the cocktail of compounds 
that were identified in street heroin.  
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3.2.3.3 Results 
3.2.3.3.1 Street heroin dose-dependently affects cell 
viability 
Street heroin was shown to be composed by 62% heroin, 12% 6-MAM, 1% 
morphine, with trace quantities of codeine, acetylcodeine (less than 0.2% each), starch 
and caffeine, and other unidentified diluents and adulterants (about 25%). The results 
are in accordance with the data published by the U.S. Drug Enforcement 
Administration (DEA) which show that the purity of the majority of street heroin samples 
ranges from 10% to 70%.  
In order to define experimental conditions of moderate neurotoxicity, we 
performed a dose-response analysis of cell viability, following the MTT reduction assay 
(Figure 3.11.A) and the LDH release assay (Figure 3.11.B), after incubation with street 
heroin, for 24 h. Street heroin induced a dose-dependent decrease in metabolic 
viability, showing an IC10 value of 128 μg/mL, corresponding to 215 μM heroin, 47 μM 
6-MAM and 4.5 μM morphine. Under these conditions, plasma membrane integrity, 
determined by the LDH leakage assay, was maintained (Figure 3.11.B). The IC50 was 
calculated to be 500 μg/mL, corresponding to 840 μM heroin, 183 μM 6-MAM and 17.6 
μM morphine. Membrane integrity was only affected by high concentrations of street 
heroin (Figure 3.11.B), suggesting that, for concentrations up to 427 μg/mL, the 
neurotoxicity induced by street heroin is independent of necrosis. As the street heroin 
sample was not pure, we tested the effect of the identified components (pure heroin, 6-
MAM and morphine) on metabolic viability (Figure 3.11.C). While no toxic effects were 
induced by either 6-MAM or morphine, pure heroin induced a similar decrease in MTT 
reduction, compared to treatment with street heroin. Despite acetylcodeine and 
codeine were present in very low quantities in street heroin, we tested the effect of 
these compounds on neuronal viability, as acetylcodeine has been reported to be more 
toxic than heroin (Soine, 1986). Acetylcodeine (1-100 μM) did not significantly affect 
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cortical neuron metabolic viability, whereas codeine (10-30 μM) induced a slight 
decrease (by about 10%) in MTT reduction (not shown).   
 
 
 
Figure 3.11: Analysis of cell viability upon 
exposure to street heroin. Cortical neurons 
were incubated with increasing 
concentrations of street heroin (4,3 – 1280 
μg/mL), for 24 h, and the dose-dependent 
changes in cell viability were evaluated by A) 
the MTT reduction assay, which evaluates 
changes in metabolic viability, and by B) the 
LDH leakage assay, in order to analyze 
changes in membrane integrity. Data are the 
mean ± SEM of 3-5 experiments performed 
in duplicate or triplicate. The dotted line in A) 
represents the IC10 interpolation, 
corresponding to 128 μg/mL (215.2 μM 
heroin, 47.0 μM 6-monoacetylmorphine, 4.5 
μM morphine). Statistical significance: *P< 
0.001 as compared to the control. C) 
Analysis of cell viability upon exposure to 
pure heroin (215 and 840 μM), 6-MAM (47 
and 183 μM) and morphine (4.5 and 17.6 μM) 
using the concentrations found in street 
heroin, corresponding to IC10 and IC50. 
Statistical significance: *P< 0.05, ***P< 0.001 
as compared to the control.  
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3.2.3.3.2 Caspases of the mitochondrial apoptotic pathway 
are preferentially activated by street heroin 
We investigated the involvement of apoptotic signalling, namely caspases 
activation, induced by the concentration of street heroin corresponding to the IC10 
values determined in Figure 3.11.A. Initiator caspases of the mitochondrial pathway, 
caspases 2 and 9, were significantly activated after 12 h of street heroin exposure 
(Figure 3.12.A), whereas caspase-8 was only slightly activated at a later time point (24 
h), indicating that the extrinsic pathway was not involved in the initiation of the 
apoptotic cascade. Caspase-3 activity in cells treated with street heroin was 
significantly increased after 12 h exposure, when compared with the control (Figure 
3.12.A), and remained elevated up to 24 h. The activity of the effector caspase-6 only 
slightly increased in 24 h street heroin-treated cells (not shown). Proteolytic processing 
of caspases -9 and -3 was confirmed by western blotting (Figure 3.12.B,C). Forty-eight 
hours exposure to street heroin resulted in a massive cell death, as indicated by a large 
decrease in MTT reduction and a major decrease in caspase-3 activity (data not 
shown). Street heroin-induced increase in caspase-3 activity at 24 h was completely 
prevented in the presence of 1 µM z-VAD-fmk, a non-selective caspase inhibitor 
(Figure 3.12.D). Pure heroin (215 μM) only slightly activated caspase-3 (1.4 fold above 
the control, Figure 3.12.E), suggesting that caspase-3 may be further activated by 
other substances present in street heroin and/or that combination of street heroin 
components act synergistically to cause apoptotic cell death. 
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Figure 3.12: Caspases activation in cells incubated with street heroin. A) Time course analysis of caspase 
activation. Cellular extracts were tested for the activity of caspases 3, 9, 2 and 8, by 
determining the extent of cleavage of caspases substrates: Ac-DEVD-pNA, Ac-LEHD-pNA, 
Ac-VDVAD-pNA and Ac-IEPD-pNA, respectively. The cells were incubated with street heroin 
(IC10), for 1-24 h. Pro-caspases 3 (B) and 9 (C) processing, after 24 h of exposure to street 
heroin, was also examined by western blotting D) Complete inhibition of street heroin-induced 
caspase-3 activation in the presence of 1μM z-VAD-fmk. E) Caspase-3 activity upon 24 h 
exposure to 215 μM pure heroin, 47 μM 6-MAM or 4.5 μM morphine, corresponding to street 
heroin IC10. Data are the mean ± SEM of the fold increase above control absorbance values 
of 3 experiments performed in duplicate. Statistical significance: **P< 0.01, ***P<0.001 
compared to the control. 
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3.2.3.3.3 DNA fragmentation induced by street heroin is 
completely dependent on caspase activity 
According to data on Figure 3.12, caspase-dependent apoptotic cell death 
seems to be involved in the neurotoxic effects of street heroin. This was further 
evaluated by analyzing the occurrence of nuclear apoptotic morphology and PARP 
cleavage in cells treated with the drug of abuse (Figure 3.13). Street heroin induced an 
increase (by about 17%) in the number of cells showing fragmented or condensed 
DNA, as evaluated by nuclear staining with Hoechst 33342 (Figure 3.13). The number 
of cells showing immunoreactivity to PARP, cleaved on the caspase cleavage site, also 
increased (Figure 3.13.A), reflecting the activation of caspase-3. DNA fragmentation 
induced by street heroin was completely prevented by 1 µM z-VAD-fmk (Figure 
3.13.B), a concentration previously shown to prevent the increase in caspase-3 activity 
induced by street heroin (Figure 3.12.D). These data support an important role for 
caspases in the neurotoxic effects of street heroin. 
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Figure 3.13: Analysis of nuclear apoptotic morphology in cortical neurons exposed to street heroin. A) 
Immunocytochemical analysis of apoptotic morphology. Apoptotic cell death upon exposure to 
street heroin (IC10, for 24 h) was evaluated by labeling cleaved PARP, using a specific 
antibody (in green), and by nuclear morphology following Hoechst 33342 staining (in blue). B) 
Complete prevention of DNA fragmentation induced by street heroin, in the presence of 1 µM 
z-VAD-fmk. About 500-700 cells were counted per coverslip. Data are the mean ± SEM of 3-4 
experiments performed in duplicates. Statistical significance: ***P< 0.001 compared to the 
control, ###P< 0.001 compared to street heroin alone. 
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3.2.3.3.4 Caspase activation is not mediated by opioid or 
ionotropic glutamate receptors and appears to 
be independent of oxidative stress 
We further investigated the mechanisms leading to caspase-3 activation 
induced by street heroin by analyzing the involvement of opioid and ionotropic 
glutamate receptors and the contribution of ROS. The involvement of opioid receptors 
was determined by using a non-selective opioid receptor antagonist, naloxone, the μ-
opioid receptor antagonists, clocinnamox and CTOP, and the delta-opioid receptor 
antagonist, naltrindole (Table 3.1.A). Under these conditions, a partial prevention of 
caspase-3 activation was observed in the presence of naloxone (about 30%). Naloxone 
also prevented (by about 25%) the appearance of nuclear apoptotic morphology 
induced by street heroin (not shown). However, the selective opioid receptor 
antagonists did not significantly affect caspase-3 activity induced by street heroin. 
These data suggest that opioid receptors do not mediate street heroin neurotoxicity, 
and that naloxone may prevent caspase-3 activation, and apoptosis, by an opioid 
receptor-independent mechanism, as previously reported (Liu et al., 2002). 
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Table 3.1 Analysis of cellular mechanisms involved in caspase-3 activation in cells incubated with street 
heroin (IC10). 
 
A) The involvement of opioid receptors was investigated by testing the effect of a non-selective antagonist 
(1 μM naloxone) and antagonists of mu (1 μM clocinnamox and 1 μM CTOP) and delta (1 μM naltrindole) 
opioid receptors. B) The involvement of ionotropic glutamate receptors in caspase-3 activation was 
investigated using antagonists of NMDA (2 μM MK-801, 3 μM ifenprodil or 100 μM d-AP-5) and AMPA (10 
μM NBQX) receptors. C) The involvement of reactive oxygen species in caspase-3 activation induced by 
street heroin was investigated using antioxidants idebenone (3 μM), trolox (100 μM) and glutathione ethyl 
ester (100 μM GSH-EE). Data are the mean ± SEM of 3 experiments performed in duplicate. Statistical 
significance: **P< 0.01, compared to street heroin alone. 
 
Moreover, as apoptotic cell death frequently depends on excitotoxic events 
mediated by ionotropic glutamate receptors, and these receptors were reported to be 
present in embryonic cortical neurons (Babb et al., 2005), we also tested the effect of 
the NMDA receptor antagonists MK-801, ifenprodil and d-AP-5, and the AMPA receptor 
antagonist NBQX, in the activation of caspase-3 induced by street heroin (Table 3.1.B). 
The results indicate that ionotropic glutamate receptors are not involved in street heroin 
neurotoxicity, as the antagonists of NMDA or AMPA receptors did not prevent street 
heroin-induced caspase-3 activation. 
Because apoptotic cell death has been associated with oxidative stress we 
tested whether the antioxidants idebenone (a benzoquinone derivative of coenzyme 
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Q10), trolox (an analog of vitamin E) or glutathione ethyl ester (a cell-permeable form 
of reduced glutathione), protected against street heroin-induced apoptosis (Table 
3.1.C). None of the antioxidants tested prevented street heroin-induced caspase-3 
activation, indicating that oxidative stress is not involved in the apoptotic process 
induced by this drug of abuse.  
3.2.3.3.5 Street heroin induces cytochrome c release and 
mitochondrial dysfunction                    
Initiator caspases (2 and 9) activated by street heroin at early time points 
(Figure 3.12.A) have been largely associated with the mitochondrial apoptotic pathway. 
Thus we analyzed whether the release of cytochrome c and mitochondrial dysfunction 
contributed to the neurotoxic effects of street heroin. 
Analysis of cytochrome c release by immunocytochemistry (Figure 3.14.A) 
showed a decrease in co-localization between cytochrome c (labeled with a specific 
antibody) and the mitochondria (labeled with MitoTracker Green) upon treatment with 
street heroin, indicating a decrease in mitochondrial cytochrome c content. Street 
heroin-mediated release of cytochrome c to the cytosol was further evidenced by 
western blotting, showing a decrease in mitochondrial cytochrome c content (by about 
60%) and a consequent increase in the cytosolic fraction (Figure 3.14.B). An increase 
in mitochondrial permeability, responsible for cytochrome c release, has been 
associated with a decrease in ΔΨm. Thus, we evaluated the changes in ΔΨm, induced 
by street heroin (Figure 3.14.C), by following the cellular retention of rhodamine 123, 
described to be higher in cells maintaining ΔΨm (Palmeira et al., 1996). Our data 
suggest that exposure to street heroin causes a great decrease in ΔΨm (by about 55%).  
 
Because street heroin neurotoxicity involved mitochondrial dysfunction, we 
investigated the requirement of a functional respiratory chain. Thus, we analyzed street 
heroin neurotoxicity in NT-2 rho0 cells, which do not possess a functional electron 
transport chain (Cardoso et al., 2001), in comparison with NT-2 rho+ cells (Figure 
3.14.D). The toxicity of street heroin in NT-2 rho0 cells was not significantly different 
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compared to NT-2 rho+ cells, suggesting that street heroin neurotoxicity is independent 
of an interaction with a functional mitochondrial respiratory chain.  
Pro-apoptotic proteins, such as Bax, have been shown to mediate the release 
of cytochrome c, whereas anti-apoptotic proteins, such as Bcl-2, modulate the activity 
of pro-apoptotic proteins. Thus, we determined the total levels of Bcl-2 and Bax, by 
western blotting, after exposure to street heroin (Figure 3.14.E and F). We found a 
significant decrease (by about 37%) in Bcl-2 levels (Figure 3.14.E), without major 
changes in the levels of Bax (Figure 3.14.F) in cortical neurons treated with street 
heroin. These results indicate that street heroin induces a decrease in Bcl-2/Bax ratio, 
favoring the proapoptotic activity of Bax, which could help to explain the mechanism 
involved in cytochrome c release induced by street heroin. The fact that street heroin 
neurotoxicity seems to be independent of a functional mitochondrial respiratory chain, 
suggests that street heroin-induced decrease in ΔΨm in cortical neurons may be due to 
the formation of mitochondrial permeability transition or Bax-composed pores. As it was 
previously described that Bax channel inhibitors can block the decrease in ΔΨm 
induced by a pro-apoptotic inducer (Hetz et al., 2005), a decrease in Bcl-2/Bax may 
lead to mitochondrial permeabilization and consequent loss of ΔΨm. 
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Figure 3.14: Analysis of cytochrome c release and mitochondrial dysfunction after exposure to street 
heroin (IC10, for 24 h). A,B) Analysis of cytochrome c release from the mitochondria, by 
immunocytofluorescence (A), using MitoTracker Green to label the mitochondria (in green), 
and an antibody against the native form of cytochrome c (in red), or by western blotting (B) 
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using subcellular fractions corresponding to the same samples. C) Analysis of rhodamine 123 
(Rh123) retention capacity of cortical neurons after exposure to the drug of abuse. Rh123 
retention capacity was used to evaluate ΔΨm in cortical neurons incubated with street heroin 
(IC10). The cells were incubated with 1 µM Rh123, for 10 min. The fluorescence of the probe 
was recorded before (Fi) and after (Ff) cell permeabilization with Triton X-100. Rh123 
retention capacity was calculated by the difference: Ff - Fi. D) Analysis of street heroin 
cytotoxicity in NT-2 rho+ and rho0 cells by following the cellular capacity to reduce MTT after 
exposure to street heroin (IC10, 24 h). E,F) Analysis of total Bcl-2 and Bax levels, by western 
blotting. Images are representative of at least 3 experiments, performed in duplicate. 
Quantitative data are the mean ± SEM of at least 3 experiments performed in duplicate or 
triplicate. Statistical significance: ***P<0.001 compared to the control. 
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3.2.3.4 Discussion 
In this study we show that street heroin induces cell death by a mitochondrial-
dependent apoptotic pathway, initiated by caspases 2 and 9, and involving cytochrome 
c release, loss of mitochondrial potential and downregulation of Bcl-2. This process is 
not dependent on the activation of opioid or ionotropic glutamate receptors, nor is it 
dependent on oxidative stress. Due to the fact that the street heroin sample was a 
mixture, the effects observed in this study may be either due to heroin, or to the 
combination of street heroin components, which can act synergistically. 
Acetylcodeine has been reported to be more toxic than heroin (Soine, 1986). 
However, in our experimental conditions, acetylcodeine did not significantly affect 
cortical neurons metabolic viability, whereas codeine induced a slight decrease in MTT 
reduction, when used in higher concentrations than those achieved in street heroin. 
Noscapine (20 μM), another alkaloid present in opium extracts, has been shown to 
induce apoptosis in HeLa cells and thymocytes (Ye et al., 1998). In addition to opium 
substances, street heroin often contains some adulterants, namely paracetamol 
(acetaminophen), caffeine and theophylline (Zhang et al., 2004), which may also 
exhibit toxic effects. Very toxic adulterants are not usually detected in this type of 
samples because when present, they are found in very low concentrations (Chiarotti et 
al., 1991; Sharma et al., 2005).  
The mechanisms of cell death induced by heroin are largely unknown. Fecho 
and Lysle (2000) showed that heroin decreased the number of leukocytes in the rat 
spleen, which presented several apoptotic features, such as annexin V labeling and 
DNA fragmentation. In contrast, the cytotoxicity of morphine, a metabolite of heroin that 
may coexist in heroin solutions (Hutchinson and Somogyi, 2002), has been 
investigated by several groups. Hu et al. (2002) showed that morphine increased the 
number of apoptotic microglia and neurons. This process of cell death was blocked by 
naloxone and involved caspase-3 activation and DNA fragmentation. Other authors 
(Mao et al., 2002) showed that prolonged morphine administration increased rat spinal 
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neuronal apoptosis, with upregulation of caspase-3 and Bax, and downregulation of 
Bcl-2 in the spinal dorsal horn. The non-selective caspase inhibitor, z-VAD-fmk and the 
caspase-3 inhibitor Ac-DEVD-CHO blocked neuronal apoptosis induced by morphine. 
Moreover, in this study, the apoptotic pathway was reported to be mediated by the 
NMDA receptors (Mao et al., 2002). In another study, Yin et al. (1999) showed that 
morphine induced the expression of Fas and promoted Fas-L-mediated apoptosis of 
lymphocytes. This effect was blocked by naloxone, suggesting the involvement of the 
opioid receptors. Furthermore, Singhal et al. (2002) showed that morphine induced 
apoptosis of T-cells, with activation of caspases -3, -8 and -10 and PARP cleavage. 
This apoptotic pathway was reported to be mediated by c-Jun N-terminal kinase (JNK) 
activation. Together, these studies suggest that morphine is able to induce apoptosis in 
several cell types, including neurons, in a process mediated by opioid receptors. 
Another study (Jiang et al., 2003) showed that morphine, heroin and cocaine 
upregulate mouse double minute-2 (MDM2) in several brain regions. MDM2 is known 
for suppressing the activity of p53. Increased MDM2 may reflect an increase in p53 
activity induced by the drugs of abuse (Jiang et al., 2003). The neurotoxicity and 
apoptotic cell death induced by morphine were also suggested to be mediated by an 
increase in JNK3 expression (Fan et al., 2003). According to our results only pure 
heroin slightly contributed for caspase-3 activation and loss of cell viability, whereas 
morphine did not exhibit toxic effects. 
Cortical neurons were previously reported to express both μ and δ opioid 
receptors (Lee et al., 2002). In the present work, although we observed a reduction of 
caspase-3 activation (by about 30%) and a reduction in apoptotic nuclear morphology 
(by about 25%, data not shown) in the presence of naloxone, the involvement of opioid 
receptors in apoptotic cell death induced by street heroin was not corroborated by 
using specific opioid receptor antagonists (Table 3.1.A). Naloxone was previously 
shown to mediate neuroprotection independently of the interaction with opioid 
receptors (Liu et al., 2002). Moreover, the stereoisomer (+)-naloxone, which has no 
activity as an opioid receptor antagonist, effectively inhibits microglial activation and 
has been demonstrated to be neuroprotective (Liu et al., 2002). It was previously 
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suggested that naloxone could also directly interact with the nicotinic receptor (Tome et 
al., 2001). In our cellular model, street heroin’s neurotoxicity is largely independent of 
opioid receptors, and naloxone may prevent apoptotic cell death induced by street 
heroin by a mechanism independent of the interaction with opioid receptors. Morphine 
was previously reported to induce loss of ΔΨm in human glioma cells by a mechanism 
mediated by naloxone-sensitive receptors (Mastronicola et al., 2004). Thus, naloxone-
mediated neuroprotection observed in the present work may be related with the 
inhibition of street heroin-induced loss of ΔΨm. In addition to these results, the PKA 
activator forskolin (1-30 µM) was not able to prevent street heroin-induced caspase-3 
activation (data not shown), suggesting that the mechanism involved in apoptosis 
induced by street heroin is not dependent on PKA inhibition, which is known to occur 
upon activation of opioid receptors.  Moreover, the fact that opioid receptors are not 
involved in street heroin-induced apoptosis is in agreement with the lack of major 
apoptotic effects of the opioid components identified in our street heroin sample (Figure 
3.12.E). 
Ionotropic glutamate receptor activation, frequently associated with excitotoxic 
cell death, was not involved in street heroin-induced apoptosis either, because 
antagonists of the NMDA or AMPA receptors were not able to rescue caspase-3 
activation induced by heroin (Table 3.1.B). Moreover, nicotine, an agonist of the 
nicotinic acetylcholine receptor, previously shown to be neuroprotective in cortical cell 
cultures through a decrease in caspase activation and inhibition of apoptosis induced 
by oxygen deprivation (Hejmadi et al., 2003), did not prevent street heroin-induced 
caspase-3 activation, when used at 10-30 µM (data not shown).  
Other mediators of cell death involving mitochondrial dysfunction are ROS. 
Previously, other authors reported that in vivo exposure of mice to heroin induced 
oxidative stress (Pan et al., 2005; Qiusheng et al., 2005). However, in the present 
study the antioxidants idebenone, trolox and glutathione ethyl ester did not prevent 
street heroin-induced caspase-3 activation (Table 3.1.C), indicating that, in our 
conditions, an increase in ROS levels is not upstream of caspase-3 activation. In 
addition, although nitric oxide synthase activation has been reported to mediate 
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mitochondrial dysfunction and apoptosis in cortical neurons subjected to glutamate 
(Almeida and Bolanos, 2001), in this work the nitric oxide synthase inhibitors N-omega-
nitro-L-arginine methyl ester (100-500 μM L-NAME) or 7-nitroindazole (10-100 μM 7-
NI) were also unable to prevent street heroin-induced caspase-3 activation (data not 
shown). 
The time course of apoptotic events in this work suggests the activation of 
caspases 2 and 9 upon 6-12 h of street heroin exposure, resulting in the activation of 
caspase 3. Caspase-3 activity is also suggested by the occurrence of PARP cleavage 
and DNA fragmentation. In addition, upon 24 h exposure to street heroin, metabolic 
viability was decreased by about 10% but there were no evidences of changes in 
plasma membrane integrity, suggesting that necrosis was not involved at this time 
point. Although the mechanism underlying street heroin-induced apoptosis does not 
seem to involve the activation of plasma membrane receptors (opioid or glutamate 
receptors), it is likely to be explained by intracellular drug-drug interactions of one or 
more components of street heroin. This interaction is likely to be directed to Bcl-2 
expression and to the mitochondria, resulting in the downregulation of Bcl-2 and the 
loss of ΔΨm. These changes may help to explain cytochrome c release. Moreover, 
street heroin-induced loss of ΔΨm in cortical neurons was similar to that induced by 
amphetamine in cortical neurons (Cunha-Oliveira et al., 2006a), although activation of 
all of the caspases studied was more evident upon treatment with street heroin. 
Furthermore, a possible interaction of heroin (or other components of street heroin) 
with the mitochondria does not require a functional mitochondrial respiratory chain, 
since the drug was as toxic in NT-2 rho0 cells as in NT-2 rho+ cells.  
Concluding, we demonstrate the importance of the mitochondrial apoptotic 
pathway involving caspases activation in the neurotoxicity of street heroin, which may 
be caused either by the drug itself or by the cocktail of street heroin components that 
can act synergistically. 
Although further studies are required to determine the mitochondrial changes 
upon in vivo heroin administration, the intrinsic apoptotic pathway appears to be an 
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important target for neuroprotective strategies in heroin addicted individuals, for whom 
the use of impure heroin represents an increased neurotoxic risk.  
  
 
 
 
 
 
4 PART IV - CONCLUSIONS 
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In Part III, several functional alterations were observed in PC12 cells upon 
chronic exposure to amphetamine, cocaine and street heroin. PC12 cells chronically 
exposed to H2O2 were used as a model of cellular adaptation to oxidative stress. Some 
changes observed in cells chronically exposed to the drugs of abuse were comparable 
to those induced by chronic exposure to H2O2, suggesting a role of oxidative stress on 
the adaptation of catecolaminergic cells to the drugs of abuse. 
 
Chronic exposure to amphetamine caused dopamine depletion upon 7-12 
months of exposure. At initial time-points of chronic exposure to amphetamine 
alterations in the activity of antioxidant enzymes were observed, which returned to 
control levels after 4 weeks. Moreover, acute amphetamine toxicity was shown to be 
independent of dopamine and oxidative stress. Briefly, amphetamine exposure induced 
the following changes in PC12 cells: 
 
 
i. Dopamine depletion, suggesting long-term tyrosine hydroxylase inhibition; 
ii. Toxicity when incubated in dopamine-depleted cells, suggesting that acute 
amphetamine effects are independent of dopamine, and possibly mediated by 
mitochondrial dysfunction; 
iii. Toxicity in cells chronically exposed to H2O2, suggesting that acute 
amphetamine effects are independent of oxidative stress; and 
iv. Biphasic changes in the activity of the antioxidant enzymes GPx, GRed and 
SOD during initial chronic amphetamine exposure, indicating the involvement 
of oxidative stress mediated by H2O2, which tends to recover at a later time 
point possibly due to dopamine depletion and/or MAO inhibition. 
 
Chronic cocaine increased PC12 sensitivity to a toxic cocaine insult. Chronic 
cocaine also increased the resistance against acute H2O2 toxicity, although only 
partially, in contrast to the complete resistance of PC12 cells chronically exposed to 
H2O2, suggesting some degree of adaptation to oxidative stress. The incomplete 
adaptation to oxidative stress may be explained by differential effects of chronic 
exposure to cocaine or H2O2 on the activity of antioxidant enzymes, observed in early 
time-points of chronic exposure. However, acute exposure to cocaine was suggested 
Conclusions 
 
 152 
to be independent of oxidative stress. Briefly, exposure of PC12 cells to cocaine 
caused the following: 
 
 
i. Increased sensitivity to acute cocaine toxicity in cells chronically treated with 
cocaine; 
ii. Increased cocaine-evoked extracellular dopamine accumulation, which may 
explain increased motor activity in response to cocaine, upon repeated 
cocaine administration in vivo; 
iii. Toxicity in cells chronically exposed to H2O2, suggesting that acute cocaine 
effects are independent of oxidative stress; 
iv. Increased resistance to H2O2 acute toxicity, highly suggesting that chronic 
exposure to cocaine involves adaptation to oxidative stress; and 
v. Increased GPx activity, probably occurring as a consequence of enhanced 
H2O2 production. 
 
Chronic street heroin caused a decrease in energy levels that may underlie the 
observed increase in cellular sensitivity to acute street heroin treatment. Cells 
chronically exposed to street heroin exhibited a partial resistance against oxidative 
stress. The following changes were observed upon exposure of PC12 cells to street 
heroin: 
 
i. Decreased intracellular levels of ATP and ADP; 
ii. Increased toxicity upon acute exposure, probably mediated by an increase in 
extracellular dopamine accumulation; 
iii. Increased toxicity in cells chronically exposed to H2O2, suggesting that acute 
street heroin effects are independent of oxidative stress; and  
iv. Increased resistance against acute H2O2 treatment, suggesting adaptation to 
oxidative stress upon chronic exposure to street heroin. 
 
Furthermore, acute cytotoxic effects of street heroin were shown to be mediated 
by NR1/NR2B composed NMDA receptors in transfected HEK293 cells. In these cells, 
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the cytotoxic effects of street heroin involved loss of plasma membrane integrity, 
suggesting the occurrence of necrotic cell death.  
In rat primary cortical neurons, a concentration of street heroin that induced a 
mild decrease in metabolic cell viability, without loss of membrane integrity, was shown 
to induce apoptotic cell death, involving early caspase -2, -3 and -9 activation, and a 
late activation of caspases -6 and -8. Street heroin-exposed cortical neurons exhibited 
chromatin condensation and fragmentation, which were caspase-dependent. Apoptotic 
cell death induced by street heroin was mediated by the mitochondrial apoptotic 
pathway and involved mitochondrial dysfunction. However, NMDA-receptors were not 
involved in street heroin-induced apoptosis. This result suggests that NMDA receptors 
mediate more severe forms of street heroin cytotoxicity, involving loss of membrane 
integrity, probably associated with necrotic cell death. Briefly, acute street heroin 
toxicity was shown to involve: 
 
i. Increased toxicity in HEK293 cells expressing NR1/NR2B composed 
receptors, in comparison with cells expressing NR1/NR2A functional 
receptors; 
ii. Activation of the mitochondrial apoptotic pathway in rat primary cortical 
neurons showing: 
 
1. Decreased Bcl-2/Bax, cytochrome c release and increased activity of 
caspases associated with the mitochondrial apoptotic pathway; 
2. Prevention of apoptosis by the non-selective caspase-inhibitor z-VAD-fmk 
and by naloxone; 
3. Caspase activation independently of the activation of opioid receptors, 
ionotropic glutamate receptors or oxidative stress; 
4. Mitochondrial dysfunction, as determined by a decrease in mitochondrial 
membrane potential; 
5. Loss of metabolic viability similarly caused by pure heroin, but the latter 
was less efficient in activating caspase-3, highly suggesting that the use of 
impure heroin represents an increased neurotoxic risk. 
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In conclusion, drugs of abuse cause the dysfunction of PC12 cells and cortical 
neurons. Chronic and acute exposures to the drugs of abuse in dopaminergic cells 
involve neuronal dysfunction and neurotoxicity mediated by changes in dopamine 
levels. Increased oxidative stress may also underlie the chronic effects of these drugs 
in dopaminergic cells. Acute, severe, street heroin toxicity seems to be mediated by 
NR1/NR2B composed NMDA receptors, in transfected HEK293 cells. However, 
apoptosis evoked by a mild insult with street heroin in primary cortical neurons does 
not involve activation of NMDA receptors or oxidative stress. Hence, apoptotic effects 
of street heroin are mediated by mitochondrial dysfunction and are dependent on the 
activity of caspases. 
Moreover, we showed that chronic exposure to cocaine or street heroin may 
sensitize the cells for subsequent drug exposure, increasing drug toxicity, and 
contributing to further brain dysfunction that may potentiate the development of drug 
addiction. Chronic exposure to amphetamine caused dopamine depletion, which may 
contribute to long-term amphetamine effects, since dopamine mediates several 
important brain functions. 
Future therapies for drug addiction disorders should take into account the 
impact of the neurotoxic effects of these drugs. Oxidative stress and mitochondrial 
dysfunction are suggested as new targets for the development of future therapeutic 
strategies against drug addiction. 
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